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Total Synthesis of (–)-Dihydroprotolichesterinic Acid via a 
Diastereoselective Conjugate Addition, Development of Enantioselective 
Halocyclization Reactions, and Progress Towards the Total Synthesis of 
Jiadifenolide 
 
John Caleb Hethcox, Ph.D. 
The University of Texas at Austin, 2015 
 
Supervisor:  Stephen F. Martin 
 
In an effort to develop a unified route to functionalized succinic acid derivatives, 
a new diastereoselective conjugate addition of monoorganocuprates, Li[RCuI], to a chiral 
fumarate was developed. The conjugate addition proceeded with good yields and a high 
degree of diastereoselectivity for a variety of alkyl and aryl nucleophiles. Application of 
this new methodology culminated in the shortest total synthesis of (–)-
dihydroprotolichisterenic acid to date.  
The novel organocatalyst developed by the Martin group was applied to 
enantioselective iodolactonization reactions. Reaction conditions were optimized and the 
resulting halolactones were obtained in high yields and enantioselectivities for a number 
of olefinic acids. Of particular note is the disclosure of the first iodolactonization 
reactions forming a C–I bond at a stereogenic center. The utility of this catalyst was 
further extended to kinetic resolution reactions. Additionally, this catalyst was found to 
promote the first enantioselective halolactamization reaction with moderate 
enantioselectivity. Finally, the catalyst was modified in an effort to enhance the 
enantioselectivity and verify the proposed bifunctional nature of the catalyst. 
 viii 
Lastly, an enantiospecific total synthesis of the neurotrophic sesquiterpenoid 
natural product (–)-jiadifenolide was progressed. The stereochemistry was introduced by 
the use of commercially available (+)-pulegone as the starting material. The first 
diastereoselective decarboxylative allylation on a cyclopentanone was developed A 
samarium diiodide mediated radical annulation was planned to forge two of the rings, and 
late stage oxidation manipulation could then lead to the completion of the synthesis. 
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TOTAL SYNTHESIS OF (–)-DIHYDROPROTOLICHESTERINIC 
ACID VIA A DIASTEREOSELECTIVE CONJUGATE ADDITION 
Chapter 1: Strategies for the Synthesis of Enantioenriched Succinic 
Acid Derivatives and Select Total Syntheses of Succinate Based Natural 
Products 
1.1 BIOLOGICALLY ACTIVE SUCCINIC ACID DERIVATIVES 
Core structures based upon succinic acid (1.1) are prevalent motifs in a number of 
biologically active molecules of both natural and unnatural origin (Figure 1.1). The 
simplest members include disubstituted succinic acids, sphaeric acid (1.2) and rocellic 
acid (1.3).1,2 The paraconic acid family of natural products, including protolichesterinic 
acid (1.4), dihydroprotolichesterinic acid (1.5), and nephromopsinic acid (1.6) among 
others, show broad spectrum anti-fungal and anti-bacterial properties and serve as a 
common testing ground for developing methods to access chiral succinates.3 
Additionally, glaucoma treatment pilocarpine (1.7),4 matrix metalloproteinase inhibitor 
BB-1101 (1.8),5 and anti-viral agent antrodin D6 (1.9) are based on a chiral succinic acid 
core. In addition to serving as the core structure of these small molecules, functionalized 
succinic acid derivatives can serve as functionalized four-carbon building blocks for the 





Figure 1.1 Natural products based on a succinic acid core. 
Due to the near ubiquity of the succinate moiety, there has been a significant 
amount of work directed toward their synthesis.7 While numerous methods have been 
established to synthesize succinates as racemic mixtures, a number of recent advances 
have been made towards the synthesis of enantioenriched succinic acids. This review 
serves to cover the advances in asymmetric syntheses of succinates, and due to the 
numerous methods that have been developed over the years some have no doubt been 
overlooked. Previously, this topic was discussed in a 2002 review by Arason and 
Bergmeier wherein the synthesis of succinate derivatives was discussed in general with 


















































advances in the field of synthesis of enantioenriched succinic acid derivatives divided 
into sections based on the method of chiral induction (e.g. auxiliary or ligand) and 
subdivided by reaction type (e.g. aldol, alkylation, and conjugate addition). 
1.2  GENERAL STRATEGIES FOR THE SYNTHESIS OF ENANTIOENRICHED SUCCINATES  
1.2.1 Chiral Auxiliary 
Chiral auxiliaries have been broadly utilized as cheap, efficient, reliable, and 
recyclable sources of chirality for the synthesis of enantioenriched molecules. Thus, it 
should come as no surprise that they have been extensively explored for the synthesis of 
chiral succinates. Aldol reactions, alkylations, conjugate additions, hydrogenations, and 
oxidative enolate coupling reactions of substrates with removable chiral appendages have 
been developed to deliver enantioenriched chiral succinic acid derivatives.  
1.2.1.1 Aldol Reactions 
The first reported synthesis of a chiral succinic acid derivative via an asymmetric 
aldol reaction came in Evans’s seminal report on chiral oxazolidinones as a chiral 
auxiliaries for aldol reactions.8 In order to demonstrate that the method could tolerate a 
more complex substrate, chiral succinate 1.10 was subjected to his newly developed 
conditions (Equation 1.1). In the event, the boron enolate of 1.10 was exposed to 
benzaldehyde providing substituted succinate 1.11 in 67% as a single diastereomer. This 
pioneering work opened the door to a number of possibilities that would not be explored 







Sibi and co-workers picked up the development of this reaction, effectively 
demonstrating that the reaction tolerated the n-alkyl aldehyde myristaldehyde 
(tetradecanal). This reaction provided access to the paraconic acids protolichesterinic acid 
(1.4) and rocellaric acid (1.14) (Scheme 1.1).9 He also demonstrated the utility of this 
strategy using alkyl aldehydes for the synthesis of 3-amino sugars.10 
 
 
Scheme 1.1 Sibi’s diastereoselective aldol reaction in the synthesis of 1.4 and 1.14 
The next extension of Evans’s oxazolidinones in the enantioselective synthesis of 
succinates was disclosed by Jacobson in 1996, wherein the use of chiral imide 1.15 
provided access to tri-substituted hydroxy succinic acid derivatives 1.17 and 1.18 when 

























n-Bu2BOTf, Et3N; myristyl aldehyde




















stereochemical outcome at the position α to the imide as expected; however, the facial 
selectivity of the addition to the ketone was less selective (dr = 63:37–83:17). The 





Perhaps the greatest contribution to this field was the discovery of a tactic to 
modify the diastereoselectivity of the aldol reaction without using the enantiomeric 
auxiliary. Hajra demonstrated that simply changing the order of addition of base and 
aldehyde, led to diastereomeric products of the aldol reaction with succinate 1.12.12 As 
shown in Equation 1.3, standard conditions using n-Bu2BOTf or TiCl4 followed by base 
and then aldehyde provided the Evans syn-aldol product 1.19 in moderate yields with 
excellent stereoselectivity. Conversely, adding base to a mixture of succinate 1.12, Lewis 
acid, and aldehyde provided the Evans anti-aldol product 1.20 in similar yields with 
excellent stereoselectivity (Equation 1.4). It should be noted that this technique only 
worked with chiral succinates like 1.12, thus the authors propose a tetra-coordinate 
transition state to explain the anti diastereoselectivity (Figure 1.2). Finally, the authors 
























R1 = CH3, CH2Ph, (CH2)2Ph, (CH2)3Ph
R2 = CH3, CH2CH3, CH2Ph








two pseudo-diastereomeric natural products, phaeseolinic acid (1.22) and 
protolichesterinic acid (1.4), from a single starting material 1.12 (Scheme 1.2). This 












O n-Bu2BOTf or TiCl4
DIPEA; RCHO
CH2Cl2














































Scheme 1.2 Hajra’s synthesis of phaseolinic acid (1.22) and protolichesterinic acid (1.4) 
As a final example of auxiliary directed aldol reactions, Park and co-workers 
showed that succinate 1.24 could direct two aldol reactions via the bis-boron enolate 
(Scheme 1.3).15 Intermediate 1.25 underwent lactonization upon oxidation of the borate to 
provide bicycle 1.26 in 88% as a single isomer. Piperonal was the only aldehyde shown 
to be effective in this transformation. Nevertheless the method provided a high yielding 
and selective strategy to access C2-symmetric bicyclic lactones and resulted in the total 








































Scheme 1.3 Bis-aldol reaction and synthesis of wodeshiol (1.27) by Kim. 
1.2.1.2 Alkylations 
Fadel reported that various chiral imides 1.28 underwent alkylation with methyl 
bromoacetate in good yields and excellent diastereoselectivities (Equation 1.5).16 Indeed, 
Evans had previously reported one example of this transformation in his seminal 
publication on auxiliary controlled alkylation reactions with 1.28 (R = Me),17 but the 
systematic exploration of the steric and functional group tolerance by Fadel proved this 
reaction to be general for the synthesis of chiral mono-substituted succinic acid 
derivatives. The reaction even worked well on tert-butyl substituted imides 1.28 (R = t-
Bu). This methodology using chiral oxizolidinones was further explored and 
demonstrated to be useful for the synthesis of β-amino acids and lactone natural products 













































The Davies group reported a competing auxiliary in 1989, demonstrating that 
chiral succinoyl complex 1.30 could be alkylated with a variety of electrophiles with 
moderate yields and excellent diastereoselectivities (Scheme 1.4).24 The auxiliary could 
be cleaved with NBS in wet THF to reveal the chiral succinate. Unfortunately, the 
auxiliary is destroyed in this transformation and therefore not recyclable like Evans’s 
oxazolidinone.  The procedure provided the products in lower yields than the reaction 
using Evans’s auxiliary, but it does represent an alternate strategy for the synthesis of 
chiral succinates. Surprisingly, this method worked well with iso-butyl iodide, whereas 
the Evans protocol required more reactive electrophiles. In fact, the yields and 
selectivities for less reaction electrophiles were generally higher than with more reactive 
electrophiles, though the authors provided no comment on the reason for this. The group 


























Scheme 1.4 Davies’s asymmetric alkylation and application to (–)-actinonin (1.32) 
Davies later expanded upon this methodology in a two step procedure that 
allowed for the synthesis of disubstituted succinic acid derivatives.26 Using various chiral 
iron complexes 1.32, stereoselective alkylation with tert-butyl bromoacetate followed by 
stereoselective alkylation with methyl or allyl iodide provided disubstituted succinates 
1.33 in moderate yield with excellent diastereoselectivity for the two steps (Equation 
1.6). However, unlike their previous work, it is unclear whether or not this two-step 
















































R = Me, allyl, Bn, CH2Naph




















Crimmins reported an alternate strategy for the synthesis of disubstituted 
succinates wherein mono-substituted succinates 1.35, available with excellent 
stereoselectivity from 1.34 (vide supra), underwent further transformation to di-
substituted succinates 1.37 (Scheme 1.5). In the event, 1.35 was hydrolyzed using 
standard conditions to provide acid 1.36 in 91% yield. The key discovery was that the 
dianion of 1.37 could be alkylated with good diastereoselectivity  (>8:1) to provide trans-
disubstituted succinates 1.37. In order to increase the utility of this method, epimerization 
to the cis-disubstituted succinates 1.38 was explored; however, the diastereoselectivity 
was low and highly variable based on substitution. 
 
 















































The Decicco group disclosed an alternate strategy for the production of chiral 
disubstituted succinates, wherein a chiral imide 1.39 was alkylated with a chiral ester 
1.40 to provide disubstituted succinates 1.41 in moderate to good yields with excellent 
diastereoselectivity (Equation 1.7).27 The enantiomer of 1.40 could be successfully used 
to provide cis-disubstituted succinates epi-1.41 with similar yields and stereoselectivities. 
Although the reaction was tolerant of a wide variety of substitution on the imide, the 
yield was reported to decrease significantly for anything other than a methyl group on the 
α position of the ester. The major drawback of this transformation was that it required the 
synthesis of two chiral starting materials, whereas other strategies utilized the chiral 




Pohmakotr and co-workers disclosed a procedure for the enantioselective 
alkylation of vicinal dianions in 2004.28 Their technique relied on succinate 1.42, which 
was deprotonated with two equivalents of LDA prior to introduction of the electrophile. 
The substituted succinic acid derivative was isolated in moderate yield with excellent 
diastereoselectivity, and could be hydrolyzed to a chiral succinic acid 1.44 in 90% yield. 
Unfortunately, as one might predict, further manipulation of diacid 1.44 was problematic. 
Conversion to butyrolactones 1.45 and 1.46 via a three-step procedure delivered a 







THF, –78 ·C to 0 °C
60-88%














that a single R group next to one carbonyl group provided. Although the protocal 
delivered chiral acids 1.44 in moderate yield, reactions involving symmetrical starting 
materials like 1.42, would most likely have the most success in methods that make 
symmetric products like the aldol reaction by Kim (Scheme 1.3). 
 
 
Scheme 1.6 Synthesis of chiral succinates and application to butyrolactones by 
Pohmakotr 
The most recent development in the field was reported by Davies using chiral 
oxazinanones.29 This new auxiliary from Davies was prepared as part of their ongoing 
efforts to improve upon the chiral oxizolidinone auxiliary. In this report, they found that 
this auxiliary performed as well as the standard Evans’s chiral oxizolidinone in a number 
of alkylation reactions, including alkylation reactions that provided chiral succinates 
(Equation 1.8). One drawback to this method was that rather than starting from a 
commercially available amino acid, the enantioenriched β-amino acid derivative must 

















































1.2.1.3 Conjugate Additions 
In 1991, Curran and Rebek disclosed a radical mediated conjugate addition 
reaction to chiral fumarimide 1.48 (Equation 1.9).30 This unique auxiliary, which was 
available in six steps from Kemp’s triacid, was acylated with a fumarate derivative and 
treated with an alkyl mercuric halide and sodium borohydride to effect conjugate addition 
providing 1.49 in an average of 70% yield and up to 94:6 dr.  Unfortunately, only 
branched nucleophiles (tert-butyl mercuric chloride and cyclohexyl mercuric chloride) 
worked well, whereas the linear n-hexyl mercuric chloride delivered 1.49 (R = n-hexyl) 
in 42% yield and 82:18 dr. It was interesting to note that competition experiments 
between the fumarimide and diethyl fumarate suggested that the origin of the 
regioselectivity was not due to increased activation of the β carbon atom of the 














































Langlois has shown that simple succinic acid derivatives can be accessed via the 
conjugate addition of cyanide ion to conjugated oxazoles like 1.50 (Equation 1.10).31 
However, the reaction provided oxazoles 1.51 in only 50% yield with a disappointing 
73:27 dr. The substrate scope was not explored any further than 1.50 (R = Me or Ph), and 
even with a thorough screen of conditions, neither the yield nor diastereoselectivity could 
be improved. The conjugate addition adduct 1.51 could be hydrolyzed to succinic acid 




Sibi and co-workers developed a highly selective, radical-mediated conjugate 
addition to chiral fumarate 1.53 (Equation 1.11).20,32-38 In the presence of Sm(OTf)3, an 
alkyl halide (RX), tri-n-butyltin hydride, and triethylborane/oxygen, 1.53 underwent 
conjugate addition to provide 1.54 in greater than 80% yield and up to 100:1 dr. A major 
drawback to this method was the use of a full equivalent of Lewis acid and super 
stoichiometric amounts of alkyl halide, triethylborane, and tin. Unfortunately, this was 
required as without the excess alkyl halide, the ethyl radicals compete in the conjugate 
addition, and without the excess tinhydride to quickly quench the resulting radical, 
byproducts would arise. Despite the need to use excess reagents, Sibi has developed a 


























Unlike other radical conjugate addition reactions, which generally only proceed 
well with branched nucleophiles, Sibi’s conditions allowed for the use of n-alkyl halides. 
They could even install a methyl group using iodo chloromethane to provide a stabilized 
radical, followed by radical dehalogenation, a tactic they exploited in their synthesis of 
rocellaric acid (1.58) (Scheme 1.7).37 In the event, conjugate addition of the radical 
generated from iodo chloromethane provided 1.55 in 91% yield and greater than 100:1 
dr. Radical dehalogenation proceeded in 76% yield to give 1.56, treatment of which with 
tetradecanal under modified Evans’s conditions delivered lactone 1.57 in 64% yield; 
hydrolysis under standard conditions provided rocellaric acid (1.58) in 92% yield. Thus, 
Sibi successfully demonstrated the utility of their conjugate addition reaction, completing 
















CH2Cl2/THF (4:1),O2, –78 °C
>80%
up to 100:1 dr
R
1.54







Scheme 1.7 Synthesis of rocellaric acid (1.58) via radical conjugate addition by Sibi 
An alternate approach to generate radicals for these types of conjugate additions 
was reported by Fagnoni and Albini, who used light to generate the radicals (Equations 
1.12 and 1.13).40 They showed that dioxalanes could add to the chiral fumarimide 1.59 in 
moderate yields with excellent diastereoselectivity (Equation 1.12). They also 
demonstrated that photosensitizers (1,4-dicyanonaphthalene (DCN)/biphenyl (BP)) could 
be used in conjunction with alkyl and aryl stanananes to provide 1.61 in similar yields 
and selectivities (Equation 1.13). The reaction, though highly stereoselective, provided 
only moderate yields of the desired products. Additionally, as demonstrated with 
previous C2-symmetrical substrates, like 1.59, chemoselective elaboration of the two 





















































Another protocol to access chiral disubstituted succinates is the Michael addition 
of enolates to chiral alkylidene bis(sulfoxides) (Scheme 1.9).41 Through the use of this 
methodology, Fensterbank and Malacria realized a three-step synthesis of (+)-roccellic 
acid. The sequence began with the aforementioned conjugate addition reaction, which 
proceeded in 79% yield and complete stereocontrol to provide 1.63. Sequential 
Pummerer reaction and hydrolysis delivered roccellic acid (1.3) in 50% yield over two 
steps. Conjugate additions into conjugated sulfoxides like 1.62 were also high yielding 
and equally as diastereoselective for a number of other nucleophiles (e.g. amines, 



















































Scheme 1.9 Synthesis of roccellic acid via diastereoselective conjugate addition by 
Fensterbank 
A final example of preparing enantioenriched succinates via auxiliary directed 
conjugate addition reactions is the work of Davies, who has shown that his chiral iron 
based auxiliary could direct conjugate addition reactions (Equation 1.14).26 Chiral iron 
fumarate derivative 1.64 underwent conjugate addition when treated with a variety of 
alkyllithiums, vinyllithium, aryllithiums, or lithiated amines to provide chiral iron 
succinimide derivates 1.65 (Equation 1.14). The reaction provided low to moderate yields 
of the desired products with a range of stereoselectivities (4:1–99:1 dr). The reaction was 
developed as part of a broader effort to expand the utility of their iron-based auxiliary, 























































Nagano has shown that hydrogenation of chiral itaconates provided divergent 
access to both diastereomers of methyl succinate derivatives 1.67 and 1.68 (Equation 
1.15 and 1.16).42 After screening a number of chiral auxiliaries, they discovered that the 
chiral sulfonimide 1.166 provided the highest diastereoselectivity. Under hydrogenation 
conditions catalyzed by Crabtree’s catalyst, 1.66 was converted to 1.67 in 97% yield and 
6.4:1 dr (Equation 1.15). Conversely, under conjugate reduction conditions, using 
magnesium iodide and tri-n-butyltin hydride, the epimer 1.68 was recovered with 86% 
yield and 1:4.4 dr (Equation 1.16) The authors did not explore the scope of the reaction 
any further than itaconate derivatives, but they did lay the ground work for future 















Crabtree's catalyst (5.8 mol %)
























1.2.1.5 Oxidative Enolate Coupling 
In 2006, Baran reported an intermolecular oxidative enolate heterocoupling that 
provided access to chiral succinate derivatives (Equation 1.17).43,44 Baran and co-workers 
discovered that the lithium enolates of a chiral imide 1.69 and an ester 1.70 in the 
presence of a copper oxidant underwent heterocoupling to provide chiral succinates 1.71. 
Unfortunately, the reaction averaged only 50% yield across all of the substrates and there 
was little to no diastereoselectivity attained. Nevertheless they did manage to overcome a 





1.2.1.6 Summary  
The use of a chiral auxiliary is a classic strategy to access enantioenriched 
products, so it is no surprise that many methods have been developed around their use to 
access enantioenriched succinic acid derivatives. One downside to the auxiliary strategy 
is that classically, one would need to have both enantiomers of the chiral moiety on hand 
to access various enantio- and diastereomeric succinates. However, Hajra’s switchable 
aldol,45 Crimmin’s epimerization strategy,46 and Nagano’s hydrogenation42 provide hope 
for the development of a divergent strategy to access a multitude of chiral succinates 


























route to disubstituted succinic acid derivatives. As the auxiliary approach has already 
proved its efficiency in many cases with respect to yield and diastereoselectivity, further 
development of divergent methods to a multitude of products is likely the best way to add 
utility to this method.  
1.2.2 Chiral Lewis Acid Catalysts 
In an effort to move away from auxiliary controlled reactions, a number of chiral 
Lewis acid-mediated methods including aldol reactions, conjugate additions, and 
homologations have been explored to provide access to chiral succinic acid derivatives. 
While this area remains less developed than the chiral auxiliary strategies discussed 
above, these reactions lay the foundation for future work in the field. Despite the sparse 
examples, the reported methods provide access to enantioenriched succinic acid 
derivatives with good yields and stereoselectivities, obviating the need for a 
stoichiometric source of chirality in the process. 
1.2.2.1 Aldol 
Evans disclosed the first report of chiral Lewis acid catalyzed aldol reactions to 
form succinate derivatives in 1997. During the course of this study, Evans and co-
workers found that the copper complex 1.7247,48 and the tin complex 1.7349 both promoted 
the aldol addition of enol silanes to pyruvate esters to provide succinate derivatives with 
good yields and a high degree of both enantio- and diastereoselectivity (Equation 1.18). 
The reaction was limited to the use of thioester silylketene acetals 1.75, as silylketene 
acetals were shown to result in poor enantioselectivity (ca. 39% ee). Although this 




differentiating the two ester moieties in the product, which could improve selectivity in 
further transformations.  
 
 




In an effort to extend the utility of aminosulfoximines beyond their use as ligands 
in palladium catalyzed reactions,50 Bolm and co-workers found that aminosulfoximine 
1.77 was a suitable ligand for copper (II) triflate in aldol reactions (Equation 1.18).51 
They found that the reaction proceeded with good yields and high enantioselectivities for 
a variety of aldol reactions using thioester silylketene acetals like 1.78. Using a variety of 
pyruvate esters 1.79 (R = alkyl), alkyl substituted hydroxy succinate derivatives were 
synthesized in good yields with excellent stereoselectivity. The scope of the 



































E or Z (>90% pure)
R'' = H or alkyl






Therefore, unlike the conditions developed by Evans (Equation 1.18), this reaction 




In 2009, Pagenkopf disclosed a modified pybox ligand 1.81 for a copper catalyzed 
aldol reaction of pyruvate esters (Equation 1.20).52 The pybox ligand 1.81 effectively 
catalyzed the addition of silyl ketene acetal 1.82 to the aryl pyruvate esters 1.83. This 
reaction was noteworthy for extending the substrate scope of the reaction to aryl pyruvate 
esters, whereas the Evans protocol was only shown to work on alkyl pyruvates. 
Unfortunately, the authors found that 1.81 did not provide the same excellent 
stereoselectivity with alkyl pyruvates, instead providing a range of moderate 
enantioselectivities from 70–80% ee. Additionally, in contrast to the competing 
methodology, which only worked well thioester silyl ketene acetals, this reaction worked 
with a benzyl silyl ketene acetal, which also provides differentiation from the ethyl ester 














1.77 (10 mol %)

















1.2.2.2 Conjugate Addition 
Lewis acid-mediated conjugate additions to provide chiral succinates have also 
been disclosed. Evans discovered that the cationic nickel complex 1.88 promoted 
Mukaiyama-Michael additions to fumarate derivatives 1.86.53,54 A variety of silyl enol 
eithers 1.87 added with excellent yields and enantio- and diastereoselectivites to fumarate 
1.86 to provide chiral succinates 1.89 (Equation 1.21). While the reaction was amazingly 
selective, one draw back was the need to activate the system for Michael addition with an 
oxazolidinone. Ultimately, the oxazolidinone must be put on and removed, which leaves 
room to question why one would not just employ a chiral oxazolidinone instead. 
Nevertheless, Evans laid the foundation for future work in this area, and perhaps a chiral 
Lewis acid mediated conjugate addition to a simple fumarate derivative (e.g. diethyl 


































Sibi and co-workers have used a similar strategy for the conjugate addition of 
malononitrile (1.91) to fumarate derivative 1.90 (Equation 1.22).55 The resulting chiral 
succinic acid derivative was formed in 80% yield and excellent enantioselectivity (98:2). 
While this method was only reported to work with unsubstituted malanonitrile, it was 
only a preliminary investigation into what could be accomplished using ligand 1.92 to 
complex Lewis acids. With many more avenues to explore, it will be exciting to see what 
will be unveiled in the future. Like the Evans procedure, this method also required the 













R' = SMe, Ph or imid




up to 99:1 dr





























1.92 (11 mol %)

















Finally, to conclude the survey of methodologies that employ chiral Lewis acids, 
Feng reported an interesting homologation reaction to form chiral quaternary succinic 
acid derivatives 1.97 using the chiral ligand 1.96. (Equation 1.23).56 In the event, a wide 
range of aryl substituted pyruvate esters 1.94 and alkyl diazoesters 1.95 underwent 
reaction in the presence of 1.96 complexed with yttrium triflate to provide succinates 
1.97 in greater than 95:5 er. It should be noted that the method required the use of 
adamantyl-substituted diazoesters to achieve high enantioselectivity. Nevertheless, this 
remains a valuable and versatile method, and one of the few methods available for the 





While relatively little work has been reported in the field of enantioselective 
synthesis of succinic acid derivatives using chiral Lewis acids, the reactions that have 
been disclosed thus far laid the foundation for the development future methods. These 


































to excellent yields. All three of the types of reactions discussed are not without 
drawbacks, mainly in that they require an activating group of some kind, (i.e. 
oxazolidinone, adamantyl ester, thioester, etc.) to effect the desired transformation. 
Ideally, all starting materials would bear only the functionality wanted in the desired 
product, and the chiral catalyst would provide that product directly, without the need for 
the addition of functionality before and removal of the functionality after the reaction. 
1.2.3 Transition Metal Catalysis 
Given the ubiquity of transition metal catalysis in organic synthesis, it comes as 
no surprise that a number of transformations have been developed using chiral transition 
metal complexes to synthesize succinic acid derivatives.  Both conjugate addition 
reaction and reduction reactions have been developed to provide high enantioenriched 
succinates. 
1.2.3.1 Conjugate Addition 
The first transition metal-catalyzed, conjugate addition to provide chiral succinic 
acid derivatives was reported in 2004 using chiral norbornadiene 1.99.57 Hayshi and co-
workers demonstrated that di-tert-butyl fumarate underwent conjugate addition in the 
presence of 1.99, rhodium, and aryl boronic acids to provide aryl succinates 1.100 in 
good yields and up to 95:5 er (Equation 1.24). Furthermore, they established that this 
method was also applicable to maleimide 1.101, delivering the aryl succinimides 1.102 in 
similar yields and selectivities as the fumarate derivatives. However, the method was 
limited to aryl boronic acids; additionally, being that two carbonyls of the succinate 1.100 
and succinimide 1.102 are very similar, selective transformations of the material will 









Fillion successfully used phosphoramidite 1.104 in conjunction with copper 
triflate to perform conjugate additions of dialkyl zinc reagents to 1.103 (Equation 1.26).58 
The resulting adducts 1.105 were obtained in good yields and up to 90:10 er. The 
products 1.105 readily underwent reaction with primary amines to deliver chiral 
succinimides 1.106 in good yields (Equation 1.27). This method remains one of the few 
reactions to form succinic acid derivatives with a chiral quaternary center, but required 






1.99 (5.5 mol %)
[RhCl(C2H4)2]2 (2.5 mol %)
KOH (10 mol %)
ArB(OH)2
dioxane/H2O (10:1), 50 °C
78–90%














[RhCl(C2H4)2]2 (2.5 mol %)
1.99 (5.5 mol %)
KOH (10 mol %)
ArB(OH)2
dioxane/H2O (10:1), 50 °C
78–90%

















Utilizing a strikingly different substrate 1.107, Liao and co-workers reported a 
conjugate addition of aryl boronic acids to conjugated oxindoles 1.107 (Equation 1.28).59 
The reaction produced unique succinic acid derivatives 1.108 with excellent yields and 
good enantioselectivities for a range of aryl boronic acids. However, the 











1.104 (5 mol %)
R2Zn (200 mol %)
Cu(OTf)2 (5 mol %)
DME, –40 °C to rt
>88%
>90:10 er








































[RhCl(C2H4)2]2 (2.5 mol %)
(R)-BINAP (5 mol %)

















The Wu group disclosed a conjugate addition similar to that of Hayashi using 
1.109 as a ligand for the rhodium catalyzed conjugate addition of aryl boronic acids to 
fumarate 1.98 (Equation 1.29).60 The yields and enantioselectivities of the resulting 
succinate 1.100 were only slightly better than Hiyashi’s approach, which used ligand 1.99 
(Equation 1.24).  Wu attempted to solve the problem of ester differentiation with the use 
of 1.110 (Equation 1.30), but they found that while they did receive succinate 1.111 in 
59% yield with excellent enantioselectivity, 41% of the product was the regioisomer. 
Thus, while 1.111 could conceivably be transformed via chemoselective reactions, there 
was not enough bias in the starting material to achieve good regioselectivity in the 










1.109 (1.2 mol %)
[RhCl(C2H4)2]2 (0.5 mol %)


















[RhCl(C2H4)2]2 (0.5 mol %)
1.109 (1.2 mol %)














The latest transition metal catalyzed conjugate addition reaction reported thus far 
came from the Korenage group, who found that BIPHEP ligand 1.113 could provide 
succinimide derivatives 1.114 with great enantioselectivities (Equation 1.31).61 This 
reaction had previously been reported by Hiyashi using a different ligand, and while 
Korenga’s yields and selectivities are slightly better, there is no improvement in substrate 




Reductions of itaconates, malaeates, and succinates have also been explored as 
useful methods for the synthesis of enantioenriched succinic acid derivatives. Burk 
reported that the hydrogenation of itaconic acid derivatives 1.115 with a chiral rhodium 
complex delivered succinic acid derivatives 1.117 in greater than 96:4 er (Equation 
1.32).62 The reaction proceeded well for a range of substitution on the olefin; however, no 













1.113 (0.5 mol %)
















Zhang reported a similar hydrogenation of itaconic acid derivatives in 2003, 
wherein itaconates 1.118 were hydrogenated in the presence of a chiral rhodium catalyst 
to give 1.119 with excellent conversion and enantioselectivity (Equation 1.33).63 The 
reaction tolerated substitution at one of the acids (R = Me or H), which allowed for 
selective functionalization of the resulting succinates 1.119. The reaction proceeded with 
similar enantioselectivities for a range of unsubstituted, alkyl, and aryl substituted olefins. 






















[Rh(1.116)(cod)]BF4 (0.1 mol %)
MeOH, H2 (80 psi)
>99% conv.
>96:4 er










O[Rh(TangPhos)(nbd)]SbF6 (0.5 mol %)
THF, H2 (20 psi)
>99% conv.
>98:2 er1.118
R = H or Me
R' = H, i-Pr, p-MeO-C6H4, p-Me-C6H4, 






One year later, Almena and Börner reported a similar hydrogenation of 1.120 to 
provide 1.122 with good conversation and excellent stereo control (Equation 1.34).65 A 
similar reduction was also developed by Rutjes, using phosphoramidite ligands 1.124 and 
1.125 (Equation 1.35). 66 Both of these reactions provided the succinic acid derivatives in 
excellent enantioselectivities, demonstrating that a variety of ligands were effective in 
these transformations. However, the substrate scope among all of these transformations 
was similar with respect to substitution on the olefin and carboxylate moieties and 















R = H or Me
R' = H, i-Pr, Ph
[Rh(1.121)(cod)]BF4 (0.1 mol %)













Pfaltz demonstrated that maleates 1.127 underwent smooth hydrogenation to 
provide succinates 1.128 with excellent conversion and a high level enantioselectivity 
using a chiral iridium complex (Equation 1.36).67 The reaction worked well for a wide 
range of both akyl and aryl substituted maleates, but due to the similar reactivity of the 
two resulting esters, further transformations would most likely be difficult. An interesting 
observation was the conversion of a mixture of maleate and fumarate 1.130 converging to 
a single enantiomer 1.131 (Equation 1.37), thus allowing for the resolution of a mixture 








[Rh(cod)2]BF4 (1 mol %)
1.124 or 1.125 (2 mol %)























Although transition metal catalysis has proved to be a reliable method in organic 
synthesis, the utility of these transformations for the synthesis of succinic acid derivatives 
remains underdeveloped. While a number of ligand and metal combinations have been 
reported, ultimately all of the substrates and products are similar. Further developments 
of these technologies are needed to widen the substrate tolerance of these reactions in 
order to solidify the usefulness of these transformations in this specific field. 
1.2.4 Organocatalysis 
Enantioselective methods to access succinic acid derivatives have also been 
developed using organocatalysis as a method to move away from stoichiometric sources 




[Ir(cod)1.129]BArF (1 mol %)









[Ir(cod)1.129]BArF (1 mol %)




















the early stages of development, these methods demonstrate the feasibility of chiral 
succinate syntheses with organocatalysts.  
1.2.4.1 Aldol 
Lattanzi and co-workers developed an enantioselective aldol reaction with β-keto 
esters 1.132 to provide lactones 1.135 in good to excellent yields and enantioselectivities 
(Equation 1.38).68 The reaction using chincona derivative 1.133 in only 3 mol % 
generated a stereogenic quaternary center for a wide range of aryl substituted ketones as 
well as for n- and iso-propyl-substituted ketones. Besides the highly variable 
enantioselectivities, the reaction required the use of the dimethylphenyl ester moiety or 
the enantioselectivity suffered tremendously. Nevertheless, the reaction provided a chiral 
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1.2.4.2 Conjugate Addition 
Conjugate addition reactions promoted by chiral organocatalysts have received 
more attention than aldol reactions; however, while a range of possible catalysts has been 
explored, the substrate scope remains fairly limited. Yuan disclosed the first 
organocatalyzed conjugate addition of this kind in 2011.69 Using chiral thiourea 1.138, 
they found that cyanoester 1.136 added to maleimide 1.137 to deliver chiral succinates 
1.139 in excellent yields, diastereoselectivities, and enantioselectivities (Equation 1.39). 
The reaction provided similar selectivities with a range of substitution on the aryl 




This reaction was also shown to work with catalyst 1.142 by Xu and Wang 
(Equation 1.40).70 Tao demonstrated that catalyst 1.144 could perform this same reaction 
with similar yields and selectivities (Equation 1.41).71 Tao also found that the related 
catalyst 1.148 could perform the reaction using aldehydes (Equation 1.42).72 Finally, Shi 
demonstrated the utility of chincona derived catalyst 1.149 in a similar transformation 

































































































































Like transition metal catalysis, the field of organocatalyzed reactions remains 
underdeveloped in the context of the synthesis of chiral succinates. The substrate scope 
for the variety of catalysts remains narrow. Significant development is needed in this 
field to fully realize the potential for organocatalyzed synthesis of succinic acid 
derivatives.  
1.2.5 Resolution 
Resolution of racemic succinic acid derivatives remains a valuable tool for the 
preparation of enantioenriched succinates. Toward this end, Gotor found that Candida 
antarctica lipase could resolve a simple succinate derivative 1.150 to succinimide 1.151 
in good yield and excellent enantioselectivity (Equation 1.44).74 While this 
transformation was not applied to more complicated substrates, this report did provide the 


































Perhaps the most versatile resolution reaction came from Bailey in 1999.75 Using 
Alcalase®, rac-1.152 was selectively hydrolyzed to provide 1.154 in 47% yield and 99:1 
er (Equation 1.45). The unreacted 1.153 was epimerized and resubjected to the resolution 
to further increase the yield of 1.154 over multiple cycles. This method was reported to 
work for a wide range of substituted succinic acids derivations and was showcased in the 




In 2001, Deng and co-workers found that a modified Sharpless ligand ((DHDQ)2-
ACN) performed the selective alkanolysis of rac-1.155 to provide mono-esters 1.156 and 
1.158 in good enantioselectivities (Equation 1.46).77 The reaction worked for a number of 
alkyl and aryl substituted succinic anhydride derivatives with similarly high yields and 















































two simultaneous enantioselective and divergently regioselective reactions occurred 




Ultimately, while the resolution reported by Bailey allowed for the recycling of 
the unwanted enantiomer, a dynamic kinetic resolution would prove most useful in this 
field. Perhaps a future report will disclose an even more efficient resolution of racemic 
succinic acid derivatives, or even a dynamic kinetic resolution. Additionally, a number of 
other methods have found the synthesis of enantioenriched succinic acids via resolution 
to be difficult.78,79 
1.2.6 Summary 
As discussed, it is obvious that the most versatile strategies to reliably provide 
enantioenriched succinic acid derivatives rely on the use of a chiral auxiliary for 
stereocontrol. However, while most of the auxiliaries can be recycled and for the most 
part provide good yields and enantioselectivities, the synthetic community is moving 
away from stoichiometric sources of chirality. Nevertheless, there is still chemistry to 
explore in this area, namely the further development of methods to allow for the 
divergent access to multiple products from a single diastereomer, which would add value 































In the context of future directions, most research groups will likely focus on 
catalytic transformations. This could be accomplished with chiral Lewis acid catalysts, 
organocatalysts, transition metal catalysts, or enzymes. Unfortunately, for Lewis acid 
catalysts, one current drawback is the necessity for a functional group to activate the 
system. While this does allow the transformation to take place and removes the need for a 
stoichiometric source of chirality, it still suffers a similar drawback in that a functional 
group must be appended prior to the reaction and then removed afterward.  
Transition metal catalysts, though they have proven extremely effective for a 
number of other transformations, still fall short in the synthesis of succinates. Future 
studies should most likely explore substrate tolerance rather than rehash the same 
substrates with new ligands. In summary, many avenues for improving the 
enantioselective synthesis of functionalized succinates exist. With the continuing 
development of catalysis technologies, it is only a matter of time until efficient methods 
are developed for the synthesis of succinates. Until then, auxiliary based approaches 
remain the most reliable tactic for the synthesis of enantioenriched substituted succinic 
acid derivatives. 
1.3 TOTAL SYNTHESES OF SELECT SUCCINATE DERIVED NATURAL PRODUCTS 
1.3.1 Select Syntheses of Pilocarpine (1.7) 
1.3.1.1 Isolation and Overview of Syntheses 
Pilocarpine (1.7) (Figure 1.4) was first isolated in 1875 by Hardy and Gerrard 
from a South American tree, Pilocarpus jaborandi.4,80 Pilocarpine has been shown to be 
useful as a parasympathetic system stimulant as well as a diaphoretic and miotic agent. 




glaucoma.  There are currently ten total syntheses81-88 and three formal syntheses of 
pilocarpine.89-91 In order to provide a concise survey and provide comparison for our own 
work in the field (vide supra), this section will only highlight the shortest total synthesis 
of pilocarpine (1.7) reported to date by Büchi as well as a formal synthesis by Zhang 
which would result in the lowest total step count to the natural product to date. 
 
 
Figure 1.4 Pilocarpine 
1.3.1.2 Büchi’s Total Synthesis of (+)-Pilocarpine (1.7) 
The total synthesis of 1.7 by Büchi began with the oxidation of commercially 
available 1.159 to butenolide 1.162.85 This sequence proceeded through selenide 1.160, 
which was prepared in 94% yield. Unfortunately, they found that direct oxidative 
elimination of 1.160 to 1.162 could not be achieved, because the product was not stable 
to the reaction conditions. In a clever work around, performing the oxidative elimination 
in the presence of cyclopentadiene provided Diels-Alder adduct 1.161 in 78% yield. 
Flash vacuum pyrolysis of bicycle 1.161 afforded butenolide 1.162 in 95% yield.  
To set the absolute stereochemistry, enantioselective reduction of 1.162 using (+)-
diisopinocamphyl chloroborane ((+)-(Ipc)2BCl) provided enantioenriched alcohol 1.163 









providing aldehyde 1.164 with no erosion of enantioselectivity. Hydrogenation of the 
enone provided the penultimate intermediate 1.165 in 59% yield, which upon imidazole 
formation using the van Leusen protocol delivered pilocarpine (1.7) in 61% yield. 
The synthesis required a series of seven steps to deliver pilocarpine (1.7) in a 7% 
overall yield. The synthesis resulted in a solution to the long-standing problem of the 
oxidation of 1.59 to 1.162, but due to the moderate yields across the last four steps, the 
overall yield suffered.  
 
 






















































1.3.1.3 Zhang’s Formal Synthesis of (+)-Pilocarpine 
Nine years later, Zhang improved upon the synthesis by Büchi using a rhodium 
catalyzed Alder-ene reaction of allyl ynoates they had developed.91 The requisite 
substrate for this transformation was synthesized in one step from 2-butynoic acid (1.166) 
to provide 1.167 in 90% yield (Scheme 1.11). Treatment of the ynoate with a chiral 
cationic rhodium complex delivered lactone 1.164 in 99% yield and 98% ee. Thus, by 
extrapolation, Zhang could complete pilocarpine (1.7) in a total of four steps and a 32% 
overall yield. This route is currently the shortest route to 1.7 reported to date. 
 
 
Scheme 1.11 Formal synthesis of pilocarpin (1.7) by Zhang 
1.3.2 Lee’s Total Synthesis of Antrodin D (1.9) 
Antrodin D (1.9) (Figure 1.5), also known as camphorataimide E, is a succinimide 
based natural product first isolated from Antrodia cinnamomea and Antrodia 
camphorata, fungi that grow solely in the heartwood of the tree Cinnamomum kanehirai.6 
The fungus has historically been used as an anti-cancer, anti-itching, anti-fatigue, and 
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against MRSA,92 HBV, and HCV.93 To date, only one total synthesis of the product has 
been completed by the Lee group.94 
 
 
Figure 1.5 Antrodin D 
The synthesis began with the preparation of cross coupling partner 1.170 from 
succinic anhydride (1.168) (Equation 1.47), whereupon treatment with bromine followed 
by benzylamine delivered bis-bromo maleimide 1.169 in 76% yield over two steps. 
Finally, copper mediated coupling of isobutylmagnesium bromide gave the desired 

































Next, the complementary cross coupling partner 1.173 was synthesized (Scheme 
1.12). Prenylation of p-bromophenol (1.171) proceeded smoothly to give 1.172 in 
quantitative yield. Stannylation of 1.172 via the lithiated arene delivered stannane 1.173 
in 96% yield. The stage was then set for the next cross coupling reaction.   
 
 
Scheme 1.12 Synthesis of coupling partner 1.173 
In the event, 1.170 and 1.173 were coupled in the presence of palladium 
tetrakis(triphenylphosphine) to give disubstituted maleimide in 94% yield (Scheme 1.13). 
Next, the imide was hydrolyzed to the anhydride and treated with ammonium acetate to 
provide unprotected maleimide 1.175. Reduction of the olefin with nickel boride 
delivered succinimide 1.176 in 75% yield as a mixture (2:1) of diastereomers. Finally, 
protection of the nitrogen atom with Boc anhydride followed by reaction with 
hydroxylamine furnished the target compound 1.9 in 72% yield over two steps. 
Lee thus completed the first and only synthesis of antrodin D (1.9) in eleven steps 
with a 12% overall yield. The synthesis hinged on the sequential cross coupling reactions 



















manipulation of the benzyl protected imide to the hydroxylimide required a total of four 
steps. Additionally, the reduction to succinimide 1.176  was poorly selective providing the 
product as a mixture (2:1) of diastereomers. While the synthesis managed to complete the 
product, this route leaves room for improvement in both yield and overall step count.  
 
 
Scheme 1.13 Synthesis of antrodin D (1.9) by Lee 
1.3.3 Total Syntheses of Dihydroprotolichesterinic Acid (DHPLA) 
1.3.3.1 The Paraconic Acid Family of Natural Products 
The paraconic acid family of natural products comprises roccellaric acid (1.14), 
nephrosteranic acid (1.6), dihydroprotolichesterinic acid (1.5), phaseolinic acid (1.177), 
nephromopsinic acid (1.178), protolichesterinic acid (1.4), and methylenolactocin (1.179) 
among others (Figure 1.6).95 These natural products have been shown to exhibit anti-








































they have received a lot of attention from the synthetic community as a platform to 
demonstrate stereocontrol in a number of methodologies.3 Dihydroprotolichesterinic acid 
(1.5) had been synthesized five times prior to our work in the field.96-100 
 
 
Figure 1.6 Representative members of the paraconic acid family of natural products. 
1.3.3.2 Mulzer’s Synthesis of (–)-Dihydroprotolichesterinic Acid 
The first total syntheses of both DHPLA (1.5) and roccellaric acid (1.14) were 
completed by Mulzer in 1993 (Scheme 1.14).96 The synthesis commenced from enoate 
1.180, which was available in two steps from (R)-glyceraldehyde. Enoate 1.180 was 
reduced and protected as a benzyl ether to provide olefin 1.181 in 75% yield over two 
steps. Removal of the acetonide moiety followed by reprotection of the primary alcohol 
delivered allylic alcohol 1.182 and set the stage for the key Eschenmoser-Claisen 
rearrangement. In the event, 1.182 was heated with N,N-dimethylacetamide dimethyl 
acetal (1.183) giving rise to amide 1.184 with no erosion of enantioenrichment. 
Hydrolysis and ozonolysis of 1.184 provided aldehyde 1.185, setting the stage for the 









1.14 R = n-C13H27 : roccellaric acid
1.6 R = n-C11H23 : nephrosteranic acid
1.5 R = n-C13H27 : dihydroprotolichesterinic acid
1.177 R = n-C5H11 : phaseolinic acid
1.178 R = n-C13H27 : nephromopsinic acid
1.4 R = n-C13H27 : protolichesterinic acid




The alkyl side chain was installed via Wittig olefination with ylide 1.186 to 
provide 52% of the pure Z-isomer of 1.187. Iodolactonization followed by radical 
dehalogenation generated lactone 1.188 in 59% yield as a single diastereomer. It should 
be noted that the authors found the Z-olefin to be crucial to the diastereoselectivity of the 
iodolactonization, even though the stereogenic C-I bond was subsequently destroyed. 
Methylation of lactone 1.188 delivered tri-substituted lactone 1.189 as the minor 
diastereomer in a mix (1:3:1) of 1.189, epi-1.189, and bis-methyl 1.189. Finally, 
hydrogenolysis and oxidation delivered DHPLA (1.15) in 59% yield over two steps. 
Mulzer thus completed the first total synthesis of DHPLA (1.5) in 15 steps and a 
1% overall yield from enoate 1.180. During the course of this study, the utility of the 
Eschenmoser-Claisen reaction was demonstrated in a highly diastereoselective 
rearrangement, effectively transferring the chirality from (R)-glyceraldehyde to 
intermediate 1.184. Additionally, the authors exploit a diastereoselective 
iodolactonization reaction to set the stereocenter at the γ carbon atom. Unfortunately, this 
sequence suffered during the alkylation of 1.188, wherein the desired product 1.189 was 
received as the minor product. Fortunately, epi-1.189 could be taken forward to 






Scheme 1.14 Synthesis of DHPLA (1.5) by Mulzer. 
1.3.3.3 Banks’s Synthesis of (–)-Dihydroprotolichesterinic Acid 
Banks and co-workers reported a much shorter synthesis of 1.9 in 1995 using their 
chiral auxiliary (–)-chiracamphox (1.190) to set the stereochemistry (Scheme 1.15).97 
Auxilliary 1.190 was coupled to E-crotonoyl chloride in the presence of zinc chloride to 
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bromide provided 1.192 in 100% yield. Under Evans’s conditions, imide 1.192 
underwent an aldol reaction with tetradecanal to give 1.193 in 82% yield. Protection of 
the alcohol delivered 1.194 in 100% yield, which was oxidized to provide acid 1.195 in 
79% yield. Finally, hydrolysis of both the acetate and the auxiliary provided DHPLA 
(1.5) in 100% yield. Thus, Banks completed the total synthesis of (–)-DHPLA (1.5) in six 
steps with an overall 60% yield. The key to their synthesis hinged on the effectiveness of 
their recently developed auxiliary (–)-chiracamphox (1.190), which set all of the 
stereocenters through a remarkably high yielding two-step Michael addition and aldol 
reaction sequence. With a 60% overall yield, this synthesis remains the highest yielding 
route to DHPLA (1.5) to date.  
 
 






















































1.3.3.4 Martín’s Synthesis of (+)-Dihydroprotolichesterinic Acid 
In 1996, Martín reported a 14 step route to (+)-DHPLA (1.5) utilizing a four step 
strategy they developed for the synthesis of α-phenylthio γ-butyrolactones from 
enantioenriched epoxides (Scheme 1.16).98,101,102 The set up for their key step required the 
enantioselective synthesis of epoxide 1.199. The route began with 1-tetradecanol (1.196), 
which was oxidized and subjected to Wittig olefination to provide enoate 1.197 in 88% 
yield over two steps. Reduction of the ester followed by asymmetric epoxidation under 
the Sharpless protocol delivered epoxide 1.199 in 98% ee. Opening epoxide 1.199 with 
acid 1.200, followed by oxidative cleavage and Wittig olefination provided key ester 
1.201 in 74% yield over three steps. Finally, diastereoselective, intramolecular Michael 
addition yielded lactone 1.202. 
Next, the synthesis required a three-step degradation of the ester. Towards this 
goal, α-oxidation of the ester moiety of 1.202 with MoOPH under Vedejs’s conditions 
provided 1.203 in 85% yield. Reduction of the ester followed by oxidative cleavage 
completed the degradation furnishing acid 1.205. Finally, oxidative elimination of the 
sulfide followed by hydrogenation delivered (+)-DHPLA (1.5).  
Unfortunately, at 14 steps with an 18% overall yield, Martín fails to improve the 
yield or step count. The synthesis nicely showcased their strategy for the synthesis of γ-
butyrolactones, but the route falls short in the four-step synthesis of the enantioenriched 
epoxide as well as the three-step degradation of the ester functionality. In short, 
showcasing the method required a forced route, which led to no improvement over the 





Scheme 1.16 Total synthesis of (+)-DHPLA (1.5) by Martín. 
1.3.3.5 Roy’s Synthesis of (±)-Dihydroprotolichesterinic Acid 
Roy chose DHPLA (1.5) as well as rocellaric acid (1.14) to showcase an epoxide 
triggered radical annulation reaction (Scheme 1.17).99,103 The synthesis began with allylic 
alcohol 1.206, which is available in one step from tetradecanal. Epoxidation of the olefin 
led to 1.207 in 85% yield as a mixture (1:1) of diastereomers. The mixture of 
1-tetradecanol
1.196
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diastereomers was allylated in 81% yield, and the product was subjected to radical 
annulation mediated by titanocene dichloride to deliver tetrahydrofuran 1.209 as a 
mixture (5:1) of diastereomers. Oxidation of 1.209 delivered a mixture of diastereomers, 
which after fractional recrystallization provided (±)-DHPLA (1.5) in 78% yield as a 
single diastereomer. 
(±)-Dihydroprotolichesterinic acid (1.5) was synthesized in five steps and 41% 
overall yield from allylic alcohol 1.206. The synthesis is concise and exploits a 
diastereoablative radical annulation of 1.207 (1:1 dr) to deliver 1.209 as a mixture (5:1) 
of diastereomers. While lacking in yield in comparison to Banks, this inventive route 
swiftly provided access to the target molecule with a unique strategy. 
 
 
Scheme 1.17 Total synthesis of (±)-DHPLA by Roy. 
1.3.3.6 Pohmakotr’s Synthesis of (±)-Dihydroprotolichesterinic Acid 
Pohmakotr realized a unique route to both DHPLA (1.5) and rocellaric acid 
(1.14). While the sequence required only four steps, the natural products were prepared as 






























vincinal dianion derived from 1.210 underwent aldol reaction with concomitant 
lactonization to provide lactone 1.211 in 76% yield a an mixture (86:11:3) of 
diastereomers. During the course of optimizing this reaction, the authors found that 
quenching with PTSA led to a loss in yield, whereas quenching with acetic acid followed 
by PTSA to promote lactonization gave them a moderate yield of the lactone.  
Alkylation of the lactone with methyl iodide delivered 1.212 in 67% yield. 
Finally, saponification followed by decarboxylation delivered both rocellaric acid (1.14) 
and DHPLA (1.5) in 80% yield as an inseparable mixture (64:36). Pohmakotr thus 
completed the synthesis of DHPLA (1.5) in four steps with an overall 13% yield, but the 
product could not be separated from rocellaric acid (1.14).  
 
 
Scheme 1.18 Total synthesis of (±)-DHPLA by Pohmakotr. 
1.3.3.7 Summary 
Since the first synthesis of dihydroprotolichesterinic acid (1.5), the molecule has 
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five syntheses have explored a number of strategies that can access the relatively simple 
molecule (Table 1.1). Unfortunately, barring cleavages of chiral auxiliaries, almost every 
synthesis thus far requires refunctionalization either through redox transformation or the 
removal of extra atoms. Thus, the syntheses of DHPLA (1.5) still have room for 
improvement before an ideal synthesis can be attained. 
 
Table 1.1 Syntheses of DHPLA (1.5) 
Group Year (+)/(–)/(±) Steps Yield 
Mulzer 1993 (–) 14 0.4% 
Banks 1995 (–) 6 60% 
Martín 1996 (+) 14 13% 
Roy 1999 (±) 6 29% 
Pohmakotr 2002 (±) 4 13% 
1.4 SUMMARY 
A number a natural products have been used to showcase the utility of methods 
that can access functionalized succinic acid cores. For such small molecules, 14 steps is 
unreasonable. Additionally, a number of the syntheses suffer from lack of 
diastereoselectivity leading to mixtures of products. Since these molecules can be used as 
drugs, an attractive strategy to access the natural products and derivatives thereof would 
be an expedient, divergent route wherein a single molecule can rapidly be manipulated 
into a variety of products, be they different natural products or derivatives of the 




Chapter 2: Development of a Diastereoselective Conjugate Addition to a 
Chiral Fumarate and Application to the Total Synthesis of (–)-
Dihydroprotolichesterinic Acid 
2.1 STRATEGY AND INSPIRATION 
2.1.1 Martin Group Strategy for the Synthesis of Functionalized Succinic Acid 
Derivatives 
Due to the numerous examples of biologically active molecules containing a 
succinate moiety (Section 1.1), a unified route to disubstituted succinic acid derivatives 
available from a single, simple chiral starting material would be of considerable value. 
Indeed, there is a single report of where a chiral auxiliary provides selective access to 
more than one possible diastereomer of enantioenriched disubstituted succinates (Section 
1.2.1.2),46 but this method is limited in scope. We thus realized there was significant 
opportunity to develop a strategy for the enantioselective and diastereoselective synthesis 
of 2,3-disubstituted succinic acid derivatives. 
We reasoned that if the diastereoselectivity of a conjugate addition reaction to 
chiral fumarate 2.1 could be modulated, we would be able to selectively access both 
monosubstituted succinic acid derivatives 2.2 and 2.3 (Scheme 2.1). An aldol reaction of 
the resultant adducts 2.2 and 2.3 would provide trisubstituted lactones 2.4 and 2.8, which 
could be elaborated to natural products such as rocellaric acid and 
dihydroprotolichesterinic acid. Additionally, 2.2 and 2.3 could undergo diastereoselective 
alkylation reactions to provide both the syn- and anti-substituted succinates 2.5 and 2.6, 
which could be used in syntheses of matrix metalloproteinase inhibitors, like BB-1101. 
Finally, selective reduction of succinates 2.5 and 2.6 could provide access to four 




represent the natural products arctegenin and pilocarpine. With the methodology for 
auxiliary controlled alkylation and aldol reactions already known, we had only to develop 



























































































2.1.2 Divergent Conjugate Addition to Chiral Crotonates by Bergdahl 
While there were no reports of conditions to switch the diastereoselectivity of 
conjugate addition reactions to chiral fumarates, Bergdahl reported a tactic to modulate 
the diastereofacial addition of monoorganocuprates, [RCuI]Li, to chiral crotonates in 
2004.104 This discovery allows for chiral crotonate 2.13 to be differentiated into either 
diastereomer 2.14 or 2.15, simply by changing the reaction conditions. Inclusion of 
iodotrimethylsilane (TMSI), delivers product 2.14 in 98:2 dr (Equation 2.1), whereas 
removal of TMSI (Equation 2.2) or use of a Grignard reagent (Equation 2.3) provides the 
opposite diastereomer. This significant advancement provides divergent access to either 
diastereomer 2.14 or 2.15 for the first time since the initial report of oxizolidinone 
directed conjugate additions in 1993.105 Prior to this discovery, switching the selectivity 












































The origin of the stereoselectivity can be explained via the differing modes of 
action of the Lewis acid in the reaction (Scheme 2.2). In the Bergdahl protocol, TMSI is 
presumed to coordinate to only one of the carbonyl moieties of 2.13 to give 2.17. The 
auxiliary adopts an S-trans conformation to minimize the dipole, with the phenyl group 
blocking the back face of the molecule and delivering 2.18 as the major product. When 
TMSI is no included, 2.13 is chelated by either magnesium 2.19 or lithium 2.21, which 
locks the auxiliary with the phenyl group blocking the front face of the olefin providing 
the intermediates 2.20 or 2.22. 
 
 









































































2.1.3 Martin Group Conjugate Addition to γ-Alkoxy Crotonates 
The Martin group previously explored the extension of the Bergdahl protocol in 
work directed toward alkaloids of stemofoline family,106,107 wherein we sought to utilize 
the Bergdahl protocol in a conjugate addition reaction to a γ-alkoxy crotonate 2.25. 
Chiral crotonate 2.25 was prepared in 70% yield from 2.23 and 2.24 and subjected to the 
reaction conditions developed by Bergdahl, providing 2.26 in 91% as a single 
diastereomer. Imide 2.26 was subjected to standard allylation conditions to deliver 2.27 
in 69% yield. Intermediate 2.27 was then advanced in a set of model studies that 
ultimately led to the syntheses of didehydrosemofoline and isodidehydrosemofoline.108,109 
During the course of this work, we found that conditions to provide the diastereomeric 













































2.2 DEVELOPMENT OF THE COPPER MEDIATED CONJUGATE ADDITION REACTION 
Inspired by the success of the Bergdahl protocol with γ-alkoxy crotonates, we 
believed that the conditions could be extended further to chiral fumarate 2.31 to realize 
our goal of a divergent route to succinic acid derivatives. While standard conditions 
failed to switch the diastereoselectivity in preliminary experiments with γ-alkoxy 
crotonate 2.25 (Equation 2.5), we believed that extensive experimentation would reveal 
optimal conditions for reactions with 2.31. If the regio- and stereochemical outcome of 
this conjugate addition reaction could be controlled, it would represent the first 
switchable diastereoselective conjugate addition reaction of its type and only the second 
divergent route to disubstituted succinic acid derivitives using substrate control. 
However, while radical conjugate additions32,37,39,110 and Mukaiyama-Michael 
reactions111,112 occur β to the imide moiety of fumarates like 2.31, there was no guiding 
precedent for the reactions of organocuprate-derived reagents with such substrates. 
In order to probe the feasibility of the designed method, fumarate 2.31 was 
prepared from commercially available monomethyl fumarate (2.29) and chiral 
oxizolidinone 2.30 in 78% yield (Equation 2.6).113 The stage was then set for the 
unprecedented conjugate addition reaction. When fumarate 2.31 was treated with lithium 
monomethyl cuprate (Li[MeCuI]) in the presence of TMSI under the conditions reported 
by Bergdahl,104 we were pleased to find that the expected succinate 2.32 (R = Me) was 



















the method was evaluated for monoalkylcuprates derived from ethyl- and n-butyllithium, 
which proceeded equally well to deliver 2.33 and 2.34 with excellent stereoselectivity 
(Table 2.1, entries B and C). We also found that the process could be extended to 
monophenyl cuprate with good yield and excellent stereoselectivity (Table 2.1, entry D). 
Unfortunately, we found that the method could not be extended to monoorganocuprates 


























Table 2.1 Substrate scope for the conjugate addition reaction 
 
 
Entry Product RLi Yield (%) dr  
A 2.32 MeLi 89 19:1 
B 2.33 EtLi 72 19:1 
C 2.34 n-BuLi 83 19:1 
D 2.35 PhLi 82 19:1 
E 2.36 t-BuLi NR –– 
F 2.37 vinyl lithium NR –– 
G 2.38 lithium pheylacetylide   NR –– 
 
Next, we turned our attention to switching the diastereofacial delivery of the 
nucleophile in order to access succinates derived from the other diastereomer, but these 
efforts were unsuccessful (Equation 2.7). Simply removing the TMSI from the reaction 
with either Grignard reagents or alkyllithium species in a number of solvents provided no 
desired product. Chelating Lewis acids, ZnCl2, and MgBr2 were also ineffective. Even the 
more reactive Gillman reagent (Me2CuLi) failed to deliver the desired product. Finally, it 
was suggested that monobutylcuprate might aggregate less than the corresponding 
monomethylcuprate, thus leading to increased reactivity; however, no improvement was 






















decomposition, including some 1,2-addition, was seen upon warming or with the more 




Although we were unable to reverse the diastereoselectivity of the conjugate 
additions to 2.31 by changing the reaction conditions, these experiments did, for the first 
time, establish the feasibility of effecting highly regio- and stereoselective additions of 
monoorganocuprates to a chiral fumarate. Because this method thus complements the 
radical conjugate addition reactions developed by Sibi,39 it is now possible to enable 
selective access to the substituted succinates 2.2 and 2.3 from a single fumarate 2.1 (Xc = 
Evans’s oxazolidinone) (Scheme 2.3). Despite the failure to realize our original goal, a 
number of biologically active targets are potentially accessible using this new 

















2.31 2.39 (R = Me)





(CuI)4(DMS)3, , MeLi, THF
(CuI)4(DMS)3, MeLi, CH2Cl2











Scheme 2.3 Divergent access to diastereomeric succinates from a single chiral fumarate 
2.3 ATTEMPTED SYNTHESIS OF (+)-PILOCARPINE 
2.3.1 Initial Strategy for the Synthesis of (+)-Pilocarpine 
Having identified conditions for enantioselective conjugate addition developed, 
only two steps from 2.33 would be required prepare the glaucoma drug pilocarpine 
(2.42). We imagined that alkylation of succinate 2.23 with the 2.46 would provide 2.41 
(Equation 2.8). Finally, selective reduction of the imide moiety followed by lactonization 
could provide pilocarpine (2.42) in four steps from commercially available material; this 





























Although imidazole 2.46 is commercially available, it is fairly expensive, but it is 
readily available in three steps (Scheme 2.4).114 Namely, reaction of dihydroxyacetone 
dimer (2.43) with potassium thiocyanate and methylamine provides 2.44 in 78% yield. 
Cleavage of the thiol with catalytic sodium nitrite in nitric acid produces 2.45 in 70% 
yield, and reaction of the resulting product in neat thionyl chloride provides the desired 
compound 2.46 as the hydrochloride salt. With chloride 2.46 in hand, the alkylation of 
2.33 could be explored. 
 
 



















































Halide 2.46 is known to undergo alkylation with softer nucleophiles such as 
anilines and malonates,86,87,115 but nothing has been reported about its reactivity with 
harder enolates. Unfortunately, despite extensive experiments involving freebasing 2.46, 
enolization of 2.33, solvents, additives, and temperatures, we were unable to find 
conditions that provided any more than a trace amount of 2.41. The recalcitrant nature of 
enolates related to those derived from 2.33 was previous noted by Evans, who found that 
only more reactive alkylating agents such as methyl iodide, allyl bromide, and benzyl 
bromide provided alkylated products in good yields.17,116 Thus, we turned our attention to 
an alternate route to pilocarpine (2.42). 
 
 
2.3.2 Revised Strategy for the Synthesis of (+)-Pilocarpine 
The revised strategy to access pilocarpine relied on utilizing a more reactive allyl 
electrophile to provide 2.47 from 2.33 (Scheme 2.42). Selective reduction of the imide 
moiety would provide lactone 2.48, which might be converted by oxidative cleavage to 
lactone 2.49, an intermediate in Büchi’s synthesis of pilocarpine.85 Finally, van Leusen 




















Freebase 2.46: K2CO3, NaH, LDA
Enolize 2.33: LDA, NaHMDS, LiHMDS, NaH, Hünig's/TiCl4
Solvent: THF, CH2Cl2
Additives: HMPA, TBAI







Scheme 2.5 Revised strategy for the synthesis of pilocarpine (2.42) 
Unfortunately, our initial attempts involving deprotonation of 2.33 with either 
lithium hexamethyl disilazide (LiHMDS) or sodium hexamethyl disilazide (NaHMDS) 
were unsuccessful, giving only trace amounts of 2.47. Imagining that aggregation of the 
enolate might be plaguing the reactivity, we added hexamethylphosphoramide (HMPA) 
after the deprotonation, but achieved the same results. Because deuterium quenching 
studies using similar conditions suggested we were not forming the enolate, thus we 
added HMPA prior to the deprotonation. Fortunately, this resulted in a 36% yield of the 
desired product. However, we were unable to optimize this yield by raising the 































Finally, we imagined that the use of a Lewis acid (MnCl2•2LiCl) in the enolization step 
could lead to increased product formation; however, we received 2.47 in only 20% yield. 
With 2.47 in hand, we moved forward to the selective reduction of the imide moiety. 
Table 2.2 Allylation of 2.33 
 
Entrya Base Additive Yield (%) 
A NaHMDS –– trace 
B LiHMDS –– trace 
C LiHMDS HMPAb trace 
D LiHMDS HMPAc 36% 
E LiHMDS MnCl2•2LiCl 20% 
a) Reactions performed in THF using allyl iodide b) HMPA added after deprotonation c) HMPA added 
prior to deprotonation 
Despite our best efforts and in contrast to literature precedent,117,118 reduction of 
2.47 with LiBH4 in THF/MeOH gave the ring-opened product 2.51 instead of the 
expected lactone 2.48 or alcohol 2.50. Although a number of other condition have been 
reported to selectively reduce succinates related to 2.47,89,119,120 standard condition 
involving Zn(BH4)2 in THF and NaBH4 in MeOH/H2O either led to no reduction or over- 
reduction. Unfortunately, our inability to selectively reduce 2.47 to give 2.48 or 2.50 
precluded our efforts to develop a short synthesis of pilocarpine (2.42). Thus, we turned 




















2.4 ATTEMPTED SYNTHESIS OF ANTRODIN E 
We envisioned that chiral succinimides, such as antrodin E (2.54), could also be 
accessed via our methodology. The symmetrical nature of the imide moiety would 
thereby obviate the need for selectivity, which had beset us previously in the attempted 
synthesis of pilocarpine (2.42). The synthesis would commence from chiral fumarate 
2.31, which we imagined would undergo a conjugate addition reaction to provide 
succinate 2.52 (Scheme 2.6). Alkylation of 2.52 would lead to disubstituted succinic acid 
derivative 2.53, which upon cyclization with hydroxylamine would deliver antrodin E 
























LiBH4, MeOH, THF, 81% (2.51)
Zn(BH4)2, Et2O, over reduction






Scheme 2.6 Strategy for the synthesis of antrodin E (2.54) 
This route required a yet untested conjugate addition using a substituted aryl 
nucleophile derived from 2.56. Known aryl bromide 2.56 was available in one step from 
4-bromophenol (2.55) in 93% yield (Equation 2.10). After subjecting the aryl bromide 
2.56 to lithium halogen exchange with n-butyllithium, we found that the monoarylcuprate 
added to fumarate 2.31 in 48% yield (Table 2.3, entry A). Imagining that the low yield 
might be do to alkylation or elimination between the aryllithium and n-butyl bromide, we 
tried t-butyllithium for the exchange, but those conditions led entirely to decomposition 
(Table 2.3, entry B).  We also used two equivalents of n-butyllithium to solve this 
potential problem, but this led to recovery of the product of 1,4-addition of the butyl 






































exchange led to a mixture of aryl and butyl addition (Table 2.3, entry D). Ultimately, 
through deuterium and methyl iodide quenching of the resultant aryllithium species we 
found that lithium halogen exchange was complete. The reaction could not be improved 
by changing the equivalents or temperature, and it is still unclear what the cause of the 
surprising lack of reactivity could be. 
 
 
Table 2.3 Optimization of conjugate addition. 
 
Entry RLi Additive Results 
A n-BuLi (1.1 eq.) –– 48% 
B t-BuLi (2.1 eq.) –– decomp. 
C n-BuLi (2.1 eq.) –– Bu addition 




























Next, we turned our attention to the alkylation of 2.52. Although not unexpected, 
based upon the observed reactivity of the enolate of 2.33, it was nevertheless 
disappointing that treating the enolate of 2.52 with isobutyl triflate (2.57) and 2-
methallylbromide (2.58) under a variety of conditions failed to deliver 2.53. Because 
alkylation of enolates of substituted succinates are challenging, it occurred to us to 
examine aldol reactions of such enolates as the products of these reactions also map onto 
a number of interesting natural products. 
 
 










































2.5 TOTAL SYNTHESIS OF (–)-DIHYDROPROTOLICHESTERINIC ACID 
In order to explore the effectiveness of aldol reactions on substituted succinates, 
we pursued (–)-dihydroprotolichesterinic acid (2.61). With 2.32 in hand, an aldol 
reaction, which we imagined might proceed with concomitant lactonization, would 
provide 2.60 (Equation 2.11). Finally, hydrolysis of the auxiliary would provide the target 
molecule 2.61. Unlike our previous attempts at natural product synthesis, which further 
exemplified the stubbornness of succinates like 2.32 in alkylation reactions, there was 
precedent for successful aldol reactions on these types of systems. Specifically, Sibi had 
used the related intermediate 2.62 in the synthesis of a rocellaric acid (Section 1.2.1.3), 




































myristyl aldehyde  














We were disappointed to find that when 2.32 was subjected to the reaction 
conditions we recovered only 24% of the desired product 2.60 along with returned 
starting material (Table 2.4, entry A). We began our optimization attempts by 
concentrating the reaction and switching to Hünig’s base,8 which provided the desired 
lactone in 36% yield (Table 2.4, entry B). Increasing the equivalents of aldehyde, 
changing the Lewis acid, and changing the base did not improve the reaction (Table 2.4, 
entries C, D, E, and F). We then began incrementally increasing the concentration (Table 
2.4, entries F, G, H, and I), finding 0.9 M to be the optimum concentration, delivering 
lactone 2.60 in 54% yield (95% based on recovered starting material. Finally, we tested 
to see if order of addition had any effect on the yield, but the yield was left unchanged 





Table 2.4 Optimization of aldol/lactonization reaction of 2.60 
 
Entrya Aldehyde L.A. (eq.) Base (eq.) Conc. (M) Resultb 
A 1.2 Bu2BOTf (1.2) TEA (1.4) < 0.1 24% 
B 1.2 Bu2BOTf (1.2) DIPEA (1.4) 0.3 36% 
C 3 Bu2BOTf (1.2) DIPEA (1.4) 0.3 38% 
D 3 TiCl4 (1.2) DIPEA (1.4) 0.3 26% 
E 3 Bu2BOTf (1.2) t-Bu2Pyr (1.2) 0.3 Trace 
F 3 Bu2BOTf (1.2) DBU (1.2) 0.3 NR 
G 1.2 Bu2BOTf (1.2) DIPEA (1.4) 0.45 38% 
H 1.2 Bu2BOTf (2) DIPEA (2.1) 0.45 44% 
I 1.2 Bu2BOTf (1.2) DIPEA (1.4) 0.9 54% 
Jc 1.2 Bu2BOTf (1.2) DIPEA (1.4) 0.9 52% 
a) Reactions performed in CH2Cl2 at 0 °C for 15 h. b) Yield based on isolated material after column 
chromatography. c) Inverse addition (enolate into solution of aldehyde) 
In an effort to reduce the step count, we attempted to perform a one-pot conjugate 
addition/aldol/lactonization reaction. Indeed, Kuwajima,121 Wada,122 and Evans123 have 
reported the transmetallation of silyl enol ethers with di-n-butylboron triflate, wherein 
treatment of adduct 2.64 with di-n-butyl boron triflate prior to introduction myristyl 
aldehyde should lead to 2.60 (Scheme 2.8). Unfortunately, these conditions were 


















multiple diastereomers of the lactones. Heathcock has reported that pre-complexation of 
the aldehydes with titanium tetrachloride results in non-Evans syn aldol products,124 but 
these results did not produce any desired product (Equation 2.13). Alternatively, the 
lithium enolates of substituted succinates like 2.32 have also been shown to give rise to 






































Cleavage of the auxiliary from 2.60 under standard conditions39 proceeded 
unremarkably to provide (–)-dihydroprotolichesterinic acid (2.61) in 85% yield. The 
rotation and melting point of 2.61 matched that reported in the literature,96 but while 
similar, the 1H and 13C spectra exhibited discrepancies  (between both our spectra and 
literature as well as between the reports in the literature). We presume that this is due to 
concentration differences between the samples, which leads to slight shifts due to 
hydrogen bonding between the compounds. While performing the experiment in MeOD 
could solve this problem, there was no published spectrum with which to compare. Thus, 
the structure of compound 2.61 was unambiguously determined via X-ray 
crystallography.125 We thus completed the total synthesis of (–)-DHPLA (2.61) in four 




















































Through the extension of the Bergdahl protocol to chiral fumarates, we realized 
the first conjugate addition of a monoorganocuprate to a chiral fumarate.126,127 
Unfortunately, we were unable to achieve the goal of switching the diastereoselectivity of 
this transformation. However, in conjunction with the radical conjugate developed by 
Sibi,39 it is now possible to diverge a single chiral fumarate to both possible 
diastereomers. Our applications of this protocal towards the synthesis of pilocarpine and 
antrodin E ultimately ended in failure, due to the difficulty in both alkylating these 
substituted succinates as well as in selectively reducing the imide moiety. However, 
synthesis of (–)-dihydroprotolichesterinic acid via an aldol reaction resulted in the 
shortest total synthesis of the molecule to date at four steps and a 31% overall yield (56% 










































































DEVELOPMENT OF ENANTIOSELECTIVE HALOCYCLIZATION 
REACTIONS 
Chapter 3: Catalytic Enantioselective Halocyclization Reactions 
3.1 INTRODUCTION 
Halogenated natural products like liguhodgcin A (3.1),128 bromophycolide A 
(3.2),129 peyssonal A (3.3),130 and pannosallene (3.4)131 have inspired the burgeoning field 
focusing on the development of enantioselective halocyclization reactions (Figure 3.1).132-
137 To date, halolactonizations (Y = O, Z = OH),138-174 haloetherifications (Y = O, Z = H-
2),175-184 and haloaminocyclizations (Y = NHR, Z = H2)185-192 have been extensively 
explored (Equation 3.1). Less explored areas include oxazolidinone formation,193,194 
oxazoline formation,195-198 and cyclization of oximes.199 Additionally, catalytic 
enantioselective halo-polyene cyclization reactions (Equation 3.2), arguably the holy 
grail of the field, have yet to be realized. However, towards this end, Ishihara has 
reported an enantioselective halo-polyene cyclization using a stoichiometric reagent, and 
Denmark has demonstrated a catalytic enantioselective sulfonium-induced 



















































Z = OH or NHR
















While a number of catalysts have been disclosed, a general halocyclization 
catalyst (i.e. one that can promote every halonium-induced cyclization) has yet to be 
reported. In fact, no catalyst reported thus far has been able to effect the cyclization of 
every substrate within a class of halocyclization (e.g. halolactonization). For example, 
most catalysts have a very limited substrate scope with respect to substitution on the 
olefins, which leads to the need for a different catalyst for each type of substrate within 
the class of reaction (e.g. lactonization and etherification). Furthermore, these reactions 
are typically specific to a given halogen, which necessitates a different catalyst for each 
halogen subtype (iodo-, bromo-, chloro-, or fluoro-) of the reactions. All of these 
reactions are mechanistically similar, involving the capture of a halonium by a 
nucleophile, so in principle a single catalyst should be able to promote all of these 
reactions; nevertheless, this ideal has yet to be achieved. In order to provide focused 
context and comparison for our work in this field, only the general challenges in 
developing halocyclization reactions and an evolutionary account of halolactonization 
reaction development will be discussed. 
3.2 CHALLENGES IN DEVELOPING ENANTIOSELECTIVE HALOCYCLIZATIONS 
3.2.1 Olefin-Olefin Transfer of Halonium Ions 
One potential problem inherent in the development of enantioselective 
halocyclization reactions involves the transfer of halonium ions between olefins (Scheme 
3.1). Brown discovered that bromonium and iodonium ions transfer between olefins at 
cryogenic temperatures.204-206 In the context of halocyclization reactions, if olefin 3.9 is 




equivalent of 3.9 can react with 3.10 to form the enantiomeric intermediate ent-3.10. This 
will result in an erosion of enantioselectivity.  
 
 
Scheme 3.1 Transfer of halonium ions between olefins 
In order to probe the configurational stability of halonium ions, Denmark and co-
workers measured the enantiospecifity of the reaction of 3.12 with sodium acetate to give 
3.13.132,207 As seen in Table 3.1 entry A, displacement of the tosylate in 3.12 with sodium 
acetate was completely enantiospecific. However, in the presence of dodecene, the 
enantiospecifity was only 28% (Table 3.1, entry B). On the other hand, the chloronium 
examples were completely stereospecific even in the presence of dodecene (Table 3.1, 
entries C and D). It was postulated that this was most likely due to the electronegativity 
of chlorine versus bromine. Specifically, the chlorine atom is less able to stabilize the 
building positive charge in the transition state (3.18 to ent-3.18) thereby attenuating the 
propensity of the chloronium to transfer between olefins. Moreover, the complete 
stereospecificity of this reaction was perplexing as carbocationic, rather than chloronium-
like intermediates, are thought to exist in these processes, which in theory should lead to 
















Table 3.1 Configurational stability of halonium ions 
 
Entry X Additive (1 equiv.) esa 
A Br — 100% 
B Br E-6-dodecene 28% 
C Cl — 100% 
D Cl E-6-dodecene 100% 
a) es = (eeproduct/ees.m.)•100 
 
In order to mediate this detrimental side reaction, Denmark hypothesized that the 
epimerization via olefin-olefin transfer of halonium ions would be reduced if the two 
halonium ions were diastereomeric rather than enantiomeric.208 If a chiral Lewis base was 
included in the reaction, upon coordination to the halonium ions two diastereomeric 
intermediates 3.14 and 3.15 would be produced (Scheme 3.2). This should skew the 
equilibrium and funnel the two diastereomeric intermediates through the lower energy 












Scheme 3.2 Mediation of olefin-olefin epimerization 
3.2.2 Stereoselectivity via Stereoselective Halonium Formation 
Another problem that might arise during chloro- and fluorolactonization reactions 
is poor stereoselectivity due to carbocation rather than halonium character in the 
transition state.132 When studying the stability of halonium ions using 3.16 and SbF5 at 
low temperature, Olah found that all bromo- and iodo-substituted substrates 3.16 (X = Br 
or I) existed as the halonium ion 3.17 (Equation 3.3).209-211 On the other hand, chloro- 
(with the exception of tri- and tetra-substituted substrates) and fluoro-substituted 
substrates 3.16 (X = Cl or F) existed as the cationic species 3.18. This is potentially 
detrimental to the stereoselectivity of the halocyclizations, as demonstrated in 
fluorolactonization reactions. When various olefinic acids 3.19 were treated with 3.20, 
the product lactones 3.21 were formed in 2.3:1 dr (Equation 3.4).212,213 This was most 
likely due to the cationic intermediate providing little steric differentiation between either 
face of the cation, whereas the nucleophile would attack from the opposite face of a fully 
formed halonium ions leading to excellent diastereoselectivity. This cationic character 
also has interesting effects in chlorolactonization reactions as demonstrated by Borhan 





















halocyclization reactions, the field has flourished with a number of reagents and catalysts 






3.3 REAGENT CONTROLLED HALOLACTONIZATION (1992-2009) 
3.3.1 Stoichiometric Enantioselective Halolactonization Reactions 
Taguchi reported the first enantioselective halolactonization reaction in 1992.214 In 
the event, prochiral diene 3.22 underwent lactonization to provide 3.24 in 67% yield with 
an 83:17 er in the presence of iodine, titanium isopropoxide, and ligand 3.23 (Equation 
3.5). Some of the lactone 3.24 suffered ring opening during the course of the reaction by 
isopropoxide, thus an acid catalyzed lactonization was necessary to increase the yield. 
Although this report went unnoticed for almost 10 years, this reaction represented the 
first time a reagent was used to induce chirality in a halolactonization reaction and laid 


















(–80 to –60 °C) 3.18
X = Cl and F
3.17
X = I, Br, and Cl*
*Cl with tetra or tri methyl
3.16































In 2000, Brown attempted to use a chiral amine to induce enantioselectivity in a 
bromolactonization reaction but was unsuccessful.215 However, two years later Wirth 
found success with amine 3.26 as a stoichiometric source of chirality.139,140 In particular, 
he showed that aryl substituted olefinic acids 3.25 underwent iodolactonization in the 
presence of 3.26 and ICl to provide lactones 3.27 with moderate enantioselectivity 




3.3.2 Seminal Catalytic Enantioselective Halolactonization Reactions 
It did not take long after the first stoichiometric amine-based reagent was 
disclosed for the first catalytic, enantioselective reaction to surface. While Gao initially 
disclosed 3.29 as a stoichiometric reagent for iodolactonization reactions,142 he quickly 
CO2H
OH
1. Ti(Oi-Pr)4, 3.23, I2, pyr., CH2Cl2, –78 °C

































learned that it could be used in substoichiometric quantitites.217 1,2-Trans-aryl olefinic 
acids 3.28 were cyclized with iodine under phase transfer conditions using 3.29 to 
provide a mixture of endo- and exo-cyclized lactones 3.30 and 3.31 (Equation 3.7). While 
Guo was able to achieve excellent regioselectivity favoring the endo adduct 3.31 for a 
number of substrates, the enantioselectivity was poor (up to 66:34 er). Nevertheless, this 
transformation represented the first time a catalyst provided enantioenriched products via 




In 2009, Gao demonstrated that chiral salen complex 3.32 effected the 
iodolactonization of the aryl olefinic acids 3.25 to provide iodolactones 3.27 with good 
yields and enantioselectivities (Equation 3.8). With this report, the use of a catalyst to 
provide synthetically useful enantioselectivities in a halolactonization reaction was 










3.29 (30 mol %)
I2 (150 mol %)
CH2Cl2/sat. NaHCO3 (aq.) (2:1), 0 °C
up to 90% (combined)
up to 100:0 regioselectivity

















3.4 CATALYTIC HALOLACTONIZATION GOLD-RUSH (2010–PRESENT) 
Once Gao had broken ground in the area, other groups quickly joined the effort. 
In 2010, a few additional reports appeared, but over the past five years, there has been an 
average of one publication a month in the field of catalytic enantioselective 
halolactonization reactions. This section will summarize these efforts and is organized by 
group in order of their entrance into the field.  
3.4.1 Borhan 
Borhan reported the first enantioselective chlorolactonization in 2010, wherein the 
benzoic acid salt of (DHDQ)2PHAL (3.33) effected the lactonization of 5-aryl-5-hexenoic 
acids 3.25 with good yields and enantioselectivities (Equation 3.9).143 Yeung later 
reported that similar conditions could be used to perform selenolactonizations,159 and 
Armstrong demonstrated that this catalyst can be used for a variety of bromolactonization 
reactions.170 Unfortunately, like most catalysts, the scope of these reactions was limited. 
For example, the enantioselectivity decreased with increasing electron-donating groups 










3.32 (40 mol %)
I2 (140 mol %)















hydantoin chlorinating reagents and the development of a halonium affinity scale for the 
prediction of olefin reactivity with halonium ions.218,219 Additional studies on 
bromolactonization reactions were performed using peptide based catalysts, but these 




Because experiments by Olah had demonstrated that carbocationic intermediates 
rather than chloronium ions exist in these types of transformations, Borhan investigated 
the diastereoselectivity of this reaction.144 As their method did not generate a C-Cl bond 
at a stereogenic center, substrate 3.36 was prepared. Surprisingly, when deuterated 
substrate 3.36 was subjected to the reaction conditions, the syn-addition product was 
received (Equation 3.10). When the reaction was run without catalyst, rac-3.37 was 
isolated as a mixture (1:0 of diastereomers. When run in the presence of quinuclidine, the 




(DHDQ)2PHAL (3.33) (10 mol %)
DCDPH (3.34) (110 mol %)
PhCOOH (100 mol %)
hexanes/CHCl3 (1:1), –40 °C
5 examples
up to 81%


























(DHDQ)2PHAL (3.33) must have controlled both the facial selectivity of the chloronium 
delivery as well as the facial selectivity of the carboxylate addition, rather than relying of 




3.4.2 Fujioka  
Fujioka entered the field in 2010, with his C3-symmetric tri-amidine catalyst 3.38. 
Catalyst 3.38 in conjunction with DBDMH (3.39) induced 6-exo bromolactonizations on 
a number of geminally substituted 5-hexenoic acids 3.40 (Equation 3.11).146 The reactions 
were generally high yielding with good enantioselectivities; however, the 








(DHDQ)2PHAL (3.33) (10 mol %)
DCDPH (3.34) (110 mol %)
PhCO2H (100 mol %)


















They later demonstrated that this catalyst 3.38 could promote similar 6-exo 
bromolactonizations on tri-substituted substrates 3.42 with good to excellent yields and 
enantioselectivities (Equation 3.12).148 The utility of this method was demonstrated in a 
short total synthesis of the natural product (–)-tanikolide (3.45) from bromolactone 3.44 





























3.38 (10 mol %)











R = Ar, Cy




3.38 (10 mol %)



















Additional experimentation revealed this catalyst to be suitable for the kinetic 
resolution of rac-3-substituted olefinic acids 3.46 with generally high enantioselectivities 
(Equation 3.14).149 Furthermore, catalyst 3.38 could induce iodolactonizations of allenes 
3.48 to provide chiral vinyl iodides 3.49 with moderate enantioselectivity (Equation 
3.15).147 Fujioka accomplished a variety of transformations using catalyst 3.38, but all of 
these were limited to 6-exo lactonization pathways on aryl-substituted olefinic acids. The 
tri-substituted olefinic acids did, however, represent a very challenging substrate class 























3.38 (10 mol %)

















3.38 (10 mol %)
I2 (220 mol %)
















3.4.3 Jacobsen  
Jacobsen and co-workers showed that the amine/urea catalyst 3.52 effected highly 
enantioselective iodolactonization reactions on 5-aryl-5-hexenoic acids 3.50 to provide 
iodolactones 3.53 (Equation 3.16).150 The substrate scope was the same as Fujioka’s 
bromolactonization, and both saw decreased selectivities for electron-rich aryl- and alkyl-
substituted olefinic acids. The most interesting observation from this report was that the 
inclusion of a catalytic amount of iodine slightly enhanced the enantioselectivity. This 
discovery has been used in a number of other iodolactonization reactions, including our 
own. While the exact reason for the enhancement has yet to be revealed, it is believed 
that the combination of N-iodo compounds, I2, and protic acid produce I3+ in situ. 220 
Jacobsen noted that I2 does not effect the rate of the background reaction, so perhaps the 
triiodonium is more effective at transferring the iodonium to the catalyst thereby 
enhancing the rate of the catalyst-promoted reaction versus the background reaction, 






















3.52 (15 mol %)














Tang developed a modified cinchona catalyst 3.55 for the bromolactonization of 
enynes 3.54.151 In the event, enyne derivative 3.54 underwent bromolactonization to 
provide chiral halo-allene 3.56 in moderate to good yields with excellent enantio- and 
diastereoselectivity (Equation 3.17). The same conditions could be used to lactonize aryl-
tethered substrates 3.57 to provide 3.58 with similarly high selectivities (Equation 3.18). 
These substrates have been otherwise unexplored in the halolactonization field. Tang also 
demonstrated that catalyst 3.55 promoted enantioselective, chlorolactonization reactions 
of 4-aryl-4-pentenoic acids.152 However, as these acids had previously been explored and 
the enantioselectivity was not improved upon, the chlorolactonization provided little 




















X = O, CH2, NTs
R1 = H, Me





3.55 (20 mol %)














3.4.5 Yeung  
Yeung, the most prolific contributor to the field, has showcased a number of 
catalysts capable of performing a wide variety of halolactonization reactions. While his 
group has managed to discover highly selective catalysts for these transformations, each 
substrate required a slightly different catalyst. Unfortunately, while they have solved 
problems associated with each substrate, an ideal catalyst applicable to a variety of 
substrates was not found. 
Yeung’s first generation catalysts 3.59 and 3.60, based on the cinchona alkaloids, 
promoted bromolactonizations of 5-aryl-5-hexenoic acids 3.61 and E-6-aryl-5-hexenoic 
acids 3.28, the two most common substrates in the field. In his first report, catalyst 3.69 
was demonstrated to effect in the bromolactonization of 3.61 to provide bromolactones 
3.62 with a high degree of enantioselectivity (Equation 3.20).153 The use of nosyl amide 
as a co-catalyst was found to be important, though it is unclear whether or not it enhanced 
halogen transfer or slowed the background reaction; recent studies by Borhan suggest the 





R = H, OMe, CF3, Br, NO2
3.55 (20 mol %)



















3.55 (5 mol %)









the presence of electron-rich aryl groups decreased the enantioselectivity; however, 
unlike previous reports, tert-butyl-substituted 3.61 cyclized with high enantioselectivities, 
the first alkyl substituted substrate to do so. They later found that catalyst 3.60 induced a 
6-endo cyclization to give lactones 3.63 with good selectivity (Equation 3.21).154 The 6-
endo cyclization pathway, rather than the 5-exo, is preferred on the trans-5-aryl-5-
pentenoic acid derivatives due to the electronic bias that the aromatic ring provides, 
which stabilizes the building positive charge most at the benzylic carbon atom making 
the benzylic position more electrophilic. During these initial investigations, studies were 
undertaken to demonstrate that these reactions could tolerate trace amounts water, 
thereby obviating the need to rigorously dry the solvents;155  however, based the prior art, 














3.59, R = H








By further modification of the cinchona scaffold to yield catalyst 3.63, Yeung was 
able to lactonize Z-aryl olefinic acids with a high degree of enantioselectivity to afford 
bromolactones 3.64, wherein the newly installed C-Br bond formed an exocyclic 
stereogenic center (Equation 3.22).156 While this reaction represents a new substrate in the 
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Yeung then developed a new class of catalysts based on proline derivatives; 
however, he again was unable to find a general catalyst for these transformations.157 
Catalyst 3.65 promoted 6-exo cyclizations of acids 3.50 with good to excellent 
enantioselectivities (Equation 3.23), and catalyst 3.66 lactonized 3.61 with similarly high 
yields and selectivities (Equation 3.24). Despite the development of the new catalysts, 
neither 3.50 nor 3.61 represented new substrates, and the yields and selectivities were 
similar to those previously reported, hence there was minimal advancement in the field.  
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3.65, R = Me








Lastly, Yeung developed a 5-endo cyclization/elimination sequence using catalyst 
3.68 to form chiral butenolides 3.69 (Equation 3.25).158 Again, a new catalyst was 
required for this substrate. While Yeung contributed significantly to this field, the goal of 
realizing a common catalyst for halofunctionalization reactions was not obtained. 
Because a different catalyst required for each type of substrate, the methodology 
involving chincona-based catalysts is not yet ready for mainstream adoption. Who wants 
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Hamashima entered the field in 2012 with a focus on desymmetrization 
reactions.222 They reported that DHDQ2PHAL (3.33) and NBS could desymmetrize 
prochiral dienes 3.70 to provide either β- or γ-bromolactones 3.71 with good 
enantioselectivities (Equation 3.26). While this represents a new substrate within this 
review, we reported the first desymmetrization of prochiral dienes via a 
bromolactonization reaction earlier the same year.166 Hamashima demonstrated the utility 














3.68 (10 mol %)
NBS (120 mol %);
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(DHDQ)2PHAL (3.33) (10 mol %)






R = Me, n = 0, 89%, 91:9 er
R = H, n = 0, 93%, 94:6 er
R = H, n = 1, 90%, 96:4 er
3.70
R = Me or H










Their next contribution came as the first enantioselective fluorolactonization 
reaction.161 Using bifunctional catalyst 3.73, Hamashima demonstrated the successful 
lactonization of acids 3.72 to give fluorolactones 3.74 with great enantioselectivities 
(Equation 3.27). The Rueping group had previously attempted this same transformation 
with (DHDQ)2PHAL, but only achieved a 27% ee at best.173 It would be interesting to see 
how a 1,2-disubstituted olefinic acid or a deuterated substrate (Section 3.4.1) behaved in 
this reaction, so that the relative stereochemistry between the C-F and C-O bonds could 
be ascertained. As previously discussed in Section 3.2.2, the carbocationic character of 
the intermediate after fluorine delivery can lead to poor diastereoselectivity of these 
reactions. Hopefully, Hamashima will report whether or not his catalyst can overcome 
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Hansen reported a squarimide based catalyst 3.75 that could effect 
enantioselective 6-exo lactonization reactions (Equation 3.28).162 The catalyst was 
extremely similar to Jacobsen’s catalyst 3.53, as was the substrate scope they explored, 
which was limited to 6-exo lactonization reactions of 5-aryl-5-hexenoic acids 3.50. 
Hansen did report that he tried to perform 5-exo lactonizations with 3.75, but these 
reactions delivered lactones with 14% ee at best. He later explored catalyst 3.76 for the 














N(C5H11)23.75 (15 mol %)
I2 (15 mol %)
NIS (100 mol %)























The Johnston group developed the catalyst 3.77, which promoted the 
iodolactonization of substrates 3.50 (Equation 3.29).164 While the substrate scope was 
generally the same as all of the other 6-exo iodolactonizations, they did demonstrate the 
highest enantioselectivity (95:5 er) for the lactonization of an n-alkyl substituted olefinic 
acid 3.50 (R = n-Bu) to date. The observation that the achiral counter anion played a 
major role in the enantioselectivity of the transformation was interesting. However, there 
was no speculation as to what its role might be. Nevertheless, besides ruling out yet 
another catalyst scaffold as a generally applicable catalyst, there was once again little 




Kim and co-workers disclosed a di-cationic palladium catalyst that induced 
bromolactonizations of aryl olefinic acids 3.61 with good enantioselectivities and yields 
(Equation 3.30).165 Since the substrate class had been explored extensively in previous 







Tf2N- 3.77 (5 mol %)

















methodologies, which suffered from poor enantioselectivity with electron-rich aromatic-




Arai and co-workers developed two organometallic-based catalysts for 6-exo 
iodocyclization reactions. The first involved ligand 3.79 and nickel acetate to catalyze the 
lactonization of 3.50 in the presence of iodine and NIS (Equation 3.31).168 Other than 
demonstrating the effectiveness of ligand 3.79, no advancement of substrate tolerance for 
6-exo cyclizations of 3.50 was reported. The second method involved a tri-nuclear zinc 
complex with ligand 3.80 to catalyze the same type of 6-exo cyclization reaction with 
substrate 3.53 (Equation 3.32).169 While this system provided little advantage over 
previously reported methodologies, it was noteworthy in that it worked extremely well on 
4-methoxyphenyl- and methyl-substituted olefinic acids. Ligand 3.80 remains the only 
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Hennecke disclosed a unique desymmetrization of prochiral diynes 3.81 using 
(DHDQ)2PHAL (3.33).171 A number of derivatives were explored, and good to excellent 









3.79 (10.5 mol %)
Ni(OAc)2•4H2O (10 mol %)
I2 (20 mol %)
NIS (110 mol %)












3.80 (1 mol %)
Zn(OAc)2 (3 mol %)
I2 (20 mol %)
NIS (110 mol %)
PhMe:CH2Cl2 (3:1), –78 °C
12 examples (Ar)
99%, 98:2-99:1 er
R = Me, 92%, 97:3 er
























performed on gram scale with no loss in either yield or selectivity. Furthermore the 




Ishihara reported the latest halolactonization reaction, wherein catalyst 3.84 
promoted the iodolactonization of benzyl substited olefinic acids 3.83 with a high degree 
of enantioselectivity (Equation 3.34).172 The substrates were new with respect to the 
previously reported methods, but perhaps the most interesting aspect was the use of half 
an equivalent of iodine to perform the transformation. N-Chlorophthalimide (NCP) is 
used as an oxidant in a redox cycle to generate two equivalents of “I+” from one 
equivalent of iodine. While this method has yet to achieve success in the development of 
a general catalyst, it provides a foundation for future development wherein the 







R1 = CO2Me, Ar, H, CH2OBn
R2 = H, Me, Et, Ar
(DHDQ)2PHAL (3.33) (10 mol %)
NBS (120 mol %)

















While a number of high yielding and highly selective halolactonizations have 
been developed, there are still a myriad of improvements that need to be developed. One 
of the main drawbacks to the current methodology is the need for a different catalyst for 
each substrate and halogenating reagent.  Ideally, one catalyst could perform the reaction 
for any substitution pattern on the olefin to produce any fluoro-, chloro-, bromo-, or 
iodolactone. Unfortunately for the methods discussed above, no catalyst has even begun 
to approach this ideal. In fact, only (DHDQ)2PHAL can promote more than one type of 
lactonization with respect to halogenating reagent. Additionally, the halolactonization 
reactions of alkyl-substituted olefinic acid derivatives are underrepresented and generally 
provide lower enantioselectivities with respect to the corresponding aryl derivatives; tri- 
and tetra-substituted olefinic aids remain all but absent in the literature. Finally, while 
two examples of halolactonizations that generate a stereogenic C-X bond were discussed, 
these reactions were unknown prior to our entrance into the field. Despite the 
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what does not work and help to narrow the field for future designs that could meet the 
requirements for an ideal halolactonization catalyst. 
3.5 PREVIOUS WORK IN THE MARTIN GROUP 
3.5.1 Catalyst Design 
The Martin group was drawn to this field by the prospect of synthesizing 
bromophycolide A (3.2). Though bromophycolide A has yet to succumb to total 
synthesis, there is one asymmetric route to the carbocyclic skeleton.224 It was imagined 
that halolactonization reactions could be used to introduce the macro-bromolactone and 
bromohydrin moiety of 3.2. However, at the onset of this work (2010), the only 
halolactonization catalysts that had been reported were Borhan’s 3.33, Yeung’s 3.59 and 
3.60, Tang’s 3.55, and Fujioka’s 3.38 (Figure 3.6). All of these catalysts were limited to 
either aryl-substituted olefinic acids or enynes, thus they were useless in the planned 
approach toward bromophycolide A (3.2). Additionally, a catalytic, enantioselective 
bromo-polyene cyclization was envisaged to synthesize the bromo-cyclohexene moiety. 
While one stoichiometric, enantioselective polyene cyclization had been reported, 200 a 
catalytic enantioselective protocol remains unknown. Furthermore, besides the synthesis 
of bromophycolide and the development of polyenecyclizations, there were limitations 
within the halolactonization field that needed to be addressed: 1) Catalysts were limited 
to 5-aryl-5-hexenoic acids and trans-6-aryl-5-hexenoic acids, 2) No catalyst had been 
developed that could form a carbon halogen bond at an exocyclic stereogenic center, and 
3) No catalyst could perform more than one type of halolactonization with respect to the 
halogen. Thus, a new catalyst(s) for both halolactonization and halopolyene cyclization 






Figure 3.6 Known catalysts at the onset of our research 
Because there were known catalysts that could promote halolactonization 
reactions, the group chose to learn from these catalysts in order develop a new catalyst. 
What was known from these successful catalysts was that they were bifunctional, 
including both a Lewis or Brønsted acid and a Lewis or Brønsted base. Consequently, it 
was decided that a new chiral scaffold capable of accepting two functional groups would 
be required. BINOL (3.86) was chosen as the catalyst scaffold because this backbone was 
unexplored in the realm of halocyclization reactions. Moreover, it is a privileged scaffold 
that is nearly ubiquitous in the field of enantioselective reactions, and it has two 
















3.59, R = H





























3.7). With this idea in mind, the group set out to design and screen derivatives based on 
the general model 3.87.  
 
 
Figure 3.7 Strategy for BINOL as a catalyst scaffold 
 Based on the four successful catalyst designs reported thus far (Figure 3.6), it was 
reasoned that a basic nitrogen atom would be needed to coordinate the carboxylic acid, 
and a Lewis acidic functional group (urea, thiourea, carbamate, or thiocarbamate) would 
activate the halogenating reaction. A number of catalysts based on derivatives 3.89, 
which contain a pyridine and a urea or thiourea were synthesized, but these designs 
provided the product lactones as racemic mixtures (Figure 3.8). As the pyridine moiety 
might not have be basic enough to coordinate the acid, the more basic imidazoline 
catalyst 3.90 was synthesized, but the product lactone was only obtained in up to 8% ee. 
Modeling catalyst 3.90 revealed that the imidizoline and thiourea were unable to adopt a 
conformation which would allow them to both participate in catalysis by coordinating 
both the acid and halogen source, thus a new design was needed to move the functionality 
away from the rigid BINOL scaffold. Additionally, the addition of steric bulk around the 
catalophore had been shown in the literature to enhance stereoselectivity,225 so catalyst 
3.92 was targeted, which borrowed a thiocarbamate from Yeung’s design 3.59 and an 











to be appended to 3.91 (Equation 3.35). As the phenyl moiety might have been blocking 
the naphthol, the synthesis of 3.94 was attempted, but 3.93 was unreactive as well 
(Equation 3.36).226 Luckily, 3.91 was serendipitously discovered to provide 
bromolactones with a high degree of enantioselectivity. 
 
 























































3.5.2 Bromolactonization reactions 
2,4,4,5-Tetrabromocyclohexadienone (TBCO) was found to be the optimum 
brominating reagent in preliminary experiments, with NBS and DBDMH reported to 
provide no reaction or low yields.226 A solvent screen then revealed that a mixture (2:1) of 
toluene and methylene chloride provided the highest selectivity.166 
In order to compare catalyst 3.91 to other catalysts, trans-6-aryl-5-hexenoic acids 
3.28 were tested, revealing that catalyst 3.91 matched the best yields and 
enantioselectivities reported in the literature (Table 3.1). For 5-aryl-5-hexenoic acids 
3.95, it was found that the catalyst was competitive as well (Table 3.2, Entries A, B, and 
C), though catalyst 3.91, like most other catalysts, lost efficiency on electron-rich 
aromatic-substituted acids (Table 3.2, Entry D). The ability to cyclize both of these 
substrates was a small victory, because no single catalyst had been reported to perform 
well on more than one type of substrate. Additionally, catalyst 3.91 was unfortunately 
inefficient in the bromolactonization of a tri-substituted olefinic acid (Table 3.2, Entry E); 





Table 3.1 Bromolactonization of trans-6-aryl-5-hexenoic acids 
 
Entry R Yield (%) er 
A Ph 94 98:2 
B 1-Np 97 96:4 
C 2-thienyl 92 94:6 
 
 
Table 3.2 Bromolactonization of 5-aryl-5-hexenoic acids and a trisubstituted acid 
 
Entry R1 R2 Yield er 
A Ph H 99 86:14 
B m-NC-Ph H 89 91:9 
C p-NC-Ph H 92 94:6 
D p-MeO-Ph H 70 58:42 
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TBCO (120 mol %)
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The bromocyclization of cis-alkyl olefinic acids 2.97, which were unreported in 
the literature, was then attempted. It was found that catalyst 3.91 provided bromolactones 
3.98 in excellent yields and enantioselectivities with branched alkyl olefinic acids (Table 
3.3). This remarkable result was the first highly enantioselective bromolactonization of a 
Z-alkyl substituted olefinic acid, and thus the first bromolactonization that generated a C-
Br bond at an exocyclic stereogenic center.  
Table 3.3 Bromolactonization of 6-alkyl-5-hexenoic acids  
 
Entry R Yield (%) er 
A Et 90 85:15 
B i-Bu 87 95:5 
C i-Pr 94 97:3 
D Cy 94 98.5:1.5 
E t-Bu 97 97:3 
 
The prochiral diene 3.99 was then subjected to the bromolactonization conditions 
(Equation 3.37). Excitingly, bromolactone 3.100 was recovered in 72% yield and 73:27 
er. After a single recrystallization, the enantioselectivity could be increased to 99:1. This 
reaction represented the first desymmetrization reaction via a halolactonization reaction. 
This reaction has since been performed on up to 2.5 g scale for our synthesis of the F ring 
O
OH
3.91 (10 mol %)
TBCO (120 mol %)










fragment of the natural product kibdelone C.227 Additionally, this was the fourth type of 
substrate that was successful with catalyst 3.91, whereas other catalysts only worked well 
on one type of substrate. It should be noted that during the course of the reaction, catalyst 
3.91 was brominated to provide 3.101 (Equation 3.36). When 3.101 was subjected to the 
halolactonization reactions, the same yields and enantioselectivities that catalyst 3.91 





3.5.3 Working Model 
Based on the results obtained thus far, the following working model was proposed 
for the induction of chirality from the catalyst to the substrate (Figure 3.9). Using cis-5-
substituted-4-pentenoic acids as the model substrate, the naphthol moiety is thought to 
participate via a hydrogen bond interaction with the carboxylate while the amidine 
stabilizes the halonium ion prior to C-O bond formation. We posit this, because when the 
naphthol moiety was masked with a methyl group, no enantioselectivity was observed 
CO2H 3.91 (10 mol %)
TBCO ( 120 mol %)
PhMe/CH2Cl2 (2:1), –50 °C, 4 d
72%, 73:27 er























(vide infra). Additionally, amidines are known to react with halogenating reagents to 
produce N-halo-amidines, which in turn react as brominating reagents themselves.228,229 
The substrate should favor alignment with the steric bulk away from the catalyst pocket, 
preferring 3.102 over 3.103, thus transferring the chirality from the catalyst to the 
substrate to provide the enantioenriched lactone 3.98 instead of epi-3.98. However, the 
possibility that the amidine acts as the base while the naphoxide stabilizes the halonium 








Figure 3.9 Working model for our bromolactonization reaction 
3.5.4 Summary 
At the conclusion of these initial studies on bromolactonization reactions, a 
catalyst was discovered that was more general than any of the previously reported 
catalysts, performing bromolactonizations on four different substrates rather than on only 
one. Catalyst 3.91 or 3.101, for the first time, promoted the bromolactonization of alkyl 
olefinic acids generating a stereogenic C-Br bond exocyclic to the lactone. Furthermore, 





















































4.36 (10 mol %)
X+ (120 mol %)
PhMe/CH2Cl2 (2:1)







provided the desymmetrized product in 98:2 er. However, trans-alkyl olefinic acids 
yielded decreased enantioselectivities (ca. 70:30 er). Additionally, like all other reported 
catalysts, thus far catalyst 3.91 only worked for bromolactonization reactions. In our 
quest to discover a general halocyclization catalyst, we sought to be able to perform 
chloro-, iodo-, and/or fluorolactonization reactions, increase the enantioselectivity of 
problematic substrates, and hopefully perform a variety of other cyclizations (e.g. 
etherifications, aminocyclizations, halolactamization reactions, and polyene cyclizations). 





Chapter 4: Development and Application of New Halocyclization 
Catalysts  
4.1 CATALYST DERIVATIVES:  SYNTHESIS AND SCREENING BROMOLACTONIZATIONS 
4.1.1 Synthesis of Amidine Catalyst Derivatives 
In the initial catalyst design, we had decided to include the phenyl group on the 3- 
position of the naphthol because literature precedent suggested that steric bulk around the 
catalaphore generally led to increased enantioselectivity.225 Thus, we set out to prepare 
the 3,3’-disubstituted catalyst 4.7 in order to query if even more bulk would enhance the 
selectivity. The synthesis commenced from bis-methoxy BINOL 4.1, which was 
iodinated and subsequently subjected to Suzuki cross-coupling conditions to provide 4.2 
in 67% yield over two steps (Scheme 4.1).230,231 Deprotection and triflation of 4.2 
delivered 4.3 in 91% yield over two steps.232 Cyanation of the triflate was accomplished 
by coupling with potassium cyanide in the presence of a nickel catalyst,233,234 which was 
then reduced with lithium aluminum hydride to provide amine 4.5 in 35% yield over two 
steps. Finally, exposure of 4.5 to N,N-dimethylacetamide dimethylacetal (4.6) provided 





Scheme 9.1 Synthesis of bis-phenyl catalyst 4.7 
We had proposed that the naphthol/amidine-based catalysts were bifunctional 
(Section 3.5.3),166 like most of the other successful halolactonization catalysts (Section 
3.4). Specifically, we proposed that both the naphthol and the amidine were involved in 
determining the stereochemical outcome of the reaction, rather than relying on the 
amidine to function solely as a chiral base. Therefore, we sought to prepare analog 4.11 
wherein the naphtoxy moiety had been masked (Scheme 4.2). Towards this end, bis-
methoxy BINOL 4.1 was mono-demethylated with niobium pentachloride and treated 
with trifluoromethanesulfonic anhydride to provide 4.8 in 95% yield over two steps.232,235 
In an analogous sequence as above (Scheme 4.1), triflate 4.8 was coupled with potassium 
O
O



















2. DIPEA, Tf2O, CH2Cl2

























cyanide, reduced, and treated with 4.6 to deliver catalyst 4.11. We were then prepared to 
test our new catalyst derivatives. 
 
 
Scheme 4.2 Synthesis of catalyst derivative 4.11 
4.1.2 Comparison of Amidine-Based Catalyst Derivatives 
Ultimately, a series of eight derivatives were prepared for testing (Table 4.1). 
These included the original catalyst 4.12 from the bromolactonization reactions (Section 
3.5.2) and 4.13 and 4.14 to test the effect of increasing steric bulk near the naphthol 
moiety (R1). Catalyst 4.15 was prepared to query if steric bulk was needed at all (R1 = R2 
= H), while derivative 4.7 would increase the sterics at both the naphthol and the amidine 



































moiety (R4 = Me, t-Bu, or Ph). Finally, we explored the importance of the naphthol by 
masking it as the methyl ether in catalyst 4.11 (R3 = Me). 
Table 4.1 List of catalyst derivatives  
 
 
Entry Catalyst R1 R2 R3 R4 
Aa 4.12 Ph H H Me 
Ba 4.13 2,4,6-(i-Pr)3Ph H H Me 
Cb 4.14 Si(Ph)3 H H Me 
D 4.7 Ph Ph H Me 
Ec 4.15 H H H Me 
Fc 4.16 H H H Ph 
Gc 4.17 H H H t-Bu 
H  4.11 H H Me Me 
a) Daniel Paull. b) Chao Fang. c) Andrew Pansick 
Our study began with acid 4.18, one of the most common test substrates in the 
literature. As before, the original catalyst 4.12 delivered the product lactone 4.19 with 
86:14 er (Equation 4.1). Catalysts 4.13 and 4.14 provided worse selectivity at 50:50 and 
76:14 er respectively. We found that both the disubstituted catalyst 4.7 and the un-
substituted catalyst 4.15 performed as well as the original catalyst 4.12. Likewise, there 










amidine 4.16; however, we found that tert-butyl-substituted amidine catalyst 4.17 
performed significantly worse at 62:38 er. Finally, as we hypothesized, blocking the 





In our initial bromolactonization studies, catalyst 4.12 provided the worse 
selectivities (70:30 er) on trans-alkyl-substituted olefinic acids like 4.20. We postulated 
that increased steric bulk might improve the enantioselectivity on this troublesome 
substrate (Equation 4.2). Unfortunately, we found that the entire series of bulky catalysts 
(4.13, 4.14, 4.7, and 4.15) performed worse than catalyst 4.12. Thus, it appeared that 
decreasing the steric interactions would lead to the increased selectivity; however, the un-
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We continued our testing with cis-substituted olefinic acid 4.22 finding that the 
bis-phenyl catalyst 4.7 performed only slightly better than catalyst 4.12 (Equation 4.3). 
Both catalyst 4.7 and 4.12 delivered lactone 4.25 in similar selectivities (Equation 4.4). 
Finally, in the desymmetrizing lactonization of 4.36, catalyst 4.12 was found to be the 
optimal catalyst (Equation 4.5). Thus, while the 3,3’-disubstituted catalyst 4.7 and the un-
substituted catalyst 4.16 performed as well as 4.12 on most of the substrates, 4.12 was the 
most consistently selective across the range of substrates. Consequently, we chose to 
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4.7, 86:14 er (4.4)
CO2H Cat. (10 mol %) TBCO (120 mol %)
PhMe/CH2Cl2 (1:1)













Figure 4.1 Our most consistently selective bromolactonization catalyst 4.12 
4.1.3 Thiourea Catalyst Derivatives 
Urea, thiourea, and thiocarbamate moieties were previously reported to be 
excellent functionalities on a number of successful organocatalysts for halocyclization 
reactions.136 Thus, during the course of our screening, we posited that a thiourea moiety 
might be an appropriate functional group for our catalyst scaffold, either by acting as a 
Lewis acid to activate the halogenating reagent or as a Lewis base to transfer the 
halonium ion. Initially, a series of three aryl thiourea catalysts were prepared from 
precursor 4.28 by reaction with the appropriate isothiocyanate to provide 4.29, 4.30, and 











Figure 4.2 Thiourea based catalysts 4.29-4.33 
We found that the catalysts 4.29, 4.30, and 4.31 performed significantly worse 
than our best amidine catalyst 4.12 for the bromolactonization of acid 4.18 (Equation 
4.6). As the thiourea catalysts did not perform as well at catalyst 4.12 on substrate 4.18, 
the transition state must be unfavorable when the thiourea catalysts coordinate 4.18. 
Thus, the transition state might in turn be favorable with the trans-alkyl olefinic acids, 
which were troublesome substrates with catalyst 4.12. While no improvement was 
observed, catalyst 4.31 delivered lactone in 70:30 er, the same enantiomeric ratio that 
catalyst 4.12 afforded (Equation 4.7). Interestingly, in contrast to the normal trends in the 
literature,136 the more electron-rich thiourea derivatives supplied the highest 
enantioselectivities. This suggests that the thiourea moiety was functioning as a Lewis 
base on our catalyst, rather than as a Lewis acid, which most other group propose. With 





















(Figure 4.2), but these analogs failed to improve the selectivity (Equation 4.7). Finally, 
substrate 4.34, another problematic substrate, was tested, but amidine 4.12 outperformed 








After extensive testing concluded that 4.12 was the most suitable catalyst for 
further development. However, it was slightly disappointing to discover that we had 
stumbled upon to the best catalyst design from the onset. Additionally, we learned via the 
use of catalyst 4.11 that the naphthol functionality is important in determining the 








Cat. (10 mol %)
 TBCO (120 mol %)
PhMe/CH2Cl2 (2:1)
–50 °C, 14 h
4.18 4.19
4.29, 85%, 51:49 er
4.30, 92%, 55.5:44.5 er
4.31, 92%, 67:33 er
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4.29, 90%, 57:43 er
4.30, 90%, 63:37 er
4.31, 90%, 70:30 er
4.32, 73%, 63:27 er
4.33, 90%, 65:35 er
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4.31, 90%, 53.5:46.5 er






catalyst now known, we set out to explore the utility of catalyst 4.12 beyond 
bromolactonization reactions.  
4.2 DEVELOPMENT OF IODOLACTONIZATION REACTIONS 
4.2.1 Initial Discovery and Reaction Optimization 
In early attempts, we found that iodolactonizations using catalyst 4.12 were 
sluggish. Remembering that during the course of the bromolactonization reaction, 
catalyst 4.12 was brominated to provide 4.36 led us to question whether 4.36 might be a 
better catalyst for iodolactonization reactions (Equation 4.9). While the reaction with 
catalyst 4.36 was slow at –50 °C, the temperature used for bromolactonization reactions, 
we found that at –20 °C in toluene/CH2Cl2 (2:1) that acid 4.18 suffered lactonization to 
provide 4.37 in 89% yield and 93:7 er (Table 4.2, entry A). To our delight, the 
iodolactonization provided a higher enantiomeric excess than the corresponding 
bromolactonization reaction (86:14 er). While it seemed intuitive that this 
iodolactonization should be feasible, at the time no reported catalyst was able to perform 
halolactonization reactions with more than one type of halogenating reagent. The fact that 
catalyst 4.36 could promote both iodo- and bromolactonization reactions was remarkable. 



















We began by changing the ratio of the solvents, finding the initial conditions of 
toluene/CH2Cl2 (2:1) to be optimal, although only marginally (Table 2.2, Entries A, B, C, 
and D).  Next, temperature was investigated. No increase in selectivity was observed 
when the reaction was cooled to –40 °C; additionally, little erosion in selectivity was 
observed as the reaction was warmed to 0 °C (Table 2.2, Entries E, F, and G). At 0 °C, 
the product was obtained with a 90:10 er in only 45 min compared to a 93:7 er in 14 
hours at –20 °C. These conditions (0 °C) are readily available to researchers without 
instrumentation to maintain a –20 °C bath overnight. Jacobsen previously reported that 
the inclusion of iodine as a co-catalyst improved the selectivity in his 
iodolactonizations,150 so we added 10 mol % I2 (Table 2.2, Entry H) and 1 mol % I2 
(Table 2.2, Entry I) but saw no improvement in enantioselectivity in either case. We later 
found that the reaction proceeded equally as well with only 5 mol % of catalyst (Table 
2.2, Entry J), but we completed our studies with 10 mol % as most of the substrate 





Table 2.2 Optimization of the iodolactonization reaction 
 
 
Entry PhMe/CH2Cl2 Temp (°C) Time (h) Yield (%)a erb 
Af 2:1 –20 14 89 93:7 
Bf 1:0 –20 38 73 83:17 
Cf 1:1 –20 38 73 89:11 
Df 1:2 –20 38 76 88:12 
E 2:1 –40 38 86 93:7 
F 2:1 –10 1.5 87 92:8 
G 2:1 0 0.75 87 90:10 
Hc 2:1 –20 14 99 90:10 
Id 2:1 –20 14 86 93:7 
Je 2:1 –20 14 86 93:7 
a) Isolated yield after column chromatography. b) er determined by chiral HPLC chromatography. c) with 








4.36 (10 mol %)








4.2.2 Exploration of Iodolactonization Substrate Scope 
4.2.2.1 Synthesis of Butyrolactones: 5-Exo-Iodolactonization Reactions 
We began our exploration of the substrate scope by continuing with the 5-exo-
iodolactonization reactions of geminally substituted olefinic acids. While electron-poor 
substrate 4.38 was lactonized to provide 4.42 with 90:10 er (Table 4.3, Entry D), the 
electron-rich 4.39 did not perform as well (Table 4.3, Entry C). This is presumably 
because the electron rich aromatic moiety can stabilize a carbocation at the benzylic 
position, which results in decreased selectivity as the carboxylate could attack from either 
face of the cation. We did find, in this case, that the addition of I2 (10 mol %) improved 
the selectivity from 74:26 to 82:18 er for the lactonization of 4.39. It remains unclear why 
I2 helps in this case, though perhaps the iodonium ion derived from I3+ is further 
stabilized which attenuates ring opening to the carbocationic intermediate.  We then 
tested alkyl substituted olefinic acids 4.40 and 4.41 and found that while methyl-
substituted lactone 4.44 was obtained in only 65:35 er (Table 4.3, Entry D), catalyst 4.36 





Table 4.3 Iodolactonization of 4-substituted-4-pentenoic acid derivatives 
 
Entry Acid R Product Yield (%)a erb- 
A 4.18 Ph 4.37 89d (86)c 93:7 (93:7)c 
B 4.38 p-NC-Ph 4.42 92d 90:10 
C 4.39 p-MeO-Ph 4.43 90e (93) 74:26 (82:18) 
D 4.40 Me 4.44 96e 65:35 
E 4.41 t-Bu 4.45 91e 83:17 
a) Isolated yield after column chromatography b) er determined by chiral HPLC chromatography c) Yields 
and er in parentheses obtained with the addition of I2 (10 mol %) d) Daniel Paull e) Chao Fang  
 
We continued our syntheses of butyrolactones with the lactonization reactions of 
cis-5-substituted-4-pentenoic acid derivatives (Table 4.4).167 Across the board, for both 
alkyl- and aryl-substituted olefinic acids, we found that the lactones were obtained with 
the highest enantioselectivities of any substrate class. In the context of our working 
model (Section 3.5.3), this makes sense as the substrates can orient the two protons of the 
olefin towards the catalyst; whereas on other substrates, some amount of steric bulk will 
point in to the catalyst pocket. The 5-exo-cyclization pathway of the aryl-substituted 
olefinic acids 4.50-4.53 was interesting and initially counterintuitive, as one would 
predict a 6-endo cyclization based on the apparent electronic bias of the substrate. This 
can be explained through analysis of the transition state model (Figure 4.3). In order for 








4.36 (10 mol %)
NIS (120 mol %)
PhMe/CH2Cl2 (2:1)
–20 °C, 14 h




to be aligned to stabilize the positive charge as in 4.62. However, this conformation 
induces A1,3 strain between the aryl group and the aliphatic side chain, so it adopts 
conformation 4.64 to alleviate this strain leading to the kinetic 5-exo-cyclization product 
4.65. 
Table 4.4 Iodolactonization of cis-5-substituted-4-pentenoic acid derivatives 
 
Entry Acid R Product Yielda erb 
A 4.46 i-Pr 4.54 93 97:3 
B 4.47 i-Bu 4.55 94c 98:2 
C 4.48 t-Bu 4.56 99 97:3 
D 4.49 Cy 4.57 97d 98.5:1.5 
E 4.50 Ph 4.58 93d 98.5:1.5 
F 4.51 p-NC-Ph 4.59 95d 99:1 
G 4.52 p-Cl-Ph 4.60 89d 98:2 
H 4.53 2-Np 4.61 94d 98:2 
a) Isolated yield after column chromatography b) er determined by chiral HPLC chromatography c) Daniel 










4.36 (10 mol %)
NIS (120 mol %)
PhMe/CH2Cl2 (2:1)







Figure 4.3 Cyclization pathways of the cis-5-aryl-substituted-4-pentenoic acids 
We found iodolactonization of the trans-alkyl substituted olefinic acid 4.62 
problematic (Equation 4.10), just like in the bromolactonization reactions. Intriguingly, 
acid 4.62 was the only substrate that provided lower enantioselectivity than the 
corresponding bromolactonization reaction. This low enantioselectivity was not improved 
with the inclusion of iodine. Another problematic substrate was tri-substituted acid 4.64, 
which provided lactone 4.65 in only 65:35 er; however, unlike 4.62, iodine did improve 
the selectivity up to 79:21 er. Thus, while iodine has not been found to be detrimental to 
any of the reactions, there was no clear trend to predict which substrates would benefit 

























4.2.2.2 Synthesis of Valerolactones: 6-Exo-Iodolactonization Reactions 
We then moved to the synthesis of valerolactones using our iodolactonization 
protocol. For cis-6-substituted-5-hexenoic acid derivatives 4.66-4.49 (Table 4.5), we 
observed similarly high yields and selectivities of the product lactones 4.70-4.73 as we 
did for the cis-substituted-5-exo substrates (Table 4.4). We then turned our attention to 
the geminally substituted substrates 4.72-4.74 (Table 4.6); however, we found the 
selectivities lacking; the selectivities were slightly enhanced with the inclusion of iodine. 
Finally, the tri-substituted olefinic acid 4.78 was subjected to the reaction conditions, but 






O4.36 (10 mol %)
NIS (120 mol %)
PhMe/CH2Cl2 (2:1)
–20 °C, 14 h
78%, 67:33 er









4.36 (10 mol %)
NIS (120 mol %)
PhMe/CH2Cl2 (2:1)
–20 °C, 14 h
80%, 65:35 er





Table 4.5 Iodolactonization of cis-6-substituted-5-hexenoic acids 
 
Entry Acid R Product Yield (%)a erb 
A 4.66 Ph 4.70 89c 99:1 
B 4.67 p-NC-Ph 4.71 88c 99:1 
C 4.68 2-Np 4.72 93c 98.5:1.5 
D 4.69 t-Bu 4.73 98c 98:2 
a) Isolated yield after column chromatography b) er determined by chiral HPLC chromatography. c) Chao 
Fang  
 
Table 4.6 6-Exo-iodolactonization reactions of geminally substituted acid derivatives 
 
Entry Acid R X Product Yield (%)a erb 
A 4.72 Ph CH2 4.75 98 (95)c 76:24 (85:15)c 
Bd 4.73 Me CH2 4.76 89 (90) 79:21 (80:20) 
C 4.74 Ph O 4.77 91 (89) 84:16 (90:10) 
a) Isolated yield after column chromatography b) er determined by chiral HPLC chromatography c) Yields 








4.36 (10 mol %)
NIS (120 mol %)
PhMe/CH2Cl2 (2:1)











4.36 (10 mol %)
NIS (120 mol %)
PhMe/CH2Cl2 (2:1)






4.2.2.3 Desymmetrization, Kinetic Resolution, and Caprolactonization Reactions 
Since a majority of the lactonization reactions worked better with NIS than 
TBCO, we thought that we might be able to perform the desymmetrization reaction with 
even better enantioselectivity. However, we found that while the reaction cleanly 
consumed diene 4.80 (Equation 4.13), the product 4.81 decomposed upon attempted 




We saw an opportunity to develop a kinetic resolution of racemic olefinic acids, 
as at the time there were no reports of resolutions using halolactonization technology. To 
this end, olefinic acid 4.82 was subjected to iodolactonization with NIS (50 mol %) to 
provide iodolactone 4.83 in 44% yield in 83:17 er (Equation 4.14). Lactone 4.83 was 
used by Overman in the synthesis of (+)-sieboldine A and Helmchen in the synthesis of 
the jasmonoid family of natural products. 236-238 Similarly, cyclohexenoic acid 4.84 was 
subjected to the reaction conditions to furnish lactone 4.85 in 43% yield and 78:22 er. 











4.36 (10 mol %)
NIS (120 mol %)
PhMe/CH2Cl2 (2:1)
–20 °C, 14 h
81%, 79:21 er









4.36 (10 mol %)
NIS (120 mol %)
PhMe/CH2Cl2 (2:1)










In our attempts to expand the scope of the reaction further, we sought to 
synthesize caprolactones. To the best of our knowledge, this substrate class had not been 
attempted in the context of enantioselective halolactonization development. 
Unfortunately, both olefinic acid 4.86 and 4.88 failed to react. Acid 4.88 even failed to 
deliver the valerolactone product, though the electron rich aryl ring should have biased 









O 4.36 (10 mol %)
NIS (50 mol %)
MePh/CH2Cl2 (2:1)







O4.36 (10 mol %)
NIS (50 mol %)
PhMe/CH2Cl2 (2:1)






4.36 (10 mol %)
NIS or NBS (120 mol %)
PhMe/CH2Cl2 (2:1)













Through a systematic exploration of steric effects around our catalyst scaffold, we 
learned that catalyst 4.12 was the best catalyst for halolactonization reactions; however, 
in the development of an iodolactonization protocol we found reason to believe 4.36 to be 
the active catalyst. Furthermore, we extended the scope of the possible halolactonization 
reactions to iodolactonization reactions,167 making catalyst 4.36 the first catalyst able to 
promote both iodo- and bromolactonization reactions. Finally, the substrate tolerance of 
catalyst 4.36 is extremely impressive. The range of substrates that 4.36 can lactonize with 
good to excellent enantioselectivities remains unrivaled. Due to the success of 4.36 in 
halolactonization reactions, we thought that we might be able to extend the utility of 
catalyst 4.36 further into a variety of halocyclization reactions. 
4.3 BEYOND HALOLACTONIZATION REACTIONS 
4.3.1 Halolactamization Reactions 
A survey of the enantioselective halocyclization literature revealed that while 
numerous reactions have been developed, halolactamization reactions were absent 
(Equation 4.18). A number of halolactamization reactions that product racemic mixtures 
have been reported,239-245 and one report of a diastereoselective halolactamization reaction 
using a chiral auxiliary exists.246 Consequently, it was extremely surprising that this 
OH
O
4.36 (10 mol %)
NIS or NBS (120 mol %)
PhMe/CH2Cl2 (2:1)











reaction had not been reported using catalyst control. Halolactams had been synthesized 
by oxidizing the product of an enantioselective haloaminations reactions,185 but a direct 
reaction from an olefinic amide 4.96 would be ideal. Thus, we sought to extend the scope 




We chose to install an electron-withdrawing group on the amide nitrogen atom in 
order to increase the acidity of the substrate enough to coordinate to the catalyst, like we 
propose the olefinic acids do. To our delight, the reaction did progress when using mesyl 
4.98, tosyl 4.99, and nosyl-sulfonimides 4.100. Unfortunately, the enantioselectivities in 
these cyclizations were only moderate (ca. 70:30) (Table 4.7). During the course of these 
experiments, tried both NBS and DBDMH to effect the bromolactamization and found 
that the results were the same as TBCO (Table 4.7, Entries E and F). While the 
selectivities were somewhat lacking, to the best of our knowledge (ca. 2012) these 
reactions represented the first direct synthesis of enantioenriched halolactams, though 
Yeung was the first to report a bromolactamization protocol earlier this year, which 























Table 4.7 Halolactamization reaction attempts 
 
Entry Amide R X+ Product Yield (%)a erb 
A 4.98 Ns TBCO 4.101 85 71:29 
B 4.99 Ts TBCO 4.102 70 72:28 
C 4.100 Ms TBCO 4.103 70 71:29 
D 4.100 Ms NIS 4.104 70 71:29 
E 4.99 Ts NBS 4.102 90 70:30 
F 4.99 Ts DMDBH 4.102 80 72:28 
a) Isolated yield after column chromatography b) er determined by chiral HPLC chromatography  
 
We also explored the use of a Boc protected amide 4.105 for the 
halolactamization reactions (Equation 4.19). Interestingly, we isolated lactone 4.107 
instead of the expected lactam 4.106 with the same enantioselectivity as the 
bromolactonization reaction (Equation 4.1). This type of cyclization was known in 
similar systems.248 With this is mind we propose the following rationale for the high 
enantioselectivity for the lactones in comparison to the lactams. Once the acid has 
coordinated to the catalyst, the olefinic acids 4.108 and the Boc amide 4.109 cyclize from 
the coordinated position such that the carbonyl oxygen atom of the substrate acts as the 
nucleophile and ends up within the ring of the lactone (Figure 4.5). Conversely, the 











4.36 (10 mol %)
"X+" (120 mol %)
PhMe/CH2Cl2 (2:1)





which may account for the decreased selectivity in the lactamization reactions. Though 
the reason why the sulfonimides release to form the lactams rather than cyclize to the 
















4.36 (10 mol %)
NBS (120 mol %)
PhMe/CH2Cl2 (2:1)



























































4.3.2 Extension of the Reagent Scope for Halolactonization Reactions 
Because we found that the lactamization reactions proceeded with equal 
selectivities regardless of the halogenating reagents, we revisited the bromolactonization 
reactions. Whereas in preliminary studies, catalyst 4.12 was reported to only work with 
TBCO, we found that brominated catalyst 4.36 worked equally well with both NBS and 
DBDMH to provide lactone 4.107 (Table 4.8, Entries A and B). We reasoned that 4.36 
may be a more reactive halogenating catalyst, which was why the bromolactonization 
studies with 4.12 were only successful with TBCO. Therefore, we retested 4.12 with 
NBS and DBDMH to find that the bromolactonization reactions were halogenating 
reagent independent with 4.12 as well (Table 4.8, Entries C, D, and E). Catalyst 4.36 was 
recovered from all three of the reactions. We also found the same results for the 6-endo 
cyclization reactions (Table 4.9). The fact that catalysts 4.12 and 4.36 are halogenating 
reagent independent makes these catalysts unique, as other catalysts in the literature only 





Table 4.8 Bromolactonization reactions with various halogenating reagents 
 
 
Entry Catalyst Br+ Yielda erb 
A 4.36 NBS 95 87:13 
B 4.36 DMDBH 90 87:13 
C 4.12 TBCO 99 86:14 
D 4.12 NBS 99 87:13 
E 4.12 DMDBH 90 87:13 
a) Isolated yield after column chromatography b) er determined by chiral HPLC chromatography  
 
Table 4.9 6-Endo bromo lactonization reactions with various brominating reagents 
 
Entry Br+ Yield (%)a erb 
A TBCO 94 98:2 
B NBS 92 99:1 
C DMDBH 92 99:1 





Cat. (10 mol %) 
"Br+" (120 mol%)
PhMe/CH2Cl2 (2:1)









4.12 (10 mol %)
"Br+" (120 mol %)
PhMe/CH2Cl2 (2:1)









4.3.3 Halo-Oxazolination Reactions 
Since we hypothesized that the lactonization reactions worked so well because the 
substrate could cyclize from the coordinated transition state (Figure 4.5), we imagined 
that halo-oxazolination reactions of olefinic amides would work well. In initial 
experiments we found the cyclization of 4.110 to be sluggish and provide poor 
enantioselectivities (Equation 4.20). We thought that this could be due to the attenuated 
acidity of the amides in comparison to the acids and imides, so we attempted the 
cyclization with a more basic guanidine catalyst 4.112. However, while the conversion 















4.36  (10 mol %)





NBS, 10% conv., 50:50 er











4.112  (10 mol %)





NBS, 50%, 50:50 er




We attempted similar transformations on the cis-aryl substituted amide 4.113 as 
our cis-alkyl/aryl acids provided the highest enantioselectivities; however, we only 
isolated oxazoline 4.114 as a racemic mixture. Additionally, we tried the geminally 








During the course of these studies, we found catalyst 4.36 to be the most 
remarkable catalyst in the halolactonization field. It was the first catalyst able to induce 
both bromo- and iodolactonization reactions with high enantiomeric excess. Catalyst 4.36 
was the first catalyst reported that formed C-I bonds at exocyclic stereogenic centers. 
Furthermore, the range of substrates that 4.36 can lactonize with excellent 























4.36 (10 mol %) 







NBS, PhMe/CH2Cl2 (2:1), 50:50 er
NIS, PhMe/CH2Cl2 (2:1), 50:50 er
DCDMH, PhMe/CH2Cl2 (2:1), 50:50 er





While the enantioselectivities were lacking, this catalyst was, to the best of our 
knowledge, the first to provide enantioenriched halolactams from olefinic sulfonimides. 
During the course of the lactamization studies, we found that catalyst 4.36 is brominating 
reaction independent, which makes the catalyst unique. To our chagrin, 4.36 was 
ineffective at almost all other types of halocyclization reactions (oxazolination, 
etherification,226 and aminocyclization249), thus we sought to develop a new BINOL-based 
catalyst that could further our development in the field. 
4.4 SELENIUM-BASED CHIRAL LEWIS BASE CATALYSIS FOR HALOCYCLIZATIONS 
4.4.1 Inspiration 
As chalcogens, specifically selenium, have been shown to be highly effective as 
achiral halogenation catalysts,250-253 we thought that a chiral BINOL-based chalcogenide 
might be an excellent halocyclization catalyst. We tested dibenzylselenide in halo-
aminocyclizations and etherification reactions to confirm the reports, and while the initial 
aminocyclization failed, the etherification progressed cleanly at –50 °C (Equations 4.24 
and 4.25). This idea materialized as three independent strategies: the use of 
dibenzylselenide as a co-catalyst with 4.36, the use of C2-symmetric catalyst 4.121, or the 
development of a new bifunctional catalyst 4.122 (Figure 4.6). With these ideas in mind, 









Figure 4.6 Selenide catalyst designs 
4.4.2 Selenide Co-Catalyst 
The easiest possibly required the use of dibenzylselenide as a co-catalyst with 
4.36. Disappointingly, in the bromoetherification reaction using 4.119, only rac-4.120 
was obtained (Equation 4.26). While the reaction did not occur in the absence of 4.36 or 
Bn2Se, both reactions with and without 4.36 in the presence dibenzylselenide progressed 
at the same rate. Thus, we thought that 4.36 might not be involved at all in the catalysis. 
With this in mind, we turned our attention to chlorolactonization reactions, which had 
been unsuccessful with catalyst 4.36. Since the chlorolactonization reaction did not 
progress with NCS, 4.36 with NCS, or Bn2Se with NCS, we imagined that Bn2Se might 





























could transfer the chloronium to 4.36 then perhaps a chlorolactonization reaction would 
be successful. Unfortunately, no reaction was observed (Equation 4.27). 
 
 
4.4.3 Monofunctional C2-Symmetric Selenide Catalyst 
Until recently, a survey of the literature suggested that bifunctional catalysts were 
required to obtain a high degree of enantioselectivity in halocyclization reactions; 
however, we thought that a C2-symmetric catalyst like 4.121 might be able to 
differentiate between the faces of the olefin and provide enantioselectivity. Chiral 
selenide 4.121 has been used as a stoichiometric reagent for the oxidation of sulfides and 
resolution of ferrocenylphosphine compounds,254,255 but its use as a catalyst in any context 
was heretofore unknown.  
The synthesis commenced with the triflation of BINOL (4.124) to provide 4.125 
in 95% yield. Cross-coupling with methylmagnesium bromide delivered 4.126 in 90% 






4.36 (10 mol %)
Bn2Se (10 mol %)
NBS (120 mol %)
PhMe/CH2Cl2 (2:1)










4.36 (10 mol %)
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PhMe/CH2Cl2 (2:1)






afforded 4.121 in 80% yield over two steps. We then set out to explore the effectiveness 
of this catalyst in halocyclization reactions.  
 
 
Scheme 4.3 Synthesis of selenide 4.121 
In a variety of haloetherifications reactions, we found that while 4.121 cleanly 
provided the product tetrahydrofurans 4.128, there was no enantioenrichment observed 
(Equation 4.28). We also screened these conditions in halopolyenecyclization reactions. 
Our rationale was based on Snyder’s protocol for halopolyenecyclization reactions using 
bromodiethylsulfonium bromopentachloroantimonate (BDSB) (Equations 4.29 and 
4.30).256,257 As the halonium ion was delivered from a sulfonium reagent, we thought the 
selenonium intermediate would provide similar results. However, we were disappointed 




































NBS, CH2Cl2 (0.1 M), –78 °C, 1.5 h, 90%, racemic
NBS, CH2Cl2 (0.03 M), –78 °C, 2 h, 90%, racemic
NBS, PhMe/Ch2Cl2 (2:1) (0.03 M), –78 °C, 9 h, 80%, racemic
NBS, PhMe (0.03 M), –78 °C, 9 h, 15%, racemic
NIS, CH2-Cl2 (0.03 M), –78 °C, NR
NCS, CH2Cl2 (0.03 M), –78 °C NR


























We imagined that we would be able to induce selectivity if we placed some steric 
bulk closer to the catalophore, represented by design 4.135. As we were working on this 
C2-catalyst design, Yeung reported his own C2-symmetric catalyst 4.136 (Figure 4.8),188 
which confirmed the hypothesis we had planned to test with derivatives 4.135. Yeung’s 
protocol effected the bromo-aminocyclization of trisubstituted olefinic sulfonamides in 
good yields with good enantioselectivity (Equation 4.33). With this report, we decided to 
move away from the C2-symmetric selenides, with hope that a bifunctional selenide 
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4.4.4 Bifuncational Selenide Catalyst 
4.4.4.1 Synthesis of a Bifunctional Selenide Catalyst 
Based on the success of our bifunctional catalyst 4.36, we set out to synthesize 
catalyst 4.140 (Figure 4.9). We imagined that this catalyst might work much like catalyst 
4.36, wherein the catalyst would be brominated to provide 4.141 and subsequently 
deprotonated to provide 4.142 (Figure 4.10). Intermediate 4.142 then has a handle to 
hydrogen bond to the substrate as well as deliver the bromonium. With this in mind, we 









4.136 (20 mol %)
4.139 (110 mol %)
PhMe/CH2Cl2 (1:1)
–75 °C, 5 d
18 examples
up to 93%

















Figure 4.9 Bifunctional selenide catalyst design 
 
 
Figure 4.10 Rationale of bifunctionality in catalyst 4.140 
Toward this end, BINOL (4.124) was monotriflated to provide 4.134 and coupled 
with potassium cyanide to give 4.144 (Scheme 4.4). Two-step reduction of the nitrile 
moiety provided diol 4.145,258 which was brominated to provide the penultimate 
intermediate 4.146. We were disappointed to find that while 4.146 was synthesized with 
ease, the final one-pot mixed selenide synthesis failed.259 We then set out to find 

























Scheme 4.4 Attempted synthesis of 4.140 
Generation of the mixed selenide from 4.146 and benzyl bromide failed to 
produce 4.140 (Equation 4.34). Reaction of 4.146 with sodium benzyl selenide, derived 
from the reduction of dibenzyldiselenide with zinc or sodium borohydride, led to no 
desired product formation.260,261,262 Finally, although the literature suggested that free 
alcohols were tolerated in selenide formation reactions, in situ protection of the naphthol 
moiety prior to introduction of the zinc selenide failed as well. Mitsunobu-like selenide 
formation with N-(phenylseleno)phthalimide (NPSP, 4.148) using Nicolauo’s protocol 
also failed (Equation 4.35).263,264 As the coupling of triflate 4.143 with potassium cyanide 
using a nickel catalyst proceeded with ease, we tried the known selenide cross-coupling 











NiBr2(PPh3)2, PPh3, Zn, KCN
MeCN, 65 °C
85%




































1. Se, NaBH4, EtOH; BnBr; 4.146
2. (BnSe)2, Zn, CH2Cl2, RT
3. (BnSe)2, Zn, AlCl3, MeCN/H2O
4. (BnSe)2, NaBH4, EtOH






















NiBr2, PPh3, Zn, (BnSe)2, DMF, 110 °C
NiBr2, bpy, Zn, (BnSe)2, DMF, 110 °C






While the literature suggested that free alcohols were tolerated in these reactions 
and in situ protection of the naphthol had previously failed, we turned our attention to 
protecting the naphthol prior to the selenide formation. This strategy began by protecting 
nitrile 4.124 as the triethylsilylnaphthol 4.150 (Scheme 4.5). Two-step reduction of the 
nitrile group delivered 4.151 in 65% yield over two steps as well as the deprotected diol 
4.145. Unfortunately, treatment of 4.151 failed to provide the desired selenide 4.152. 
 
 
Scheme 4.5 Attempted synthesis of 4.147 
We then returned to the alkylation of metal selenides with a naphthyl halide. To 
this end, bromide 4.146 was protected as the triethylsilyl naphthol 4.153 in 93% yield 
(Scheme 4.6). We were pleased to find that upon exposure to sodium benzylselenide, 
derived from the reduction of dibenzyl diselenide with sodium borohydride, that 4.153 
underwent selenation to provide selenide 4.154 in 75% yield. Finally, deprotection of the 
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Scheme 4.6 Synthesis of catalyst 4.140 
4.4.4.2 Test Reactions with Bifunctional Selenide Catalyst 4.140 
We were disappointed to find that that when 4.119 was subjected to 
bromoetherification with catalyst 4.140, only rac-4.120 was isolated in 90% yield 
(Equation 4.37). We attempted the cyclization of 4.155, as the selectivities of the cis-
substituted olefins provided the highest selectivities with 4.36, but found that the 
cyclization returned starting material (Equation 4.38). This catalyst also failed to perform 
halolactonization reactions (Equations 4.39, 4.40, and 4.41). Though the cause of the 
deficiency in selectivity remains unknown, we propose that it arises from a lack of 
selectivity in the halogenation of the catalyst. Upon exposure to NBS, catalyst 4.140 
might provide diastereomeric selenonium intermediates 4.160 and 4.161 (Equation 4.42). 
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As both our newly designed selenide catalysts failed to induce enantioselective 
halocyclizations, we assessed the value of continuing to pursue this goal. Yeung had 
demonstrated the first C2-symmetric selenide catalyst, so we decided that if we were to 
continue in this field that we would need to focus on the bifunctional selenides. However, 
as discussed above there are inherent problems with these catalyst designs. In order to 
find a feasible catalyst, numerous derivatives would need to be synthesized, resulting in a 
high-risk situation wherein a functional catalyst may never be found. We therefore 

































 PROGRESS TOWARDS THE TOTAL SYNTHESIS OF 
JIADIFENOLIDE 
Chapter 5: Jiadifenolide – Isolation and Previous Syntheses 
5.1  ISOLATION 
Natural products that promote the growth of neurons are quickly becoming a 
focus in the synthetic community as they could prove to be promising drug leads for the 
treatment of both acute and chronic neurological conditions.266 These natural products 
either mimic or enhance the effect of neurotrophins, proteins responsible for the 
development and maintenance of neurons.267 Unfortunately, these proteins are limited in 
their utility as drugs because they cannot be administered orally and present difficulty in 
crossing the blood-brain barrier. Therefore, in an ongoing search to find treatments for 
neurological diseases, such as Alzheimer’s and Parkinson’s disease, many groups are 
turning towards small molecules for inspiration.268 
The Illicium sesquiterpenoids comprise jiadifenolide (5.1),269 majucin (5.2),270 
jiadifenin (5.3),271 anisatin (5.4),272 and jiadifenoxolanes A/B (5.5/5.6)269 among others 
(Figure 5.1). While anisatin (5.4) and the related molecules that bear a β-propiolactone 
moiety are toxic and lead to neurodegeneration,269,272 the majucin-type Illicium 
sesquiterpenoids 5.1, 5.2, 5.3, 5.5, and 5.6, which characterized by their γ-butyrolactone 
moeity, promote neurite outgrowth.269 Due to their compact and complex architecture 
paired with their interesting neurological activity, this family of natural products has 
attracted significant attention from the synthetic community,273 though jiadifenoxolanes A 
and B (5.5 and 5.6) have yet to succumb to total synthesis.  
Jiadifenolide (5.1) is the most potent member of this family discovered to date, 




presence of nerve growth factor.269 Additionally, it contains a densely functionalized 
cyclohexane moiety and seven contiguous stereocenters, which add a significant 
challenge to its synthesis. To date, Theodorakis,274-276 Sorensen,277 Paterson,278 Shenvi,279 
and Zhang280 have reported syntheses of jiadifenolide (5.1).  
  
 
Figure 5.1 Representative members of the Illicium sesquiterpenoids. 
5.2 PREVIOUS SYNTHESES OF JIADIFENOLIDE (5.1) 
5.2.1 Theodorakis’s Total Synthesis of (–)-Jiadifenolide 
5.2.1.1 Synthesis of (–)-Jiadifenolide 
Theodorakis began his synthesis with the preparation of trione 5.8 via a Tsuji 
allylation of dione 5.7 followed by a Michael addition into methyl vinyl ketone (MVK) to 
provide 5.8 in 63% yield over two steps (Scheme 5.1).274 Treatment of 5.8 with D-

























































with >90% ee. Stereoselective reduction followed by protection proceeded smoothly to 
afford 5.10, which was subsequently subjected to a sequential carboxylation reaction 
using magnesium methyl carbonate (MMC) and methylation to give β-keto ester 5.11 in a 
modest 43% yield.  
Focus then turned to the construction of the fused γ-butyrolactone and bridged δ-
lactone moieties through elaboration of the β-keto ester and allyl functionalities. The 
lengthy sequence commenced with the reduction of both the ketone and the ester of 5.11 
with lithium aluminum hydride, followed by protection of the primary alcohol and 
oxidation of the secondary alcohol. Ketone 5.12 was converted to a vinyl triflate, which 
allowed for the assembly of γ-lactone 5.13 via an intramolecular palladium-catalyzed 
carbonylative alkoxylation. Formation of the bridged δ-lactone proceeded through 
epoxide 5.14 followed by two additional oxidations. Finally, deprotection with 
tetrabutylammonium fluoride (TBAF) afforded tetracycle 5.15 in 19 steps and 7.2% 
overall yield from 5.7. Intermediate 5.15 was then used to diverge to three of the Illicium 







Scheme 5.1 Synthesis of key intermediate 5.15 by Theodorakis. 
With their key intermediate 5.15 in hand, jiadifenolide (5.1) was a mere nine steps 
away (Scheme 5.2). Rearranged tetracycle 5.16 was attained via a two-step oxidation 
procedure. In the event, 5.15 was epoxidized from the top face, which upon oxidation of 
the alcohol underwent isomerization and translactonization from the bridged δ-lactone to 
the fused γ-lactone 5.16. Hydrogenation of the enone and protection of the secondary 
alcohol led to 5.17, which was further transformed into a vinyl triflate and cross-coupled 
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with trimethyl aluminum to give 5.18. Finally, a series of redox transformations delivered 
jiadifenolide (5.1) in 28 steps with an overall 0.47% yield.  
 
 
Scheme 5.2 Synthesis of jiadifenolide (5.1) by Theodorakis. 
Overall, the Theodorakis synthesis of jiadifenolide (5.1) was lengthy and low 
yielding. Little innovative methodology was explored in a synthesis that relied on the 
time-tested Hajos-Parrish reaction as the key step. A lengthy sequence of redox 
transformations was required to install both lactone moieties that continued into another 
lengthy string of redox manipulations to furnish the target compound. Despite these 
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value was found in the ability to diverge from intermediate 5.15 to two additional natural 
products, jiadifenin (5.3) and ODNM (5.23). 
5.2.1.2 Divergence to Jiadifenin (5.3) and ODNM (5.23) 
In addition to jiadifenolide (5.1), Theodorakis manipulated intermediate 5.15 into 
the related majucin-like Illicium sesquiterpenoids jiadifenin (5.3) and ODNM (5.23).275 
Toward that end, 5.15 was dehydrated with Martin sulfurane, and the resultant 
disubstituted olefin was selectively reduc098iuy- .ed to give 5.20. Allylic oxidation 
proceeded in 65% yield to provide enone 5.21, which upon exposure to excess NaHMDS 
and one equivalent of Davis’s oxaziridine delivered α-hydroxy lactone 5.22. Methylation 
of the cyclopentenone moiety afforded ODNM (5.23), and oxidative rearrangement of 
5.23 provided jiadifenin (5.3). Again, much like the synthesis of jiadifenolide (5.1), the 
sequence is lengthy and low yielding. However, through these routes, they were able to 
synthesize enough material to perform biological testing of jiadifenolide (5.3), ODNM 
(5.23), and jiadifenin (5.3). The sequence was relatively straightforward and left a 






Scheme 5.3 Synthesis of ODNM (5.23) and jiadifenin (5.3) by Theodorakis 
5.2.1.3 Second Generation Synthesis of the Tetracyclic Core  
In order to address the step count issue, Theodorakis reported a second-generation 
approach to the Illicium sesquiterpenes.276 This approach focused on early installation of 
the methyl group on the cyclopentane moiety, rather than the lengthy late stage 
installation used in the first synthesis (Scheme 5.2). First, enone 5.9 was protected as the 
allylic dithiane to provide 5.24, which was subsequently converted to alcohol 5.25 in 
three steps (Scheme 5.4). In this sequence, the cyclopentanone was subjected to 
sequential Wittig olefination, hydrolysis, and reduction to furnish 5.25. Mesylation 
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group. Oxidative deprotection delivered enone 5.26 in 66% over three steps. Intermediate 
5.26 was then subjected to a twelve-step sequence analogous to the previous route to 
deliver tetracycle 5.27 (Scheme 5.1). They concluded that tetracycle 5.27 could be a 
viable intermediate for diversity-oriented synthesis; however, this compound was not 
elaborated to any neurotropic molecule of natural or synthetic origin. With another 
straightforward, non-innovative synthesis that required 24 steps and did not result in the 
synthesis of any neurotropic molecules, Theodorakis again left room for improvements 
for future syntheses. In fact, it is difficult to assign any value to this second generation 
strategy at all. 
 
 
Scheme 5.4 Second-generation approach to the Illicium sesquiterpenes by Theodorakis. 
5.2.2 Sorensen’s Total Synthesis of (–)-Jiadifenolide 
Sorensen began the synthesis of jiadifenolide (5.1) from chiral β-keto ester 5.28, 
which was available in three steps from (+)-pulegone.277 Robinson annulation of 5.28 































strategy to that of Theodorakis. Bismethylation with methyl iodide afforded 5.30 in 91% 
yield. Protection of the ketone of 5.30 followed by a redox sequence delivered aldehyde 
5.31 from ester 5.30 in 91% yield over three steps. Homologation of the neopentyl 
aldehyde using the van Leusen protocol proceeded smoothly to provide nitrile 5.32 in 
90% yield. Exposure of 5.32 to sulfuric acid in wet methanol delivered tricycle 5.33 in 
quantitative yield. Finally, condensation with hydroxylamine delivered key intermediate 
5.34, setting the stage for a daring diastereoselective C-H oxidation.  
In the event, oxime 5.34 was subjected to Sanford’s conditions to give 5.35, albeit 
in a meager 22% yield.281 In addition to the desired product 5.34, both epi-5.34 (22%) and 
bisacetoxy-5.34 (yield not reported) were isolated. This represented the first application 
of the C-H oxidation protocol developed by Sanford in a total synthesis. To forge the 
southeastern γ-butyrolactone moiety, Sorensen borrowed a sequence from Theodorakis 
wherein the acetyl-oxime was reduced, converted to vinyl triflate 5.35, and subjected to a 







Scheme 5.5 Synthesis of intermediate 5.36 by Sorensen 
Upon sequential exposure to methoxide and basic peroxides, enoate 5.36 
underwent lactonization and epoxidation to provide 5.38 in 61% yield. Oxidation to the 
penultimate intermediate 5.40 was accomplished in two steps via α-iodination followed 
by an iodoso-Pummerer reaction. Finally, treatment of 5.40 with lithium hydroxide 
completed the synthesis of jiadifenolide (5.1). Sorensen thus completed the second total 
synthesis of jiadifenolide in 21 steps with an overall 1% yield from known 
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Scheme 5.6 Synthesis of jiadifenolide (5.1) by Sorensen. 
The synthesis relied on a number of sequences similar to the strategy that 
Theodorakis utilized, including the opening Robinson annulation and palladium-
catalyzed carbonylative methoxylation. The use of (+)-pulegone to set the 
stereochemistry, which we were exploring when Sorensen reported his synthesis, served 
him well. However, the key step involving the first application of the directed C-H 
oxidation developed by Sanford (Scheme 5.5) suffered from a complete lack of 
selectivity. Finally, the iodoso-Pummerer rearrangement proved to be a clever method for 
introducing the α-keto lactone. Overall, the synthesis was seven steps shorter than the 
route by Theodorakis, but again left significant room for improvement. 
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5.2.3 Paterson’s Synthesis of (±)-Jiadifenolide 
By comparison, the synthesis of jiadifenolide (5.1) by Paterson used a strikingly 
different approach than the two previous syntheses. Notably, his key step was similar to 
that which we had planned to utilize.278 Beginning from cyclopentenone 5.41, sequential 
Luche reduction, peracid oxidation, and protection delivered epoxide 5.42 in 65% yield 
(Scheme 5.7). Boron trifluoride diethyl etherate triggered a stereoselective Meinwald 
rearrangement of 5.42 to deliver ketone 5.43, which was transformed into enoate 5.45 via 
a Horner-Wadsworth-Emmons olefination. Reduction and acylation delivered allylic 
acetate 5.46 setting the stage for a key Ireland-Claisen rearrangement. In the event, 5.46 
was converted by action of LDA and TBSCl to a silyl ketene acetal, which underwent 
rearrangement upon heating. Reduction of the resultant acid provided alcohol 5.47 in 
63% yield over two steps. Finally, hydrolysis of the silyl ether and bisoxidation using the 






Scheme 5.7 Synthesis of aldehyde 5.48 by Paterson. 
The next stage of the synthesis hinged upon coupling aldehyde 5.48 with a 
masked butenolide to form 5.51. Unfortunately, despite extensive screening, they found 
that metallated furan 5.50 would not react with the homo-neopentyl aldehyde 5.48 
(Equation 5.1). Luckily, they discovered that the extended boron enolate of 5.52 added 
smoothly into 5.48, albeit with poor diastereoselectivity (Scheme 5.8). The 
stereoselectivity was thought not to be an issue as both diastereomers oxidized readily to 
provide 5.53 in 83% yield. However, when 5.53 was treated with samarium diiodide, 
tricycle 5.54 was never obtained. Additionally, neither diastereomer of alcohol 5.51 
underwent cyclization when treated with samarium diioide. 
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Scheme 5.8 Successful aldol and unsuccessful radical annulation by Paterson. 
Undeterred by these results, both diastereomers of 5.51 were protected as the 
triethylsilyl ether 5.55 (and epi-5.55) and subjected individually to the cyclization 
conditions (Scheme 5.9). In the event, butenolide 5.55 underwent reductive annulation, 
which upon deprotection delivered tricycle 5.57. Despite extensive screening, the authors 
found that the reaction could only be taken to 51% completion with the remaining 
products being returned starting material and/or decomposition products upon forcing 
conditions; epi-5.55 was found to be unreactive. 
With the key cyclization completed, the group began the final stage of forming 
the last two rings. Oxidation of alcohol 5.57 to β-keto ester 5.54 proceeded in 81% yield. 








































ether of 5.54. Directed reduction of 5.58 with ammonium triacetoxy borohydride 
delivered triol 5.59 in 87% yield with excellent diastereoselectivity. Protection of 5.59 as 
silyl ether 5.60 followed by two oxidations provided α-keto lactone 5.61 in 84% yield 
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Paterson thus completed the total synthesis of 5.1 in 23 steps (27 steps including 
the synthesis of 5.49) with a 1.8% overall yield. The synthesis was two steps longer 
(LLS) than the route by Sorensen, but it almost doubled the overall yield. While the 
synthesis by the Sorensen group closely resembled many sequences of the route taken by 
Theodorakis, Patersen managed to realize a unique route to jiadifenolide (5.1). Key 
sequences of the synthesis included the Luche reduction, directed epoxidation, and 
Meinwald rearrangement, which set the stereochemistry for the remainder of the 
synthesis. A crucial Johnson-Claisen rearrangement installed one of the two quaternary 
centers with ease. Finally, a reductive annulation induced by samarium diiodide, not too 
dissimilar from one we had planned (vide infra), formed the core tricycle of the molecule; 
however, since only one diastereomer cyclized with 51% conversion, this reaction was 
severely detrimental to the overall yield. While failing to best the step count of the 
synthesis by Sorensen, the route makes up for it in its innovation and by nearly doubling 
the overall yield. Yet, despite its successes with creative disconnects, this route still left 






5.2.4 Shenvi’s Total Synthesis of (–)-Jiadifenolide  
Shenvi has realized the most concise and high yielding route to the natural 
product to date. Where as the previous syntheses were linear, resulting in >20 total steps 
(longest linear sequences), Shenvi reaped the rewards of convergence and audacious 
disconnects in his 10 step (eight LLS) synthesis of 5.1. 
The synthesis commenced from (R)-citronellal (5.62), which was dehydrated with 
tert-butylimino-tri(pyrrolidino)phosphorane (BTPP) and nonafluorobutanesulfonyl 
fluoride (NfF), ozonylized, and subjected to Pauson-Khand conditions to deliver bicyclic 
butenolide 5.63 in 35% yield (Equation 5.2). Known butenolide 5.65 was prepared in two 
steps from dioxalane 5.64 in 45% yield (Equation 5.3), setting the stage for an ambitious 
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In the event, 5.65 underwent Michael addition by the anion of 5.63, which upon 
exposure to excess titanium tetrachloride and LDA succumbed to an intramolecular 
Michael addition to afford tetracycle 5.67 in 70% yield with 20:1 dr (Scheme 5.10). A 
series of redox transformations then delivered jiadifenolide (5.1) in four additional steps. 
 
 
Scheme 5.10 Synthesis of jiadifenolide (5.1) by Shenvi. 
The brevity of this route allowed for the synthesis of more than a gram of 
jiadifenolide (5.1). The only major drawback to the sequence was the use super 
stoichiometric amounts of Mo(CO)6 for the Pauhsen-Khand reaction. Though they served 
Shenvi well, the last four steps parallel similar transformations from the previous 
syntheses. Regardless of these minor shortcomings, the formal [4+2] cycloaddition (or 
Michael/Michael cascade) of the readily available butenolides 5.63 and 5.65 which 
swiftly constructed the core more than made up for the transition metal waste and the 
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the previous reported syntheses, this remarkable route has raised the bar significantly for 
future attempts at the synthesis of 5.1. 
5.2.5 Zhang’s Total Synthesis of (–)-Jiadifenolide 
The Zhang group reported the most recent total synthesis of jiadifenolide in 
October of 2015.280 The synthesis borrowed a number of strategies from both Sorensen 
and Paterson, as well as the use of similar late stage redox manipulations that all of the 
syntheses have utilized. The synthesis began from cyclopentanone 5.28, the same starting 
material that Sorensen used, which was allylated and ozonolyzed to provide aldehyde 
5.69 in 91% yield over two steps (Scheme 5.11). Aldehyde 5.69 was subjected to the 
same aldol conditions that Paterson used to afford butenolide 5.70 in 84% yield as a 
mixture (1:1) of diastereomers. As Paterson had previously demonstrated that only one 
diastereomer cyclized in a moderate 50% yield (Scheme 5.9), Zhang decided to remove 
the hydroxyl group in effort to increase the efficiency of the reductive cyclization. 
Toward this end, the hydroxyl group of 5.70 was eliminated to afford 5.71. The 
butenolide and cyclopentanone carbonyl groups of 5.71 were protected as the enolates, 
the ester was reduced by action of DIBAL, and then hydrogenation afforded alcohol 5.72. 
Samarium diiodide induced a reductive annulation of 5.72 to provide tricycle 5.73 in 80% 
yield as a mixture (7:1) of diastereomers. Though removal of the hydroxyl group did 
increase the yield of the reductive cyclization, the diastereoselectivity suffered. Finally, 





Scheme 5.11 Zhang’s synthesis of intermediate 5.74 
A formal [4+1] cycloaddition was effected with trimethylsilyldiazomethane to 
afford tetracycle 5.75. Selenide oxidation provided 5.76, which was oxidized with 
dimethyldioxirane (DMDO) to deliver epoxide 5.77. Oxidation of the tetrahydrofuran 
moiety with ruthenium trichloride provided α-keto lactone 5.40, which upon treatment 
with lithium hydroxide completed the synthesis of jiadifenolide 5.1.  
O
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Scheme 5.12 Zhang’s synthesis of jiadifenolide (5.1) 
Zhang thus completed the fifth total synthesis of jiadifenolide in 13 steps with a 
7.9% overall yield from known 5.28.  The synthesis relied on a number of similar 
strategies that have been previously reported including the use of pulegone as a starting 
material to prepare 5.28, the installation of the butenolide through an aldol reaction, the 
samarium mediated reductive cyclization, and the late-stage oxidative manipulations to 
complete the core. During the course of this work, Zhang did develop a new formal [4+1] 
cycloaddition with trimethylsilyldizomethane to synthesize tetrahydrofurans. This 


























































substrates. Though Zhang was unable to best Shenvi’s step count, he more than doubled 
the overall yield. This synthesis is currently the highest yielding synthesis of 5.1 to date.  
5.2.6 Summary of Previous Syntheses 
Jiadifenolide (5.1) has been synthesized five times since its isolation in 2009 
(Table 5.1). Theodorakis’s synthesis, though it was the first, lacked innovation and was 
exceedingly lengthy. As a result, were we to complete our route, we undeniably stood to 
compete with him in terms of step count and innovation; however, during the course of 
our study, Sorensen and Patersen both reported syntheses that included key strategies 
central to our route (the use of pulegone and the reductive annulation). Despite these 
disappointing revelations, both of these syntheses were lengthy as well, so we continued 
to press forward via a modified route to the target molecule (vide infra). Yet, Shenvi’s 
elegant 10 step total synthesis ultimately befell our goal of realizing the most concise 
synthesis of jiadifenolide (5.1). Zhang’s recent report of the highest yielding synthesis of 
5.1 to date ultimately foiled our plans of testing the reductive annulation with the 
hydroxyl group removed.   
Table 5.1 Total syntheses of jiadifenolide (5.1) 
Group Year (+)/(–)/(±) Steps Yield (%) 
Theodorakis 2011 (–) 28 0.5 
Sorensen 2014 (–) 21 0.9 
Patersen 2014 (±) 23 1.8 
Shenvi 2015 (–) 10 4.1 




5.3 PAST MARTIN GROUP EFFORTS TOWARDS JIADIFENOLIDE 
The Martin group began their efforts towards jiadifenolide (5.1) in 2011, shortly 
before Theodorakis reported the first total synthesis. Much like the other total syntheses 
(vide supra), it was envisaged that 5.1 could be disconnected to 5.78 through a series of 
late stage redox manipulations (Scheme 5.13). Tetracycle 5.78 would be made from 5.79 
via a reductive annulation with concomitant lactonization. Butenolide 5.79 would be 
formed through an acylation of synthon 5.80 with 5.81. Acyl chloride 5.81 would be 
attained through a series of manipulation after alkylation of the thermodynamic enolate of 
5.82, which in turn could be made from a conjugate addition/alkylation reaction with 
cyclopentenone. This synthesis could potentially be completed in as few as 16 steps. 
 
 




































With the desired sequence outlined, work began to assemble butenolide 5.79 in 
effort to test the reductive cyclization reaction.282 Due to the relative expense of 
cyclopentenone (5.84), synthesis began from cyclopentanone (5.83) (Scheme 5.14). The 
silyl enol ether of 5.83 was oxidized with 2-iodoxybenzoic acid (IBX) to deliver 
cyclopentenone (5.84) in 78% yield (two steps).283 One-pot conjugate addition and 
alkylation of 5.84 proved to be difficult, thus the task was completed in two steps. First, 
conjugate addition in the presence of chlorotrimethylsilane provided silyl enol ether 
5.85,284 which upon deprotection with methyllithium in the presence of 20 equivalents of 
5.86 delivered ketoester 5.87 in 72% yield. Unfortunately, despite extensive attempts at 
optimization, alkylation of the thermodynamic enolate of 5.87 failed to deliver 
synthetically useful amounts of 5.89. Unable to acquire enough material to continue the 




Scheme 5.14 Martin group synthesis of diester 5.89 
O
1. LDA, TMSCl, 95%
2. IBX, DMSO, 82%



























The second approach was designed to circumvent the problems associated with 
the alkylation of cyclopenatanone 5.87 (Scheme 5.15). Still relying on a late stage redox 
strategy, the synthesis was still planned to progress through tetracycle 5.78. However, to 
remove the need for the second alkylation, the fused lactone moiety would need to be 
installed after the reductive cyclization; thus, they imagined that lactone 5.78 could be 
formed via rhodium catalyzed C-H activation of diazoester 5.90. Reductive cyclization of 
5.92 could provide tricycle 5.91, and a similar acylation strategy would be used on a 
simpler cyclopentanone derivative 5.93 to access butenolide 5.92. 
 
 
Scheme 5.15 Martin group second generation retrosynthesis of 5.1 
In the event, deprotection of silyl enol ether 5.85 with methyllithium in the 
presence of 5.88 delivered 5.94 in 76% yield (Equation 5.4). Hydrogenolysis of the 
benzyl ester followed by treatment with thionyl chloride provided 5.93, setting the stage 













































Bromofuran 5.99 was targeted as an equivalent of 5.80 (Scheme 5.14). Thus, 
citraconic anhydride (5.95) was selectively reduced to butenolide 5.96 in 30% yield 
(Scheme 5.14).285 Bisbromination of 5.96 yielded 5.97, which underwent elimination in 
the presence of 2,4,6-collidine to provide α-bromobutenolide 5.98.286 Finally, protection 
of 5.98 as the silyloxyfuran delivered the latent nucleophile 5.99. With both 5.92 and 
5.99 in hand, the key reductive cyclization substrate was only one step away. Furan 5.99 
was metallated with tert-butyllithium followed by addition of acyl chloride 5.92 
(Equation 5.5); unfortunately, 5.92 was prone to self-acylation and only bicycle 5.101 
was recovered. Because it was not possible to access the reductive cyclization substrate 
5.92, it was necessary to re-evaluate the routes to either 5.79 or 5.92. 
 
 



































































Chapter 6: Progress Towards the Total Synthesis of Jiadifenolide 
6.1 REVISED STRATEGY 
In an effort to remove the problematic alkylation (Scheme 5.2) and acylation 
reactions (Equation 5.5), we reassessed our approach to jiadifenolide (6.1). We still 
sought to utilize the yet untested mid- and end-game strategies that were previously 
planned, which once again led us from 6.1 to 6.2 to 6.3 (Scheme 6.1). However, instead 
of using an acyl chloride, we would progress through aldehyde 6.4, which would be 
accessible via oxidative cleavage of olefin 6.5. We reasoned that the cyclopentanone 6.5 
would arise from conjugate addition and allylation of cyclopentenone 6.6, thereby 
eliminating the need to generate the thermodynamic enolate prior to a second alkylation. 
 
 
Scheme 6.1 Revised retrosynthesis of jiadifenolide (6.1) 
We then saw an opportunity to reduce the step count by removing redox 
manipulations that would be required to progress from 6.5 to 6.3. This possibility would 






























that dioxenone 6.7 would also be derived from a conjugate addition and alkylation of 6.6. 
This simple change would, if reduced to practice, lower the total step count from sixteen 
to eleven total steps barring any unforeseen complications.  
 
 
6.2 CONJUGATE ADDITION/ALKYLATION ROUTE 
6.2.1 Synthesis of Starting Materials  
With our plan laid out, we sought to push forward to the key reductive cyclization 
of butenolide 6.3. Cyclopentanone (6.8) was condensed with morpholine under Dean-
Stark conditions to yield enamine 6.9,288 which was condensed with ethyl glyoxylate and 
hydrolyzed to provide enoate 6.10 (Scheme 6.2). Acid catalyzed isomerization of 6.10 
provided cyclopentenone 6.6 in 65% yield over three steps.289 This method is readily 




















Scheme 6.2 Synthesis of cyclopentenone 6.6 
With enone 6.6 in hand, we turned our attention to the synthesis of a dioxenone 
electrophile. Following the literature procedure,290,291 trimethyldioxenone 6.12 was 
sequentially treated with LiHMDS and 1,2-dibromotetrachloroethane; however, instead 
of the desired product 6.13, only polybrominated products and starting material were 
recovered (Equation 6.2). An alternate procedure for the synthesis of 6.13 via radical 












































As the direct synthesis of 6.13 proved difficult, we decided to target acetate 6.17. 
Beginning the synthesis with 6.14 with the halide installed would facilitate the synthesis, 
as installation of a halide on dioxenone 6.12 was difficult. Additionally, as conjugate 
addition/alkylation sequences on α-substituted cyclopentenones have been shown to be 
problematic,275,276,293-298 we decided that a Tsuji-Trost allylation with acetate 6.13 might be 
more suitable, reasoning that the more reactive allyl cation should be more reactive with 
less basic and reactive enolate species, thus attenuating polymerization, polyalkylation, 
and enolate isomerization. Toward this end, ethyl 4-chloroacetoacetate (6.14) was 
hydrolyzed with concentrated HCl to provide 6.15 in 40% yield.299 Treatment of 6.15 
with acetic anhydride, sulfuric acid, and acetone delivered chlorodioxenone 6.16, which 
underwent nucleophilic displacement of the chloride by sodium acetate to give 6.17.300,301 






























6.2.2 Conjugate Addition/Alkylation Attempts 
6.2.2.1 Dioxenone Route 
We first attempted to convert 6.6 directly to 6.7 via a one-pot conjugate 
addition/Tsuji allylation. When enone 6.6 was exposed to dimethylzinc in the presence of 
catalytic copper (II) triflate, complete consumption of the starting material was observed 
after eleven days (Equation 6.4).302 Conditions reported to provide a faster reaction using 
copper (I) thiophene-2-carboxylate (CuTC) failed to yield any conjugate addition 
adduct.303,304 Despite zinc enolates having been demonstrated to be effective nucleophiles 
in Tsuji allylations,303 the reactivity of 6.17 in transition metal-mediated allylation 
processes was unknown. Unfortunately, only the conjugate addition adduct 6.21 was 
recovered from the reaction after treating 6.18 with 6.17 and palladium (Equation 6.4). 
We then turned our attention to a two-step conjugate addition and Tsuji-Trost reaction via 











Me2Zn (150 mol %), Cu(OTf)2 (2.5 mol %), P(OEt)3 (5 mol %), CH2Cl2, –20 °C to rt, NR
Me2Zn (150 mol %), CuTC (2.5 mol %), P(OEt)3 (5 mol %), CH2Cl2, –20 °C to rt, >99%
6.17












While not immediately successful, conditions to perform the conjugate addition to 
enone 6.6 were quickly realized (Table 6.1). We found that conditions developed by 
Bergdahl for conjugate addition to cyclopentenones using monoorganocuprates were 
unsuccessful on the α-substituted cyclopentenone 6.6 (Table 6.1, Entries A and B). 
284,305,306 We next attempted to effect the same transformation with a Gilman reagent and 
chlorotrimethylsilane, but only achieved 50% conversion in 4 h (Table 6.1, Entry C). 307 
We found that by increasing the equivalents of the Gilman reagent, we could consistently 
effect the desired transformation with complete consumption of starting material in 30 
min (Table 6.1, Entry D). Additionally, we found that use of copper cyanide, although it 
slowed the reaction, provided similar results (Table 6.1, Entry E). Despite the swift 
reaction times and lack of by-products, silica gel chromatography of the crude reaction 
mixtures resulted in hydrolysis of approximately 60% of the product. Fortunately, 
switching to chlorotriethylsilane resulted in less hydrolysis, and we were able to isolate 
6.20 in 70% yield (Table 6.1, Entry F). Through further experimentation, we found that 






Table 6.1 Optimization of the conjugate addition to enone 6.6 
 
 
Entry Cu (equiv.) MeLi (equiv.) TMSX (equiv.) Solvent Conv. (%) 
A CuBr•DMS (1.3) MeLi (1.25) TMSI (1.25) THF NR 
B CuBr•DMS (1.3) MeLi (1.25) TMSI (1.25) THF/HMPA NR 
C CuBr•DMS (1.2) MeLi (2.4) TMSCl (4) THF 50 
D CuBr•DMS (1.8) MeLi (3.7) TMSCl (4) THF 100 (40)* 
E CuCn (1.8) MeLi (3.7) TMSCl (4) THF 100 (50)* 
F CuBr•DMS (1.8) MeLi (3.7) TESCl (4) THF 100 (70)* 
G CuBr•DMS (1.8) MeLi (3.7) TESCl (1.2) THF 100 (71)* 
*Yields in parentheses are isolated yields after silica gel chromatography 
 
We then began to explore the use of nucleophile 6.19 in Tsuji-Trost reactions. 
However, while substituted silyl enol ethers are known to react with allyl cationic species 
derived from allyl acetates and palladium,308 we once again observed no desired product 
formation and isolated only 6.21 from the reaction (Equation 6.5). As dioxenone 6.17 had 
not been used in Tsuji-type allylation reactions, we turned our attention to standard 






6.6 6.19, R = Me






6.2.2.2 Allylation Route 
We first attempted to prepare cyclopentanone 6.5, via a one-pot conjugate 
addition/allylation sequence that we had initially planned to use with 6.7. We found that 
allylation of a zinc enolate derived from a copper-catalyzed conjugate addition of 
dimethylzinc only led to formation of the conjugate addition adduct 6.21 (Equation 6.6). 
Use of conditions developed by Alexakis for the catalytic conjugate addition of Grignard 
reagents to cyclohexenones provided mainly polymerized material due to the more 
reactive magnesium enolate reacting with 6.6.309,310 We found minor success with the 
copper-mediated conjugate addition followed by allyl tosylate, but we recovered the 
product in only 40% yield as an inseparable mixture (1:1.6) of diastereomers (Equation 
6.7). At the time, the stereochemistry of the major isomer was unknown, though we now 
know that the major was in fact the desired isomer (shown) of 6.5. 
We then turned to the alkylation of silyl enol ethers. Attempts to unmask the 
latent nucleophile with methyllithium were unsuccessful (Equation 6.8), as were attempts 
to allylate using silver trifluoroacetate (Equation 6.9).311 We then attempted a Tsuji-Trost 
reaction with the silyl enol ether 6.20; however, like we observed with the dioxenone 




































Cu(OTf)2, P(OEt)3, Me2Zn, CH2Cl2, –20 °C, 11 d; allyl iodide, HMPA, 0 °C, no alkylation
Cu(OTf)2, MeMgBr, Et2O, –30 °C, polymerization


































allyl acetate or allyl methyl carbonate














6.2.2.3 Vinylcarbonate Route 
We reasoned that if we used an intramolecular Tsuji allylation that the hydrolysis 
would be less of a problem as it had been demonstrated that these intramolecular 
reactions could tolerate water;312 however, this is most likely influenced by the ligands on 
palladium and whether attack on the allyl palladium cation is inner-sphere or outer-
sphere. Unfortunately, preparation of the vinyl carbonate 6.22 proved to be low yielding. 
Copper-mediated conjugate addition followed by allyl chloroformate provided 6.22 in 
35% yield with the remainder of the material being the conjugate addition adduct 6.21 
(Equation 6.10). Copper-catalyzed addition of trimethylaluminum, which we hoped 
would provide a more reactive enolate, failed to provide any of the desired adduct 6.22 
(Equation 6.11).313,314 Attempts to transmetallate the copper enolate with methyllithium 
was less efficacious than use of the copper enolate (Equation 6.12). Activation of the 
aluminum enolate with methyllithium to give the alanate provided the vinyl carbonate in 
36% yield (Equation 6.13). Finally, use of Stoltz’s conditions to prepare vinyl carbonates 
from silyl enol ethers were unsuccessful (Equation 6.14).315,316 Despite our inability to 
prepare 6.22 in high yield, we had enough material to attempt preliminary studies on the 
Tsuji allylation. However, we once again received hydrolyzed product upon exposure of 







i. CuBr•DMS, MeLi, THF






















































1. CuBr•DMS, MeLi, TMSCl, THF
















i. Cu(OTf)2, Me3Al, P(OEt)3, Et2O

















6.3 THIRD GENERATION STRATEGY: STEREOSELECTIVE SYNTHESIS 
We thought that the desired ketone 6.5 could be attained via a Tsuji-Trost reaction 
of β-keto ester 6.23 (Equation 6.16). Alkylation and esterification of methyl β-keto ester 
6.24 would allow access to 6.23, and we found that 6.24 could be prepared as a single 
enantiomer in three steps from (+)-pulegone (6.25). This new route not only removes the 
conjugate addition/allylation sequence required in the previous route, but also shortens 
the route and allows for an enantioselective synthesis of 5.1. During the course of our 
studies on this route, Sorensen disclosed his synthesis of jiadifenolide (5.1) which also 
began from pulegone (6.25).277 
 
 
6.3.1 Synthesis of Tsuji-Trost Substrate 6.23 
The route began from (+)-pulegone (6.25), which was smoothly transformed into 
ester 6.26 via bromination and Favorski rearrangement (Equation 6.17). Ozonolysis of 




































Elaboration of 6.24 to the desired substrate 6.23 took place over two steps (Equation 
6.18). Transesterification of 6.24 with allyl alcohol using DMAP and 4 Å molecular 
sieves proved to be low yielding,320 as did use of Otera’s catalyst (Equation 6.18). 321,322 
We then found that heating 6.24 in the presence of DMAP and allyl alcohol with 
azeotropic removal of methanol provided 6.27 in moderate yield.323 Finally, treatment of 
6.27 with potassium carbonate and ethyl bromoacetate delivered 6.23 in 66% yield, and 






























DMAP (1.5 eq), allyl alcohol (3 eq), 4 Å MS, 32%
Otera's catalyst (0.1 eq), allyl alcohol (10 eq), toluene, ∆, 44%

































6.3.2 Decarboxylative Allylation Reactions with 6.23 
With β-keto ester 6.23 in hand, we set out the test the palladium mediated 
decarboxylative allylation. In the event, 6.23 was exposed to Pd2dba3 and dppe in THF to 
provide allyl cyclopentenone 6.5 as the sole product, but as a mixture (1:1.4) of 
diastereomers as determined by 1H NMR of the crude reaction mixture (Table 6.2, Entry 
A). The stereochemistry of the two diastereomers was determined by 1D and 2D NOESY 
experiments, wherein an NOE between the methyl group protons and the protons of the 
allyl group could be observed (Figure 6.2). Despite the poor diastereoselectivity, we were 
pleased to find that the reaction proceeded smoothly with no by-products. Although there 
was no information regarding diastereoselective Tsuji allylations of cyclopentanones and 
little information was available on diastereoselective Tsuji reactions in general,325-329 the 
panoply of information on Tsuji-Trost reactions in the literature made us confident that 
we would find suitable conditions for the transformation. 
Shown in Table 6.2, switching to Pd(PPh3)4 in THF proved to be detrimental to 
the stereoselectivity (Entry B). Furthermore, it seemed that solvent was not a major 
contributing factor to the poor selectivity (Entry C). It had been shown in the literature 
that the addition of lithium chloride enhanced diastereoselectivity in select cases, possibly 
due to disruption of the ion pair.330,331 Unfortunately, we found that lithium chloride 





Table 6.2 Initial studies of the palladium mediated decarboxylative allylation of 6.27. 
 
Entry Metal Ligand/Additive Solvent (0.03 M) dr (6.5:epi-6.5) 
A Pd2dba3 dppe THF 1.4:1 
B Pd(PPh3)4 – THF 1.1:1 
C Pd(PPh3)4 – PhMe 1.2:1 


























NOE between both protons of the ester and methyl







NOE between both allylic protons and methyl
NOE between one vinyl proton and methyl




As the rate-determining step of the decarboxylative Tsuji-Trost reaction is 
believed to be decarboxylation,332 we envisioned that slowing down the C-C bond 
forming step would likely be difficult; however, if possible, this would hopefully provide 
some enhancement of the diastereoselectivity. It had been demonstrated that the 
electronics of the phosphine ligands influenced the rate of the reactions,333 presumably by 
either stabilizing or destabilizing the allyl palladium cation intermediate; however, the 
ligand electronics may only change the rate of decarboxylation. Accordingly, we 
screened a number of ligands with differing electronic character. 
As demonstrated in Table 6.3, ligand electronics did have a profound effect on the 
reaction, but it was not a desirable one. We noted in the above reactions that 
dibenzylideneacetone co-elutes with the product, so we switched to palladium acetate for 
the following experiments. The electron-deficient perfluorotriphenylphosphine shut down 
the reaction completely (Entry A), as did triphenylphosphite and tricyclohexylphosphine 
(Entries B and C). We were pleased to find that rac-BINAP not only promoted the 
reaction but also increased the dr to 1:1.6, the best selectivity observed thus far (Entry D). 
While not yet synthetically useful, it was certainly a step in the right direction. We also 
tested triphenylphosphite and perfluorotriphenylphosphine with palladium dibenzylidene 
acetone to exclude the possibility that palladium acetate did not form the active palladium 
(0) catalyst with the different phosphines, but received the same results as with palladium 






Table 6.3 Screening ligand electronics in the allylation of 6.27 
 
Entry Metal Ligand/Additive Solvent (0.03 M) dr (6.5:epi-6.5) 
A Pd(OAc)2 P(C6F5)3 THF NR (rt, 40 °C) 
B Pd(OAc)2 P(OPh)3 THF NR (rt, 40 °C) 
C Pd(OAc)2 P(C6H11)3 THF NR (rt, 40 °C) 
D Pd(OAc)2 rac-BINAP THF 1.6:1 (40 °C) 
F Pd2dba3 P(C6F5)3 THF NR (rt, 40 °C) 
G Pd2dba3 P(OPh)3 THF NR (rt, 40 °C) 
 
Based on the results obtained thus far, we began screening bidentate ligands. The 
rationale being that if a ligand dissociated from the metal during the course of the 
reaction, more transition states would be possible due to the open coordination site and 
less steric bulk in the local environment. Having the phosphines tethered should keep as 
many coordination sites occupied on the catalyst as possible. 
We previously tested dppe and obtained the product cleanly with a 1:1.4 dr (Table 
6.2, Entry A). Thus we expanded our testing to the other bidentate phosphines. As shown 


















(dppb) did nothing to improve the diastereoselectivity of the reaction (Entries A and B). 
Furthermore, bis(diphenylphosphino)ferrocene (dppf) and xantphos returned similar 
results as the other achiral bidentate phosphines. In reviewing all of the results, rac-
BINAP had performed the best, thus we queried if better selectivity might be achieved 
with an enantiopure ligand. 
Table 6.4 Screening bidentate ligands for the allylation of 6.27 
 
 
Entry Metal Ligand Solvent (0.03) dr (6.5:epi-6.5) 
A Pd2dba3 dppp THF 1.4:1 
B Pd2dba3 dppb THF 1.3:1 
C Pd2dba3 dppf THF 1.4:1 
D Pd2dba3 xantphos THF 1.3:1 
 
As shown in Table 6.5, (R)-T-BINAP reversed the stereoselectivity of the reaction 
(Entry A); however, we were disappointed to find that (S)-T-BINAP did not improve the 
selectivity over rac-BINAP (Entry B). We switched solvents from THF to toluene in 
order to test any effect that had with a chiral ligand (Entries C and D). While we did find 


















(Entry C), no enhanced selectivity was observed. Additionally, when we formed the 
catalyst at 60 °C and cooled the reaction back to room temperature prior to addition of the 
substrate, we saw little change in the selectivity (Entry D). The ligands designed by Trost 
have been shown to be extremely effective in enantioselective Tsuji-Trost allylations for 
a number of substrates,324,334-337 as well as one diastereoselective prenylation.327 Despite 
the success with other substrates, we were disappointed to find that the reactions returned 
starting material, even upon heating (Entries E, F, G, and H). The PHOX ligands have 
been explored extensively in a wide variety of applications since their introduction by 
Pfaltz,338 Helmchen,339 and Williams.340 During the past ten years, Stoltz has pioneered 
these ligands use in a variety of decarboxylative allylation reactions with a high degree of 
enantioselectivity.315,316,329,341-347 More importantly for us, he has shown that these ligands 
were useful in diastereoselective allylations of cyclohexanones.329,344 Although he had 
reported that the enantioselective allylation of cyclopentanones was problematic,315 based 
on those examples, we should at least expect to see diastereoselectivities greater than 2:1, 
provided that we did not have a mismatched substrate and ligand. Unfortunately, we once 
again found that the ligands were unsuccessful with all reactions returning starting 





Table 6.5 Screening chiral ligands for the allylation of 6.27 
 
Entry Metal Ligand Solvent (0.03 M) dr (6.5:epi-6.5) 
A Pd2dba3 (R)-T-BINAP THF 1:1.2 
B Pd2dba3 (S)-T-BINAP THF 1.7:1 
C Pd2dba3 (S)-T-BINAP PhMe 1.7:1 (60 °C) 
D Pd2dba3 (S)-T-BINAP PhMe 1.8:1 (rt) 
E Pd2dba3 R,R-naph-Trost THF NR 
F Pd2dba3 S,S-naph-Trost THF 1:1.2 
G Pd2dba3 R,R-Trost THF NR 
H Pd2dba3 R,R-Trost PhMe NR 
I Pd2dba3 S-iPr-PHOX THF NR 
J Pd2dba3 R-iPr-PHOX THF NR 
K Pd2dba3 S-iPr-PHOX PhMe NR 





















Figure 6.2 Chiral ligands for Tsuji-Trost allylations 
Unfortunately, we had thus far been unable to improve the stereoselectivity using 
tactics frequently utilized in the literature. One condition that is not frequently changed 
during the course of reaction optimization for similar reactions is concentration. Most 
reactions, especially enantioselective variants of the decarboxylative allylations, are run 
at 0.03 or 0.05 M. Although it is only a slight enhancement, we found that increasing the 
concentration incrementally from 0.03 to 1 M led to a slight increase in the 
stereoselectivity (Table 6.6). We then tested (S)-T-BINAP at 1 M concentration. Indeed, 
combining the two best conditions so far increased the dr consistently to 1:2 with an 























Table 6.6 Changing concentration for the allylation of 6.27 
 
Entry Metal Ligand THF (M) dr (6.5:epi-6.5) 
A Pd(PPh3)4 – 0.03 1.1:1 
B Pd(PPh3)4 – 0.1 1.2:1 
C Pd(PPh3)4 – 0.5 1.4:1 
D Pd(PPh3)4 – 1.0 1.4:1 
E Pd2dba3 (S)-T-BINAP 1.0 2:1 
 
 
6.3.3 Various Tsuji-Trost Attempts: New Substrates and Catalysts 
As we found minimal success by varying ligands and solvents, we envisaged that 
perhaps increasing the size of the latent electrophile could lead to enhanced 
stereoselectivity. Thus, we sought to synthesize prenyl β-keto ester 6.29. The synthesis 
was straightforward and was performed in an analogous manner as 6.27. Known methyl 
β-keto ester 6.24 underwent transesterification with prenyl alcohol to provide 6.28 
(Equation 6.19). Upon treatment of 6.28 with potassium carbonate and ethyl 
bromoacetate, 6.29 was formed in 65% yield over two steps. With substrate 6.29 in hand, 
we were excited to see what effect the increased size of the electrophilic prenyl palladium 
cation would have on the diastereoselectivity. Despite our best efforts, the substrate failed 


















recovered starting material (Equation 6.20). It was known in the literature that prenyl β-
keto esters generally react slower than their corresponding allyl substrates, but it is 






With many options involving palladium exhausted, we moved on to other metals 
known to promote this reaction. It had been demonstrated in the literature that iridium,341 
rhodium,348-350 molybdenum, and tungsten promote Tsuji-Trost reactions.351 In fact, it is 
believed that the octahedral transition metal complexes Mo(CO)n(L)6-n and W(CO)n(L)6-n 
(n = 3,4, or 6) impart better selectivity, in some cases, than the square planar or 

































Pd(PPh3)4, THF (RT, 40 °C), RSM
Pd(PPh3)4, PhMe (RT, 40 °C, 60 °C, 100 °C), RSM
Pd2dba3, (R)-T-BINAP, THF (RT, 40 °C), RSM
Pd2dba3, (S)-T-BINAP, THF (RT, 40 °C), RSM
Pd2dba3, (R)-T-BINAP, PhMe (RT, 40 °C, 60 °C, 100 °C), RSM




to find that for both prenyl substrate 6.29 and allyl substrate 6.27, only starting material 





As the prenyl substrate failed to react, we decided to explore the crotyl analog 
6.32. If the sterics associated with the tri-substituted olefin were a problem for substrate 
6.29, perhaps the disubstituted croyl variant 6.32 would react. The synthesis of 6.32 













W(CO)3(MeCN)3, bpy, THF, RSM
Rh(PPh3)3Cl, THF, RSM
[Rh(CO)2Cl]2, THF, RSM
Mo(CO)6, THF, µW, RSM























Sequential esterification and alkylation provided 6.32 in 45% yield over two steps 
(Scheme 6.4). However, we were disappointed to find that while the decarboxylative 
allylation proceeded in 85% yield, we received an intractable mixture of diastereomers of 
both the linear 6.33 and branched addition products 6.34. 
 
 
Scheme 6.4 Attempted decarboxylative allylation of prenyl substrate 6.32 
We reasoned that the ester moiety in 6.27 could be problematic if it formed an 
unfavorable chelate with the catalyst during the course of the reaction. Indeed, there was 
a single example in the literature of an enantioselective decarboxylative allylation on a 
cyclohexanone wherein a chelate was proposed, but Trost reasoned that this chelate was 
favorable.352 As there was no information available on chelate effects in 
diastereoselective Tsuji allylations or on cyclopentanones, we chose to explore the 
reaction of masked ester functionalities that would not be able to chelate. 
The syntheses of the target molecules were again straightforward, involving 
alkylation of the allyl β-keto ester 6.27 and the stereochemistry was once again assigned 



































in 6.35, we observed no enhancement in stereoselectivity (Equation 6.23). We thought 
that perhaps increasing the size of the masked ester could benefit the diastereoselectivity, 
but again found no enhancement with the use of acetal 6.38 (Equation 6.24). Only a 
marginal increase in selectivity was obtained when using the prenylated substrate 6.40 
(Equation 6.25). Finally, we achieved the highest diastereoselectivity thus far when the 
ester was masked as a vinyl bromide (Equation 6.26); however, upon analysis of 6.44 
with both 1D and 2D NOESY experiments, we found that the stereochemistry was 
opposite to that which we had expected and desired as there was an NOE between the 
methyl protons and every position of the allyl group and no NOE between the methyl 
group protons and the bromoallyl group (Figure 6.3). In an attempt to achieve an equal 
but opposite result, we prepared vinyl chloride 6.45 (Equation 6.27); however, we found 




















































































NOE between the Me group and all positions of the allyl group






As varying the substituents on the α-position of the cyclopentanone had no 
beneficial effect, we reasoned that the methyl group was not providing enough steric 
differentiation between the two faces of the enolate. Thus, we turned our attention to 
increasing the size of the β-substituent via a removable functionality. Toward this end, 
cyclopentanone 6.47 was esterified to provide 6.48 (Scheme 6.5). Despite literature 
precedent,353 we found the oxidation of 6.48 to 6.49 via a selenide low yielding because 
the product was not stable to the reaction conditions. This was not surprising,85 and we 
were pleased to find that dehydrogenation with DDQ proceeded smoothly in 90% 
yield.354 Conjugate addition to 6.49 provided a moderate amount of 6.50, which was 
alkylated under standard conditions to provide 6.51. However, when 6.51 was subjected 
to decarboxylative allylation conditions, we found minimal improvement over the methyl 
variant (Equation 6.28); the stereochemistry was not assigned as the selectivity was not 
synthetically useful. This is most likely due to the position of the silyl group relative to 
the enolate (Figure 6.2), which we believe to favor 6.53 over 6.54 due to minimization of 
steric interactions between the TMS group and the ester side chain. We believed that the 
diastereoselectivity could therefore be improved by using the dithiane derivative 6.55, 








Pd(PPh3)4, THF, rt to 50 °C, RSM
Pd(PPh3)4, Et2O, rt to 35°C, RSM
Pd2dba3, P(C6F5)3,THF,  rt to 50 °C, RSM 




    cyclohexane, 80 °C, 67%
2. allylbromide, K2CO3
 






however, attempts at the synthesis of 6.55 were unsuccessful due to non-productive 
decomposition of the starting material under the reaction conditions (Equation 6.29).355 
 
 




















1. Br2, Ph2Se2, pyr, CH2Cl2, 85%
2. 30% H2O2-, CH2Cl2, 20%








































Figure 6.3 Analysis of enolate 6.56 
 
6.3.4 Stoltz’s Electron Deficient PHOX ligand 
During the course of our studies on diastereoselective decarboxylative allylations 
of cyclopentanones, Stoltz reported a new electron deficient PHOX ligand 6.59 (Figure 
6.4).356-359 In addition to promoting Tsuji allylations with challenging substrates, this 
ligand generally provided higher enantioselectivities with all substrates. We were excited 
to try this new ligand with our substrate, despite the failure of the standard PHOX ligand 
6.29 in previous attempts (Table 6.5, Entries I, J, K, and L). In the event, we found that 
when 6.27 was exposed to the reactions conditions, we recovered 6.5 in 85% yield and 
10:1 dr! To the best of our knowledge, this reaction represents the first diastereoselective 
decarboxylative allylation on a cyclopentanone.  In fact, while Stoltz has reported 
excellent enantioselectivities with cyclobutanones,343 cyclohexanones,315 and 






























R = H, 6.57
R = TMS, 6.58
6.57, n-BuLi, CuBr•DMS
or






making this perhaps one of the first highly stereoselective Tsuji allylations of a 
cyclopentanone in general.  
  
 




6.3.5 Attempts to Elaborate Cyclopentanone 6.5 
6.3.5.1 Additions to Aldehyde 6.4 
Having access to 6.5 with synthetically useful diastereoselectivity, we had only to 
elaborate 6.5 to 6.3 in order to test the key reductive cyclization reaction. We found that 
the olefin of 6.5 underwent oxidative cleavage under standard Johnson-Lemiuex 
conditions, though the two-pot procedure consistently provided higher yields (Equation 
6.31). We soon found, like Paterson reported,278 that the homo-neopentyl aldehyde 6.4 























similar system;278 however, the boron enolate of 6.60 failed to add to aldehyde 6.4 
(Equation 6.32). We then attempted a Baylis-Hilman reaction with 6.60 and 6.62, which 
could be converted to the butenolide via ring closing metathesis, but both attempts failed 
to deliver the desired product (Equations 6.32 and 6.33). Because Paterson demonstrated 
that a related keto-butenolide did not undergo the radical addition (Section 5.5),278 we 

















O3, MeOH; DMS, decomp.
OsO4, NaIO4, THF/H2O, decomp.
OsO4, NaIO4, 2,6-lutidine THF/H2O, 60%

































Toward this end, we attempted an aldol condensation of 6.4 with 6.65, but no 
product was observed (Equation 6.35). Additionally, the lithium enolate derived from 
6.65 failed to react with aldehyde 6.4 (Equation 6.36). We thought that perhaps a Julia 
olefination of 6.4 could provide access to 6.66, so we prepared 6.71 via a known three-
step procedure (Scheme 6.6).361 However this too failed to add into the aldehyde. Most of 
the above reactions returned starting material, presumably because the nucleophile 
deprotonated our electrophile, though non-productive decomposition of the starting 




















































Scheme 6.6 Synthesis of lactone 6.71 
 
 
6.3.5.2 Cross Metathesis Attempts 
As we no longer required the oxygen atom that had proved problematic for 
Patersen, we reasoned that the step count could be reduced if olefin 6.5 were directly 
converted to 6.66 via cross metathesis. Lactone 6.65 was converted to α-methylene-γ-
butyrolactone 6.73 via condensation with formaldehyde (Equation 6.38),362 though the 
yield of the lactone was low due to olefin isomerization to the butenolide 6.74. With both 
6.73 and 6.5 in hand, we attempted cross metathesis. Both Howell and Cossy have 
reported conditions for the cross metathesis of unsubstituted α-methylene-γ-
butyrolactones using additives to suppress olefin isomerization.363,364 However, we were 

































methylene lactone 6.73, leading to the recovery of 6.74, starting material, and dimerized 
starting material (Equation 6.39). The Johnson group has also reported that they were 






Undeterred by this failure, we turned our attention to cross metatheses involving 
non-isomerizable olefins that could in turn be elaborated to the required butenolide. We 
were pleased to find that cross metathesis of 6.75, available from acryloyl chloride and 
hydroxyacetone,366 proceeded smoothly to provide 6.76 in 85% yield (Equation 6.40). 
With 6.76 in hand, we had only to perform a 1,4-reduction and aldol reaction to give 

























OG-II or HG-II (5 or 10 mol %)
additive (10 or 20 mol %)
CH2Cl2 or PhMe (0.4 M to neat*)
rt or reflux












cyclization. Unfortunately, nickel hydride,367 Stryker’s reagent,368 catechol borane with 
and without Wilkenson’s catalyst,369 copper hydrides,370-372 and ruthenium hydrides373 all 
failed to deliver 6.77 though they did hydrogenate the enoate to give 6.78.  
Though similar reactions have been reported to work beautifully on enones and 
enals, the hydrogen-mediated reductive aldol reactions developed by Krische also failed 
to promote the hydrogenative aldol reaction of enoate 6.76 delivering only 6.78.374-377 We 
were later informed, as the reactions were not reported in the literature, that these were 
the same results that they had obtained when attempting hydrogen-mediated reductive 
aldol reactions with acrylates and crotonates. Additionally, a Kulinkovich-like reaction 
failed, and Baylis-Hilman reactions failed to give the unsaturated product.  
Samarium diiodide has been utilized in a similar fashion to form 
cyclopentanones,378-381 so we believed the method could be applicable to the synthesis of 
butyrolactones. However, both sets of conditions only provided the reductive cleavage 
product 6.79 (Equation 6.42). We thought that perhaps 6.78 could be converted to the 
appropriate intermediate 6.77, but all attempts to perform a base-mediated aldol 
cyclization were unsuccessful (Equation 6.43), most likely due to the need for the 
deprotonation to occur at the second least acid position of the molecule. Finally, we 






















































Et2Zn, Ni(acac)2, THF, 0 °C to rt
Stryker's reagent, PhMe, –40 °C
catecholborane, THF, rt
Wilkinson's catalyst, catecholborane, THF, 0 °C
Cu(OAc)2, dppf, SiEt3H, KOtBu, THF
CuCl, PhMe2SiH, DMF
RuCl3, SiEt3H, THF
Rh(cod)2OTf, PPh3, K2CO3, H2, DCE
Rh(cod)2, PPh3, KOAc, H2, DCE
Rh(cod)2, P(p-CF3-Ph)3, KOAc, H2, DCE
Rh(cod)2OTf, PPh3, K2CO3, H2, DCE, 60 °C (pre-heated)





















w/ and w/o HMPA



































Scheme 6.7 Intermolecular reductive aldol reaction of 6.80 
Next, we focused on the reductive cycloisomerization of propargyl enoates. 
Substrate 6.83 was readily accessible via cross metathesis with acryoyl chloride followed 
by propargyl alcohol (Equation 6.44).382 Although reductive cycloisomerization of allyl 
ynoates had been explored,383 we were unable to effect the desired transformation on 
propargyl enoate 6.83 (Equation 6.45). In all cases either partially hydrogenated or fully 



















































As the unprecedented reductive aldol and cycloisomerization reactions were 
proving difficult, we decided to reassess how we might attach the butenolide. Our new 
strategy would rely on more reliable methods to form the butenolide after the cross 
metathesis; however, this strategy would require unprecedented cross metatheses. We 
imagined that 6.82 could be synthesized through enoate 6.86 via a standard esterification 
reaction followed by isomerization, but the cross metathesis with the requisite sterically 
conjested enoate would likely be challenging (Scheme 6.8). Alternatively, we could use a 
carbonylative alkoxylation on vinyl halide 6.87 to install the butenolide, though this 
would require the cross metathesis of a vinyl halide, a reaction for which there is little 


















Rh(cod)2OTf, rac-BINAP, H2, DCE
Pd(PPh3)4, AcOH, PMHS, CHCl3
[Rh(cod)Cl]2, AgSbF6, rac-BINAP, DCE





Scheme 6.8 Alternate strategies to access butenolide 6.82 
We imagined that both vinyl bromide 6.92 and enoate 6.93 could be synthesized 
via the same route. Hydroxy ester 6.88 was protected as silyl ether 6.89 and subjected to 
a one-pot reduction/Ohira-Bestmann reaction to provide alkyne 6.91 in 72% yield 
(Scheme 6.9).385 Bromination of the alkyne proceeded in 80% yield to deliver 6.92; 
however, we were unable to successfully prepare 6.93 via a carbonylative coupling. With 
vinyl bromide 6.92 in hand, we attempted cross metathesis with 6.82, but were unable to 
produce the desired product 6.87 (Equation 6.46). We then turned our attention to an 





























Toward this end, ethyl acrylate (6.94) was subjected to Baylis-Hillman conditions 
to produce 6.95 in 72% yield (Scheme 6.10).386 Bromination of 6.95 delivered 6.96, and 
subsequent indium-mediated allylation of formaldehyde provided 6.97 in 65% yield. The 
hydroxyl group was then protected to afford enoate 6.98. We were disappointed to find 
that neither 6.97 nor 6.98 would undergo cross metathesis with 6.82 under a variety of 









i. DIBAL, CH2Cl2, –78 °C; MeOH, rt
ii. 6.90, K2CO3, MeOH, –78 °C to 0 °C
TBDPSO
B-Br-9-BBN; AcOH
hexanes/CH2Cl2 (1:1), –20 °C
80%
TBDPSO
Br Pd(PPh3)4, TEA, MeOH































Scheme 6.10 Synthesis of enolates 6.97 and 6.98 
 
 
With our plans once again foiled, we decided to attempt an entirely new approach. 
This route would rely on installation of the southeastern γ-butyrolactone moiety after the 
reductive cyclization reaction. We imagined that cross metathesis would provide allylic 
epoxide 6.100, which we could subject to a samarium-mediated reduction cyclization to 
provide 6.102. Allylic epoxides have been shown to undergo a similar intermolecular 




















































envisaged that chelation of the samarium alkoxide and ketone in intermediate 6.101 
would control the diastereoselectivity. Finally, hydroformylation would install the 
lactone,389 and an oxidation to the α-methylene lactone 6.104 would allow us to continue 
forward to jiadifenolide (6.1). At the very least, 6.104 would represent a formal synthesis 
of 5.1 by intercepting a late-stage intermediate in Sorensen’s synthesis.277 
 
 

































Unfortunately, simply performing the cross metathesis with allylic epoxide 6.105 
proved fruitless, as the epoxide was immediately isomerized to aldehyde 6.106 (Equation 
6.48). This was unfortunate, though not unexpected, as similar results have been observed 
in transition metal reactions employing 6.106.390 In order to mediate this unwanted 
isomerization, we tried a two-step protocol. Cross metathesis of 6.82 with methyl vinyl 
ketone (MVK) proceeded smoothly to deliver enone 6.107 in 67% yield (Scheme 6.12). 
However, we again failed to reach our goal, as the desired product 6.100 isomerized to a 
dihydrofuran 6.108 during the course of the reaction with trimethylsulfonium iodide. 
Because of the failures with the cross metathesis routes, we once again redesigned our 
























Scheme 6.12 Attempted synthesis of 6.100 
6.3.5.3 Latest Strategy and Future Directions 
As we have thus been unable to progress forward via cross metathesis attempts, 
we decided to attempt to install the butenolide moiety during the decarboxylative 
allylation reaction. Ideally, this could be accomplished through the use of 6.109, which 
could undergo a Tsuji allylation to deliver 6.82 after isomerization of the olefin (Equation 
6.49). However, as the olefin isomerization preceded cross metathesis in previous 
attempts, we decided to target an intermediate that could be readily manipulated after the 
allylation. Stoltz recently reported a fluoride-triggered allylation of (trimethylsilyl)ethyl 
esters like 6.110 (Equation 6.50),391 and we imagined that this methodology would serve 
us well here, though it should be noted that it had never been tested on cyclopentanones 
or on electrophiles as complicated as we wished to employ. With this strategy, we would 
require electrophile 6.112, 6.113, or 6.114 (Figure 6.5). Thus, we set out to synthesize 
































Figure 6.5 Electophiles for the intermolecular Tsuji allylation 
 
β-Keto ester 6.110 was readily available via an analogous route used for the 
preparation of the allylation precursors. Esterification of 6.47 with alcohol 6.115 
provided the silyl-ethyl ester 6.116, and alkylation with ethyl bromoacetate gave 6.110 
(Scheme 6.13). We had only to synthesize the necessary electrophiles to test our new 






































Scheme 6.13 Synthesis of pronucleophile 6.110 
The most interesting allylic electrophile imagined was 6.117, which had never 
been tested by Stoltz. We thought we would be able to synthesize 6.117 by the addition 
of excess vinylmagnesium chloride to 6.89, but were unable to isolate any of the desired 
product (Scheme 6.14). We imagined that we would have better luck via a sequential 
addition of vinyl Grignard, so we prepared the Weinreb amide 6.118. The first addition of 
vinylmagnesium chloride proceeded smoothly to afford enone 6.119 in 80% yield; 
however, we were once again unable to isolate 6.117 after addition of vinyl Grignard into 
6.119. The starting material was quickly consumed during the course of the reaction, but 
we imagine that the doubly allylic alcohol was especially prone to ionization, which 
precluded our attempted isolation. We then turned our attention to allylic epoxide 6.120, 





































Lastly, we turned our attention to a more traditional Tsuji electophile, allylic 
acetate 6.127. The synthesis commenced from diol 6.121, which was protected and 
epoxidized to provide 6.123 in 76% yield over two steps (Scheme 6.15). Nucleophilc 
opening of the epoxide delivered alcohol 6.124, and oxidation with Dess-Martin 
periodinane afforded ketone 6.125. Unfortunately, preliminary attempts to add a Grignard 
reagent into the ketone have precluded further work on this route. Future attempts will 
include less basic nucleophiles, such as cerates and vinylzinc species. Once the addition 





































Scheme 6.15 Towards allylic acetate 6.127 
The synthesis will then progress by testing the decarboxylative allylation of 6.127 
with 6.110, which with any luck should provide 6.128, as we believe the silyl groups will 
be deprotected during the course of the reaction (Scheme 6.16). From that point, allylic 
oxidation proceeding with concomitant lactonization would afford lactone 6.82 after 
isomerization. Finally, we will be able to test the proposed reductive cyclization. If 
successful, we would be but one oxidation away from a formal synthesis of jiadifenolide 










































Scheme 6.16 Planned end-game for the formal synthesis of 6.1 
6.4 SUMMARY 
Through our continued studies towards the synthesis of jiadifenolide (6.1), we 
developed a strategy to use (+)-pulegone (6.25) to access a chiral trisubstituted 
cyclopentenone 6.5, thereby eliminating the need to either generate thermodynamic 
enolates or perform conjugate addition/alkylation reactions on cyclopentenones, both of 
which are known to be problematic. Unfortunately, this strategy was reported by 
Sorensen while we were pursuing 6.1.277 Additionally, with the use of Stoltz’s electron-
deficient PHOX ligand (6.59), we were able to effect a diastereoselective Tsuji-Trost 





































diastereoselective Tsuji allylation on a cyclopentanone, and one of the first 
diastereoselective allylation reactions of a non-multicyclic substrate. Unfortunately, our 
inability to install the butenolide moiety via known methodology and attempts at 
unprecedented reductive aldol and cycloisomerization reactions has thus far precluded 
our attempts to both test the proposed radical annulation and complete the synthesis of 
6.1. However, during the course of our work, Patersen reported a similar radical 
annulation in his synthesis of 6.1,278 thereby suggesting that were we to complete the 
installation of the butenolide, the annulation would be possible. Future work will 





Chapter 7: Experimental Procedures 
7.1 GENERAL EXPERIMENTAL 
Tetrahydrofuran and diethyl ether were dried by filtration through two columns of 
activated, neutral alumina according to the procedure described by Grubbs.392 Methanol, 
acetonitrile and dimethylformamide were dried by filtration through two columns of 
activated molecular sieves, and toluene was dried by filtration through one column of 
activated, neutral alumina followed by one column of Q5 reactant.  Benzene was distilled 
from sodium and benzophenone. Methylene chloride, diisopropylamine, triethylamine, 
and diisopropylethylamine were distilled from calcium hydride immediately prior to use.  
Pyridine was distilled from potassium hydroxide (KOH) and calcium hydride and stored 
over KOH pellets. Dioxane was distilled from sodium metal and benzophenone prior to 
use. All solvents were determined to have less than 50 ppm H2O by Karl Fischer 
coulometric moisture analysis. All reagents were reagent grade and used without 
purification unless otherwise noted. All reactions involving air or moisture sensitive 
reagents or intermediates were performed under an inert atmosphere of nitrogen or argon 
in glassware that was flame dried.  Solutions were degassed using three freeze-thaw 
cycles under vacuum. Reaction temperatures refer to the temperature of the 
cooling/heating bath. Volatile solvents were removed under reduced pressure using a 
Büchi rotary evaporator at 25–30 °C.  Thin layer chromatography performed using run on 
pre-coated plates of silica gel with a 0.25 mm thickness containing 60F-254 indicator 
(Merck).  Chromatography was performed using forced flow (flash chromatography) and 
the indicated solvent system on 230-400 mesh silica gel (E. Merck reagent silica gel 60) 




Infrared (IR) spectra were obtained either neat on sodium chloride or as solutions 
in the solvent indicated and reported as wavenumbers (cm-1).  Proton nuclear magnetic 
resonance (1H NMR) and carbon nuclear magnetic resonance (13C NMR) spectra were 
obtained at the indicated field as solutions in CDCl3 unless otherwise indicated.  
Chemical shifts are referenced to the deuterated solvent and are reported in parts per 
million (ppm, δ) downfield from tetramethylsilane (TMS, δ = 0.00 ppm).  Coupling 
constants (J) are reported in Hz and the splitting abbreviations used are: s, singlet; d, 
doublet; t, triplet; q, quartet; m, multiplet; comp, overlapping multiplets of magnetically 









(R,E)-Methyl 4-oxo-4-(2-oxo-4-phenyloxazolidin-3-yl)but-2-enoate (2.31). 
(JCH-I-181). A solution of methyl fumarate (2.29) (2.66 g, 20.4 mmol) and pivaloyl 
chloride (2.70 g, 2.76 mL, 22.5 mmol) in THF (40 mL) was cooled to –20 °C.  
Triethylamine (4.13 g, 5.68 mL, 40.8 mmol) was added dropwise, and the mixture was 
stirred 1.5 h at   –20 °C.  The cooling bath was removed, and the solution was allowed to 
warm to room temperature.  Solid LiCl (0.953 g, 22.5 mmol) and (R)-phenyl-oxazolidone 
2.30 (5.00 g, 30.6 mmol) were added portionwise, and the reaction was stirred 12 h. H2O 
(10 mL) and EtOAc (50 mL) were added. The layers were separated, and the aqueous 
layer was extracted with ethyl acetate (2 x 10 mL).  The combined organic layers were 
washed with 1 M HCl (1 x 25 mL), saturated Na2CO3 (2 x 50 mL), saturated brine (50 
mL), dried (Na2SO4), and concentrated under reduced pressure.  The crude product was 
purified by column chromatography, eluting with hexanes/ethyl acetate (3:1) to provide 
3.25 g (58%) of the chiral methyl fumarate 2.31 as a white solid: mp 92-94 °C; 1H NMR 
(400 MHz) δ 8.17 (d, J = 15.7 Hz, 1 H), 7.43 (comp, 5 H), 6.87 (d, J = 15.7 Hz, 1 H), 
5.50 (dd, J = 4.0, 8.9 Hz, 1 H), 4.76 (t, J = 8.9 Hz, 1 H), 4.36 (dd, J = 4.0, 8.9 Hz, 1 H), 




















128.8, 125.9, 70.2, 57.7, 52.2; IR (neat) 1780, 1727, 1690, 1387, 1341, 1306, 1279, 1196 
cm-1; HRMS (CI) m/z 275.0869 [C14H13NO5 (M+1) requires 275.0794]. 
NMR Assignments: 1H NMR (400 MHz, CDCl3) δ 8.17 (d, J = 15.7 Hz, 1 H, 
C3-H), 7.31-7.43 (comp, 5 H, C10-H, C11-H, C12-H, C13-H, and C14-H), 6.87 (d, J = 
15.7 Hz, 1 H, C4-H), 5.50 (dd, J = 4.0, 8.9 Hz, 1 H, C7-Ha), 4.76 (t, J = 9.0 Hz, 1 H, C8-
H), 4.36 (dd, J = 4.0, 8.9 Hz, 1 H, C7-Hb), 3.81 (s, 3 H, C1-H); 13C NMR (100 MHz, 
CDCl3) δ 165.1 (C2), 163.1 (C5), 153.2 (C6), 138.2 (C9), 133.8 (C3), 132.2 (C4), 129.1 





(S)-Methyl 2-methyl-4-oxo-4-((R)-2-oxo-4-phenyloxazolidin-3-yl) butanoate 
(2.32). (JCH-I-277) A suspension of (CuI)4(DMS)3 (prepared according to House)394 
(0.405 g, 1.71 mmol) in THF (8.6 mL) was prepared and cooled to –78 °C, whereupon 
MeLi (1.31  M in hexanes, 1.2 mL, 1.59 mmol) was added dropwise.  The resulting 
orange solution was stirred for 40 min at –78 °C.  Iodotrimethylsilane (0.33 g, 0.25 mL, 
1.65 mmol) was added dropwise, and stirring was continued for 30 min.  A solution of 



















the reaction was stirred for 6 h at –78 °C.  Triethylamine (0.620 g, 0.836 mL, 6.12 mmol) 
was added, and the reaction was stirred 1 h. Saturated NH4Cl (10 mL) was added, and the 
cooling bath was removed.  Upon reaching room temperature, the septum was removed, 
and the solution was stirred until a homogeneous blue solution was obtained.  The 
reaction mixture was poured into H2O (10 mL) and ethyl acetate (10 mL), and the layers 
were separated. The aqueous layer was extracted with ethyl acetate (3 x 15 mL).  The 
combined organic layers were washed with brine (30 mL), dried (Na2SO4), and 
concentrated under reduced pressure. The crude product was purified via flash 
chromatography, eluting with hexanes/ethyl acetate (5:1) to provide 0.521 g (86%) of 
2.32 as a white solid: mp 77-78 °C; 1H NMR (400 MHz) δ 7.40-7.27 (comp, 5 H), 5.42 
(dd, J = 3.9, 8.7 Hz, 1 H), 4.70 (t, J = 8.7 Hz, 1 H), 4.27 (dd, J = 3.9, 8.7 Hz, 1 H), 3.55 
(s, 3 H), 3.44 (dd, J = 7.5, 17.8 Hz, 1 H), 3.04-2.90 (comp, 2 H), 1.21 (d, J = 7.5 Hz, 3 
H); 13C NMR (100 MHz) δ 175.5, 170. 8, 153.6, 138.6, 128.9, 128.4, 125.5, 70.0, 57.3, 
51.6, 38.9, 34.9, 16.8; IR (neat) 1781,1733, 1707, 1386 cm-1; HRMS (CI) m/z 291.1107 
[C15H17NO5 (M+1) requires 291.1107]. 
NMR Assignments: 1H NMR (400 MHz) δ 7.40-7.27 (comp, 5 H, C10-H, C11-
H, C12-H, C13-H, and C14-H), 5.42 (dd, J = 3.9, 8.7 Hz, 1 H, C7-Ha), 4.70 (t, J = 8.7 Hz, 
1 H, C8-H), 4.27 (dd, J = 3.9, 8.7 Hz, 1 H, C7-Hb), 3.55 (s, 3 H, C1-H), 3.44 (dd, J = 7.5, 
17.8 Hz, 1 H, C3-H), 3.04-2.90 (comp, 2 H), 1.21 (d, J = 7.5 Hz, 3 H, C15-H); 13C NMR 
(100 MHz) δ 175.5 (C2), 170.8 (C5), 153.6 (C6), 138.6 (C9), 128.9 (C11 and C13), 









(2.33). (JCH-I-113) Compound 2.33 was prepared on 1.25 mmol via the same method as 
2.32, employing n-BuLi in place of MeLi.  Isolated 0.210 mg (72 %) of 2.33 as a white 
solid: mp 80-81 ºC; 1H NMR (300 MHz, CDCl3) 7.26-7.41 (comp, 5 H), 5.42 (dd, J = 
3.84, 8.70 Hz, 1 H), 4.70 (t, J = 8.97 Hz, 1 H), 4.26 (dd, J = 4.10, 8.97 Hz, 1 H), 3.42 (dd, 
J = 9.73, 18.19 Hz, 1 H), 3.04 (dd, J = 4.61, 18.19 Hz, 1 H), 2.77-2.86 (m, 1 H), 1.55-
1.72 (comp, 2 H), 0.92 (t, J = 7.43 Hz, 3 H); 13C NMR (75 MHz, CDCl3) 174.9, 171.1, 
153.7, 138.6, 129.0, 128.5, 125.6, 70.0, 57.4, 51.5, 41.8, 37.0, 24.8, 11.4; IR (neat) 1782, 
1733, 1707 1386, 1197 cm-1; HRMS (CI) m/z 306.1340 [C16H20NO5 (M + 1) requires 
306.1340]. 
NMR Assignments: 1H NMR (300 MHz, CDCl3) 7.26-7.41 (comp, 5 H, C10-H, 
C11-H, C12-H, C13-H, and C14-H), 5.42 (dd, J = 3.84, 8.70 Hz, 1 H, C7-H), 4.70 (t, J = 
8.97 Hz, 1 H, C8-H), 4.26 (dd, J = 4.10, 8.97 Hz, 1 H, C7-H), 3.42 (dd, J = 9.73, 18.19 
Hz, 1 H, C5-H), 3.04 (dd, J = 4.61, 18.19 Hz, 1 H, C5-H), 2.77-2.86 (m, 1 H, C3-H), 
1.55-1.72 (comp, 2 H, C15-H), 0.92 (t, J = 7.43 Hz, 3 H, C16-H); 13C NMR (75 MHz, 




















(C12), 125.6 (C10 and C14), 70.0 (C7), 57.4 (C1), 51.5 (C8), 41.8 (C3), 37.0 (C4), 24.8 





(2.34). (JCH-II-075) Compound 2.34 was prepared on 1 mmol via the same method as 
2.32, employing n-BuLi in place of MeLi.  Isolated 0.275 g (83%) of 2.34 as a clear oil. 
1H NMR (300 MHz) δ 7.43-7.29 (m, 5 H), 5.44 (dd, J = 8.8, 4.3 Hz, 1 H), 4.72 (t, J = 8.8 
Hz, 1 H), 4.31-4.26 (m, 1 H), 3.54 (s, 3 H), 3.43 (dd, J = 18.0, 9.6 Hz, 1 H), 3.06 (dd, J = 
18.0, 4.3 Hz, 1 H), 2.92-2.82 (m, 1 H), 1.67-1.48 (m, 3 H), 1.30-1.28 (m, 3 H), 0.89-0.87 
(m, 3 H); 13C NMR (75 MHz): δ 175.4, 171.5, 154.0, 138.9, 129.1, 126.0, 77.7, 70.4, 
57.8, 51.9, 40.8, 37.8, 31.8, 29.4, 22.7, 14.1; IR (neat) 2957, 2861, 1785, 1733, 1704, 
1386 cm-1; HRMS (CI) m/z 334.1656 [C16H20NO5 (M + 1) requires 336.1654]. 
NMR Assignments: 1H NMR (300 MHz) δ 7.43-7.29 (m, 5 H, C10-H, C11-H, 
C12-H, C13-H, and C14-H), 5.44 (dd, J = 8.8, 4.3 Hz, 1 H, C7-Ha), 4.72 (t, J = 8.8 Hz, 1 
H, C8-H), 4.31-4.26 (m, 1 H, C7-Hb), 3.54 (s, 3 H, C1-H), 3.43 (dd, J = 18.0, 9.6 Hz, 1 
H, C4-Ha), 3.06 (dd, J = 18.0, 4.3 Hz, 1 H, C4-Hb), 2.92-2.82 (m, 1 H, C3-H), 1.67-1.48 




















C20-H); 13C NMR (75 MHz): δ 175.4 (C2), 171.5 (C5), 154.0 (C6), 138.9 (C9), 129.1 
(C11 and C13), 126.0 (C10 and C14), 77.7 (C12), 70.4 (C8), 57.8 (C1), 51.9 (C7), 40.8 





(2.35). (JCH-II-064) Compound 2.35 was prepared on 1 mmol via the same method as 
2.32, employing PhLi in place of MeLi. Isolated 0.290 g (82%) of compound 2.35 as a 
clear oil. 1H NMR (300 MHz) δ 7.46-7.29 (m, 9 H), 7.27-7.26 (m, 1 H), 5.58 (dd, J = 
11.2, 4.4 Hz, 1 H), 5.37 (dd, J = 8.8, 3.5 Hz, 1 H), 4.58 (t, J = 8.8 Hz, 1 H), 4.21 (dd, J = 
8.8, 3.4 Hz, 1H), 3.53 (s, 3 H), 3.27 (dd, J = 17.3, 11.2 Hz, 1 H), 2.62 (dd, J = 17.3, 4.4 
Hz, 1 H); 13C NMR (125 MHz) δ 172.5, 171.5, 153.0, 138.9, 136.9, 129.9, 129.1, 128.8, 
128.6, 128.5, 128.3, 128.1, 127.8, 125.7, 70.0, 58.1, 51.7, 44.8, 38.6, 29.7; IR (neat) 
2922, 2852, 1781, 1735, 1699, 1383, 1192 cm1; HRMS (CI) m/z 354.1336 [C20H20NO5 (M 
+ 1) requires 354.1341]. 
NMR Assignments: 1H NMR (300 MHz) δ 7.46-7.29 (m, 9 H, C10-H, C11-H, 
























C10-H, C11-H, C12-H, C13-H, C14-H, C16-H, C17-H, C18-H, C19-H, or C20-H), 5.58 
(dd, J = 11.2, 4.4 Hz, 1 H, C7-Ha), 5.37 (dd, J = 8.8, 4.4 Hz, 1 H, C7-Hb), 4.58 (t, J = 8.8 
Hz, 1 H, C8-H), 4.21 (dd, J = 8.8, 3.4 Hz, 1H, C5-H), 3.53 (s, 3 H, C1-H), 3.27 (dd, J = 
17.3, 11.2 Hz, 1 H, C4-Ha), 2.62 (dd, J = 17.3, 4.4 Hz, 1 H, C4-Hb); 13C NMR (125 MHz) 
δ 172.5 (C2), 171.5 (C5), 153.0 (C6), 138.9 (C15 or C9), 136.9 (C15 or C9)), 129.9 
(C13), 129.1 (C11), 128.8 (C20), 128.6 (C19), 128.5 (C18), 128.3 (C17), 128.1 (C16), 







enoate (2.47). (JCH-I-210) n-Butyllithium (2.5 M solution in hexanes, 0.7 mL, 1.8 
mmol) was added to a solution of hexamethyldisilazane (0.31 g, 1.9 mmol) in THF (1.9 
M) at –78 °C. The solution was stirred for 15 min at –78 °C, 30 min at 0 °C, and then 
cooled to –78 °C. Hexamethylphosphoramide (0.47 g, 2.6 mmol) was added to the 
solution, and succinate 2.33 (0.36 g, 0.85 mmol) in THF (1.6 mL) was added dropwise. 























added. The reaction was stirred for 6 h, whereupon 1 M HCl (2.5 mL) was added and the 
reaction was allowed to warm to room temperature. The mixture was extracted with 
EtOAc (3 x 5 mL). The combined organic extracts were washed with brine (20 mL), 
dried (MgSO4), and concentrated under reduced pressure. The resulting crude reaction 
mixture purified via column chromatography, eluting with hexanes/EtOAc (8:1 à 6:1) to 
provide 0.10 g (34%) of 2.47 as a clear colorless oil: 1H NMR (600 MHz, CDCl3) δ 7.35-
7.26 (m, 5H), 5.48 (dddd, J = 17.0, 10.2, 7.6, 6.7 Hz, 1 H), 5.42 (dd, J = 8.7, 3.7 Hz, 1 
H), 4.77 (ddt, J = 10.2, 1.8, 0.9 Hz, 1 H), 4.72 (dq, J = 17.0, 1.5 Hz, 1 H), 4.67 (t, J = 8.9 
Hz, 1 H), 4.30 (td, J = 8.5, 4.7 Hz, 1 H), 4.26 (dd, J = 8.9, 3.8 Hz, 1 H), 2.65 (ddd, J = 
10.7, 8.5, 3.8 Hz, 1 H), 2.32-2.27 (m, 1 H), 2.23-2.19 (m, 1 H), 1.67-1.60 (m, 1 H), 1.55-
1.48 (m, 1 H), 0.85 (t, J = 7.4 Hz, 3 H); 13C NMR (150 MHz; CDCl3): δ 174.4, 173.4, 
153.3, 138.9, 133.7, 129.0 (2C), 128.7, 126.2 (2C), 117.7, 69.6, 57.9, 51.6, 49.0, 44.1, 
34.9, 23.5, 11.9; IR (film, NaCl) 2968, 1779, 1733, 1701, 1384, 1195, 1168 cm-1; HRMS 
(ESI) m/z 368.1498 [C19H25NO5Na+ (M + Na)+ requires 368.1474].  
NMR Assignments: 1H NMR (600 MHz, CDCl3) δ 7.35-7.26 (m, 5H, C10-H, 
C11-H, C12-H, C13-H, and C14-H), 5.48 (dddd, J = 17.0, 10.2, 7.6, 6.7 Hz, 1 H, C18-H), 
5.42 (dd, J = 8.7, 3.7 Hz, 1 H, C19-Ha), 4.77 (ddt, J = 10.2, 1.8, 0.9 Hz, 1 H, c19-Hb), 
4.72 (dq, J = 17.0, 1.5 Hz, 1 H, C7-Ha), 4.67 (t, J = 8.9 Hz, 1 H, C8-H), 4.30 (td, J = 8.5, 
4.7 Hz, 1 H, C17-Ha), 4.26 (dd, J = 8.9, 3.8 Hz, 1 H, C7-Hb), 2.65 (ddd, J = 10.7, 8.5, 3.8 
Hz, 1 H, C17-Hb), 2.32-2.27 (m, 1 H, C3-H), 2.23-2.19 (m, 1 H, C4-H), 1.67-1.60 (m, 1 
H, C5-H), 1.55-1.48 (m, 1 H, C15-H), 0.85 (t, J = 7.4 Hz, 3 H, C16-H); 13C NMR (150 




(C11 and C13), 128.7 (C9), 126.2 (C10 and C14), 117.7 (C12), 69.6 (C8), 57.9 (C1), 51.6 





enoate (2.51). (JCH-I-219) Imide 2.47 (0.070 g, 0.203 mmol) was dissolved in a mixture 
of THF (1 mL) and MeOH (0.04 mL) and cooled to –78 °C. Lithium borohydride (2 M in 
THF, 1 mL, 2.0 mmol) was added, and the reaction was transferred to a 0 °C bath and 
stirred for 1 h. The reaction was quenched with sat. aq. Rochelle’s salt (3 mL), the ice 
bath was removed, and the reaction was stirred 1 h at room temperature. EtOAc (5 mL) 
was added, and the layers were separated. The aqueous layer was extracted with EtOAc 
(2 x 5 mL). The combined organic extracts were washed with brine (10 mL), dried 
(Na2SO4), and concentrated under reduced pressure. The residue was purified via column 
chromatography, eluting with hexanes/EtOAc (4:1 à 3:2) to provide 0.064 g (81%) of 
2.51 as a clear oil: 1H NMR (400 MHz, CDCl3): δ 7.37-7.27 (m, 5 H), 6.44 (d, J = 7.2 
Hz, 1 H), 5.64 (ddt, J = 17.1, 10.1, 7.1 Hz, 1 H), 5.08 (dt, J = 7.1, 5.0 Hz, 1 H), 5.04-4.94 
(m, 2H), 3.87 (d, J = 5.0 Hz, 2 H), 3.70 (s, 3 H), 2.64 (td, J = 9.5, 4.3 Hz, 1 H), 2.49 (td, J 























7.4 Hz, 3 H); 13C NMR (100 MHz, CDCl3): δ 175.7, 173.2, 138.7, 134.8, 128.8 (2C), 
127.9, 126.8 (2 C), 117.57, 117.51, 66.5, 55.9, 51.7, 49.58, 49.44, 35.5, 23.8, 11.9; IR 
(film) 3298, 2935, 2877, 1733, 1645, 1541, 1733, 1645, 1541, 1272, 1166, 700 cm-1; 
HMRS (ESI) m/z 342.1670 [C18H25NO4Na+ (M + Na)+ requires 342.1676]. 
NMR Assignments: 1H NMR (400 MHz, CDCl3): δ 7.37-7.27 (m, 5 H, C10-H, 
C11-H, C12-H, C13-H, and C14-H), 6.44 (d, J = 7.2 Hz, 1 H), 5.64 (ddt, J = 17.1, 10.1, 
7.1 Hz, 1 H), 5.08 (dt, J = 7.1, 5.0 Hz, 1 H, C18-H), 5.04-4.94 (m, 2H, C7-H), 3.87 (d, J 
= 5.0 Hz, 2 H, C19-H), 3.70 (s, 3 H, C1-H), 2.64 (td, J = 9.5, 4.3 Hz, 1 H, C8-H), 2.49 
(td, J = 9.5, 4.3 Hz, 1 H, C3-H), 2.4-2.33 (m, 1 H, C4-Ha), 2.14-2.07 (m, 1 H, C4-Hb), 
1.70-1.54 (m, 2 H, C15-H), 0.89 (t, J = 7.4 Hz, 3 H, C16-H); 13C NMR (100 MHz, 
CDCl3): δ 175.7 (C2), 173.2 (C5), 138.7 (C18), 134.8 (C19), 128.8 (C9), 127.9 (C10 and 
C14)), 126.8 (C12), 117.57 (C11 or C13), 117.51 (C11 or C13), 66.5 (C8), 55.9 (C1), 








enoate (2.52). (JCH-I-148) n-BuLi (2.54 M in hexanes, 0.37 mL, 0.90 mmol) was added 
dropwise to a solution of aryl bromide 2.56 (0.22 g, 0.91 mmol) in THF (2.0 mL) at –78 
°C, and the solution was stirred 15 min. The resulting solution was added via cannula to a 
suspension of (CuI)4(DMS)3 (0.22 g, 0.95 mmol) in THF (2.8 mL) at –78 °C, and the 
resulting black solution was stirred 20 min. Iodotrimethylsilane was added dropwise to 
the reaction and stirring continued for 5 min. A solution of fumarate 2.31 (0.20 g, 0.73 
mmol) in THF (1.0 mL) was added dropwise, and the reaction was stirred 6 h at –78 °C. 
Triethylamine (1.8 g, 17.9 mmol) was added, and was stirred for 1 h, whereupon sat. 
NH4Cl (10 mL) was added. The reaction was warmed to room temperature, the septum 
was removed, and the solution was stirred until a homogenous blue solution was attained. 
The reaction was diluted with H2O (20 mL) and extracted with ethyl acetate (3 x 20 mL). 
The combined organic layers were washed with brine (30 mL), dried (Na2SO4), and 































chromatography, eluting with hexanes/ethyl acetate (3:1) to afford 0.179 (56%) of 2.52 as 
a white solid: mp 120–122 °C; 1H NMR (600 MHz, CDCl3) δ 7.27-7.40 (comp, 5 H), 
7.19 (d, J = 8.7 Hz, 2 H), 6.84 (d, J = 8.8 Hz, 2 H), 5.46-5.49 (m, 1 H), 5.40 (dd, J = 3.9, 
8.8 Hz, 1 H), 4.66 (t, J = 8.8 Hz, 1 H), 4.48 (d, J = 6.8 Hz, 2 H), 4.25 (dd, J = 3.9, 8.8 Hz, 
1 H), 4.06 (dd, J = 5.2, 9.7 Hz, 1 H), 3.84 (dd, J = 9.7, 18.2 Hz, 1 H), 3.51 (s, 3 H), 3.29 
(dd, J = 5.2, 18.2 Hz, 1 H), 1.79 (s, 3 H), 1.73 (s, 3 H); 13C NMR (150 MHz, CDCl3) δ 
173.4, 170.8, 158.4, 153.7, 138.6, 138.4, 129.5, 129.2, 128.9, 128.6, 125.7, 119.6, 114.9, 
70.2, 64.8, 57.5, 52.2, 45.7, 39.5, 25.8, 18.2; IR (film, NaBr) 2917, 1781, 1733, 1704, 
1611, 1511 cm-1; HRMS (ESI) m/z 460.1733 [C25H27NO6Na+ (M + Na) requires 460. 
1731].  
NMR Assignments: 1H NMR: (600 MHz, CDCl3) δ 7.27-7.40 (comp, 5 H, C10-
H, C11-H, C12-H, C13-H, and C14-H), 7.19 (d, J = 8.7 Hz, 2 H, C17-H and C19-H), 
6.84 (d, J = 8.8 Hz, 2 H, C16-H and C20-H), 5.46-5.49 (m, 1 H, C3-H), 5.40 (dd, J = 4, 
8.8 Hz, 1 H, C7-H), 4.66 (t, J = 8.8 Hz, 1 H, C8-H), 4.48 (d, J = 6.8 Hz, 2 H, C21-H), 
4.25 (dd, J = 3.9, 8.8 Hz, 1 H, C7-H), 4.06 (dd, J = 5.2, 9.7 Hz, 1 H, C22-H), 3.84 (dd, J 
= 9.7, 18.2 Hz, 1H, C4-H), 3.51 (s, 3 H, C1-H), 3.29 (dd, J = 5.2, 18.2 Hz, 1 H, C4-H), 
1.79 (s, 3 H, C24-H or C25-H), 1.73 (s, 3 H, C24-H or C25-H); 13C NMR: 13C NMR (150 
MHz, CDCl3) δ 173.3 (C2), 170.8 (C5), 158.3 (C18), 153.6 (C6), 138.6 (C9), 138.3 
(C23), 129.5 (C16 and C20), 129.1 (C11 and C13), 128.9 (C12), 128.6 (C15), 125.7 (C10 
and C14), 119.6, 114.9 (C17 and C19), 70.1 (C7), 64.7 (C21), 57.5 (C8), 52.1 (C1), 45.7 









phenyloxazolidin-2-one (2.60). (JCH-II-033) A solution of 2.32 (0.250 g, 0.858 mmol) 
in CH2Cl2 (1 mL) was cooled to 0 °C, whereupon dibutylboron triflate (0.354 g, 1.29 
mmol) was added dropwise. Hünig’s base (0.184 g, 0.250 mL, 1.29 mmol) was added 
and the solution was stirred for 30 min at room temperature and then cooled to –78 °C.  A 
solution of freshly distilled tetradecanal (0.220 g, 0.260 mL, 1.03 mmol) in methylene 
chloride (0.2 mL) was added dropwise, and the solution was stirred for 20 min at –78 °C 
and then at 0 °C for 15 h.  A solution of MeOH/H2O2 (30% in H2O) (2:1, 1 mL) was 
added, and the mixture was stirred 1 h.  The layers were separated, and the aqueous layer 
was extracted with methylene chloride (3 x 2 mL).  The combined organic layers were 
washed with brine (5 mL), dried (Na2SO4), and concentrated under reduced pressure 
yielding a clear oil.   Purification by recrystallization from methyl tert-butyl ether yielded 
0.217 g (54%) of 2.60 as a white solid: mp 107-108 °C; 1H NMR (600 MHz) δ 7.41-7.34 
(comp, 5 H), 5.43 (dd, J = 3.5, 8.9 Hz, 1 H,), 4.79-4.74 (comp, 2 H), 4.43 (dd, J = 3.5, 8.9 
Hz, 1 H), 4.21 (dd, J = 7.5, 9.2 Hz, 1 H), 3.21 (dq, J = 7.5, 9.2 Hz, 1 H), 1.69-1.58 (comp, 
2 H), 1.39-1.26 (comp, 22 H), 0.88 (t, J = 6.9 Hz, 3 H), 0.80 (d, J = 7.5 Hz, 3 H); 13C 

































49.3, 37.7, 34.7, 29.7, 29.7, 29.7, 29.6, 29.6, 29.6, 29.5, 29.4, 29.4, 29.4, 29.3, 29.1, 25.5, 
24.7, 22.7, 14.1, 11.6; IR (neat) 2917, 2848, 1787, 1758, 1696, 1382, 1204 cm-1 ; HRMS 
(CI) m/z 472.3063 [C28H42NO5 (M+1) requires 472.30]. 
NMR Assignments: 1H NMR (600 MHz, CDCl3) δ 7.41-7.34 (comp, 5 H, C24-
H, C25-H, C26-H, C27-H, and C28-H), 5.43 (dd, J = 3.5, 8.9 Hz, 1 H, C21-Ha), 4.79-
4.74 (comp, 2 H, C22-H and C14-H), 4.43 (dd, J = 3.5, 8.9 Hz, 1 H, C21-Hb), 4.21 (dd, J 
= 7.5, 9.2 Hz, 1 H, C15-H), 3.21 (dq, J = 7.5, 9.2 Hz, 1 H, C16-H), 1.69-1.58 (comp, 2 H, 
C13-H), 1.39-1.26 (comp, 22 H, C2 – C12-H), 0.88 (t, J = 6.97 Hz, 3 H, C1-H), 0.80 (d, J 
= 7.5 Hz, 3 H, C18-H) ; 13C NMR (150 MHz, CDCl3) δ 177.2 (C17), 169.3 (C19), 153.2 
(C6), 138.3 (C23), 129.3 (C25 and C27), 129.3 (C28 and C24), 126.6 (C26), 79.1 (C14), 
70.2 (C21), 57.8 (C22), 49.3 (C15), 37.7 (C16), 34.7, 29.6 (C12), 29.6 (C11), 29.5 (C10), 
29.4 (C9), 29.4 (C8), 29.4 (C7), 29.3 (C6), 29.1 (C5), 25.5 (C4), 24.7 (C3), 22.7 (C2), 









(dihydroprotolichesterinic acid) (2.61).  (JCH-II-042) To a solution of 2.60 (0.243 g, 
0.515 mmol) in THF/H2O (4:1, 4.2 mL) at 0 °C was added H2O2 (30% in H2O, 2.1 mmol, 
0.25 mL) and LiOH•H2O (0.032 g, 0.773 mmol). The flask was removed from the 
cooling bath and stirred at room temperature for 5 h.  The reaction was quenched with 
10% aqueous Na2S2O3 (2 mL).  The THF was removed under reduced pressure.  The pH 
was adjusted to pH = 12 with 3 M NaOH and extracted with EtOAc (3 x 3 mL). The pH 
of the aqueous layer was then adjusted to pH = 1 with 1 M HCl, and the mixture was 
extracted with EtOAc (3 x 3 mL).  The combined organic layers were washed with brine 
(1 x 10 mL), dried (Na2SO4), filtered, and concentrated under reduced pressure to yield 
0.142 g (85%) of 2.61 as a white solid: mp 105-106 °C (lit. 106 °C);96 [α]D22 = –51.1° (c 
= 1.75, CHCl3) [lit. α]D20 = –49.5° (c = 1.75, CHCl3)];96  1H NMR (600 MHz) δ 4.65 
(comp, 1 H), 3.10-3.08 (comp, 1 H), 2.97 (dq, J = 8.8, 7.5 Hz, 1 H), 1.70-1.61 (comp, 2 
H), 1.41-1.28 (comp, 25 H), 0.88 (t, J = 6.9 Hz, 3 H); 13C NMR (150 MHz) δ 177.9, 
174.8, 80.0, 50.2, 36.7, 34.5, 31.9, 29.7, 29.7, 29.7, 29.6, 29.6, 29.5, 29.4 29.3, 25.4, 22.7, 
14.1, 11.5; IR (neat) 2955, 2919, 2852, 1765, 1726, 1698 cm-1; HRMS (ESI) m/z 

























NMR Assignment: 1H NMR (600 MHz, CDCl3) δ 4.65 (comp, 1 H, C14-H), 
3.10-3.08 (comp, 1 H, C15-H), 2.97 (dq, J = 8.8, 7.5 Hz, 1 H, C16-H), 1.70-1.61 (comp, 
2 H, C13-H), 1.41-1.28 (comp, 25 H, C2-H, C3-H, C4-H, C5-H, C6-H, C7-H, C8-H, C9-
H, C10-H, C11-H, C12-H, and C18-H), 0.88 (t, J = 6.96 Hz, 3 H, C1-H);13C NMR (150 
MHz, CDCl3) δ 177.9 (C17 or C19), 174.8 (C13 or C19), 80.0 (C15), 50.2 (C16), 36.7 
(C14), 34.5 (C13), 31.9 (C12), 29.7 (C11), 29.7 (C10), 29.7 (C9), 29.6 (C8), 29.6 (C7), 





R-(2'-Methoxy-[1,1'-binaphthalen]-2-yl)methanamine (4.10). (JCH-II-090) R-
(2'-Methoxy-[1,1'-binaphthalen]-2-yl)methanamine (4.9) (available in four steps  from 
(R)-BINOL)234,232,235 (0.250 g, 0.808 mmol) was dissolved in THF (8 mL) and cooled to 0 
°C. Lithium aluminum hydride (0.250 g, 6.5 mmol) was added portionwise, and the 
reaction was stirred until the starting material was consumed as indicated by thin layer 
chromatography. Water (0.25 mL) was added, followed by 3 N NaOH (0.25 mL), then 
water (0.75 mL). The reaction was stirred 1 h, then vacuum filtered and concentrated 





















MHz, CDCl3) δ 7.98 (dd, J = 12.1, 8.7 Hz, 2 H), 7.87 (t, J = 8.9 Hz, 2 H), 7.68 (d, J = 8.5 
Hz, 1 H), 7.44 (d, J = 9.1 Hz, 1 H), 7.40 (ddd, J = 8.1, 6.8, 1.3 Hz, 1 H), 7.31 (ddd, J = 
8.1, 6.8, 1.2 Hz, 1 H), 7.22-7.16 (m, 2 H), 7.09 (dd, J = 8.5, 0.8 Hz, 1 H), 6.94 (dd, J = 
8.5, 0.8 Hz, 1 H), 3.74 (s, 3 H), 3.54 (d, J = 1.2 Hz, 2 H); 13C NMR (100 MHz, CDCl3) δ 
154.5, 139.7, 134.0, 133.1, 132.7, 131.7, 129.7, 129.0, 128.4, 128.0, 126.7, 126.5, 126.11, 
126.04, 125.3, 125.0, 123.7, 120.9, 113.5, 56.4, 45.1; IR (NaCl, film) 3055, 3006, 2934, 
2839, 1621, 1592, 1507, 1462, 1432, 1353, 1333, 1265, 1261,  1147, 1083 cm-1; HRMS 
(ESI) m/z 336.1364 [C22H19NO (M+Na) requires 336.1359]. 
NMR Assignments: 1H NMR (400 MHz, CDCl3) δ 7.98 (dd, J = 12.1, 8.7 Hz, 2 
H), 7.87 (t, J = 8.9 Hz, 2 H), 7.68 (d, J = 8.5 Hz, 1 H), 7.44 (d, J = 9.1 Hz, 1 H), 7.40 
(ddd, J = 8.1, 6.8, 1.3 Hz, 1 H), 7.31 (ddd, J = 8.1, 6.8, 1.2 Hz, 1 H), 7.22-7.16 (m, 2 H), 
7.09 (dd, J = 8.5, 0.8 Hz, 1 H), 6.94 (dd, J = 8.5, 0.8 Hz, 1 H), 3.74 (s, 3 H), 3.54 (d, J = 
1.2 Hz, 2 H); 13C NMR (100 MHz, CDCl3) δ 154.5, 139.7, 134.0, 133.1, 132.7, 131.7, 
129.7, 129.0, 128.4, 128.0, 126.7, 126.5, 126.11, 126.04, 125.3, 125.0, 123.7, 120.9, 









dimethylacetimidamide (4.12). (JCH-II-092) N,N’-dimethylacetamide dimethyl acetal 
(0.019 g, 0.021 mL, 0.14 mmol) was added to a solution of amine 4.10 (0.040 g, 0.13 
mmol) in acetonitrile (0.25 mL) and stirred 2 h. The solvent was removed under reduced 
pressure and the crude reaction mixture was purified via flash column chromatography, 
eluting with CH2Cl2/MeCN/MeOH/NEt3 (80:15:4:1) to provide 0.040 g (80%) of 4.11 as 
an amorphous solid: 1H NMR (400 MHz, CDCl3) δ 8.01 (d, J = 9.0 Hz, 1 H), 7.96 (d, J = 
8.6 Hz, 1 H), 7.89-7.85 (m, 2 H), 7.79 (d, J = 8.6, 1 H), 7.46-7.40 (m, 2 H), 7.30 (ddd, J = 
8.1, 6.9, 1.2 Hz, 1 H), 7.22-7.16 (m, 2 H), 7.11 (dd, J = 8.5, 0.6 Hz, 1 H), 6.89 (dd, J = 
8.5, 0.6 Hz, 1 H), 4.42 (s, 2 H), 3.76 (s, 3 H), 1.98-1.97 (m, 6 H), 1.64 (s, 3 H); 13C NMR 
(100 MHz, CDCl3) 175.9, 163.6, 154.3, 133.60, 133.46, 133.0, 132.7, 131.8, 130.3, 
128.94, 128.87, 128.18, 128.12, 127.0, 126.4, 126.10, 125.92, 125.4, 124.7, 123.8, 119.4, 
113.2, 56.2, 46.4, 40.8, 22.3, 14.8, 1.9; IR (NaCl, film) 3415, 1645, 1592, 1558, 1508, 
1265, 1251 cm-1; HRMS (ESI) m/z 383.2120 [C26H26N2O (M+Na) requires 383.2118]. 
NMR Assignments: 1H NMR (400 MHz, CDCl3) δ 8.01 (d, J = 9.0 Hz, 1 H), 
7.96 (d, J = 8.6 Hz, 1 H), 7.89-7.85 (m, 2 H), 7.79 (d, J = 8.6, 1 H), 7.46-7.40 (m, 2 H), 

























6.89 (dd, J = 8.5, 0.6 Hz, 1 H), 4.42 (s, 2 H), 3.76 (s, 3 H), 1.98-1.97 (m, 6 H), 1.64 (s, 3 
H); 13C NMR (100 MHz, CDCl3) 175.9, 163.6, 154.3, 133.60, 133.46, 133.0, 132.7, 
131.8, 130.3, 128.94, 128.87, 128.18, 128.12, 127.0, 126.4, 126.10, 125.92, 125.4, 124.7, 






yl)methyl)thiourea (4.32). (JCH-II-194) tert-Butyl isothiocyanate (0.015 g, 0.13 mmol) 
was added to a solution of 4.28 (0.50 g, 0.13 mmol) in CH2Cl2 (0.65 mL), and the 
solution was stirred for 2.5 h. H2O (1 mL) was added, and the layers were separated. The 
aqueous layer was extracted with CH2Cl2 (2 x 1 mL), and the combined organic layers 
were washed with brine (3 mL), dried (MgSO4), and concentrated under reduced 
pressure. The residue was purified via column chromatography, eluting with CH2Cl2 on 
SiO2 (12 mL) to provide 0.038 g (60%) of 4.32 as a tan foam: 1H NMR (400 MHz, 
CDCl3) δ 8.01 (d, J = 8.5 Hz, 1 H), 7.94 (d, J = 6.7 Hz, 2 H), 7.90-7.88 (m, 1 H), 7.83 (d, 


































1H), 7.36-7.29 (m, 3 H), 7.24-7.20 (m, 1 H), 6.94 (d, J = 8.1 Hz, 1 H), 5.86 (d, J = 0.5 
Hz, 1 H), 5.78-5.74 (m, 1 H), 4.77-4.71 (m, 1 H), 4.65-4.60 (m, 1 H), 1.16 (s, 9 H); 13C 
NMR (100 MHz, CDCl3) δ 180.9, 148.2, 138.3, 137.0, 135.6, 133.44, 133.27, 132.8, 
130.9, 130.46, 130.27, 129.65, 129.60, 129.56, 129.53, 129.1, 128.8, 128.43, 128.28, 
128.24, 128.0, 127.15, 127.03, 126.95, 126.4, 125.9, 124.22, 124.14, 118.1, 117.8, 29.3; 
IR (NaCl, film) 3410, 3058, 2964, ,2925, 2853, 1697, 1649, 1538, 1455, 1427, 1360, 
1196 cm-1; HRMS (ESI) m/z 513.1971 [C32H30N2OS (M+Na) requires 513.1971]. 
NMR Assignments: 1H NMR (400 MHz, CDCl3) δ 8.01 (d, J = 8.5 Hz, 1 H), 
7.94 (d, J = 6.7 Hz, 2 H), 7.90-7.88 (m, 1 H), 7.83 (d, J = 8.5 Hz, 1 H), 7.68-7.65 (m, 2 
H), 7.49 (ddd, J = 8.0, 5.6, 3.7 Hz, 3 H), 7.42-7.38 (m, 1H), 7.36-7.29 (m, 3 H), 7.24-7.20 
(m, 1 H), 6.94 (d, J = 8.1 Hz, 1 H), 5.86 (d, J = 0.5 Hz, 1 H), 5.78-5.74 (m, 1 H), 4.77-
4.71 (m, 1 H), 4.65-4.60 (m, 1 H), 1.16 (s, 9 H); 13C NMR (100 MHz, CDCl3) δ 180.9, 
148.2, 138.3, 137.0, 135.6, 133.44, 133.27, 132.8, 130.9, 130.46, 130.27, 129.65, 129.60, 
129.56, 129.53, 129.1, 128.8, 128.43, 128.28, 128.24, 128.0, 127.15, 127.03, 126.95, 








phenethylthiourea (4.33). (JCH-II-195) (2-Isothiocyanatoethyl)benzene (0.021 g, 0.13 
mmol) was added to a solution of 4.28 (0.50 g, 0.13 mmol) in CH2Cl2 (0.65 mL), and the 
solution was stirred for 2.5 h. H2O (1 mL) was added, and the layers were separated. The 
aqueous layer was extracted with CH2Cl2 (2 x 1 mL), and the combined organic layers 
were washed with brine (3 mL), dried (MgSO4), and concentrated under reduced 
pressure. The residue was purified via column chromatography, eluting with CH2Cl2 on 
SiO2 (14 mL) to provide 0.060 g (86%) of 4.32 as a white foam: 1H NMR (400 MHz, 
CDCl3) δ 8.01 (d, J = 8.5 Hz, 1 H), 7.94 (d, J = 9.9 Hz, 2 H), 7.88 (dd, J = 8.2, 0.3 Hz, 1 
H), 7.76-7.73 (m, 1 H), 7.65 (dt, J = 8.1, 1.6 Hz, 2 H), 7.52-7.47 (m, 3 H), 7.44-7.39 (m, 
1 H), 7.34-7.26 (m, 3 H), 7.19-7.14 (m, 2 H), 6.91-6.88 (m, 2 H), 6.81 (d, J = 8.4 Hz, 1 
H), 5.58-5.54 (m, 1 H), 5.11-5.07 (m, 1 H), 4.41-4.31 (m, 2 H), 2.67-2.56 (m, 2 H); 13C 
NMR (100 MHz, CDCl3) δ 136.9, 134.4, 133.7, 133.1, 132.9, 130.9, 130.52, 130.36, 
130.12, 130.02, 129.86, 129.55, 129.48, 129.2, 128.92, 128.89, 128.67, 128.53, 128.48, 
128.46, 128.41, 128.33, 128.28, 128.14, 127.22, 127.14, 127.03, 126.93, 126.48, 126.41, 








































1650, 1554, 1497, 1454, 1427, 1360, 1260 cm-1; HRMS (ESI) m/z 561.1970 [C36H30N2OS 
(M+Na) requires 561.1971].  
NMR Assignments: 1H NMR (400 MHz, CDCl3) δ 8.01 (d, J = 8.5 Hz, 1 H), 
7.94 (d, J = 9.9 Hz, 2 H), 7.88 (dd, J = 8.2, 0.3 Hz, 1 H), 7.76-7.73 (m, 1 H), 7.65 (dt, J = 
8.1, 1.6 Hz, 2 H), 7.52-7.47 (m, 3 H), 7.44-7.39 (m, 1 H), 7.34-7.26 (m, 3 H), 7.19-7.14 
(m, 2 H), 6.91-6.88 (m, 2 H), 6.81 (d, J = 8.4 Hz, 1 H), 5.58-5.54 (m, 1 H), 5.11-5.07 (m, 
1 H), 4.41-4.31 (m, 2 H), 2.67-2.56 (m, 2 H); 13C NMR (100 MHz, CDCl3) δ 136.9, 
134.4, 133.7, 133.1, 132.9, 130.9, 130.52, 130.36, 130.12, 130.02, 129.86, 129.55, 
129.48, 129.2, 128.92, 128.89, 128.67, 128.53, 128.48, 128.46, 128.41, 128.33, 128.28, 
128.14, 127.22, 127.14, 127.03, 126.93, 126.48, 126.41, 125.89, 125.74, 125.0, 124.3, 
124.0, 36.2, 34.9, 32.4. 









yl)methyl)thiourea (4.30). (JCH-II-167) 4-Isothiocyanatobenzonitrile (0.021 g, 0.13 
mmol) was added to a solution of 4.28 (0.50 g, 0.13 mmol) in CH2Cl2 (0.70 mL), and the 
solution was stirred for 2 h. H2O (1 mL) was added, and the layers were separated. The 
aqueous layer was extracted with CH2Cl2 (2 x 1 mL), and the combined organic layers 
were washed with brine (3 mL), dried (MgSO4), and concentrated under reduced 
pressure. The residue was purified via column chromatography, eluting with 
CH2Cl2/MeOH (97:3) on SiO2 (16 mL) to provide 0.060 g (85%) of 4.30 as a white foam: 
1H NMR (400 MHz, CDCl3) δ 8.01 (d, J = 8.4 Hz, 1 H), 7.94-7.92 (m, 2 H), 7.86 (t, J = 
9.0 Hz, 2 H), 7.58-7.47 (m, 7 H), 7.36-7.28 (m, 3 H), 7.21-7.19 (m, 2 H), 7.14 (ddd, J = 
8.4, 7.0, 1.3 Hz, 1 H), 6.96-6.94 (m, 1 H), 6.86 (dd, J = 8.3, 0.6 Hz, 1 H), 5.03-4.90 (m, 1 
H), 4.40 (dd, J = 14.1, 4.1 Hz, 1 H); 13C NMR (100 MHz, CDCl3) δ 147.5, 136.63, 
136.61, 136.3, 133.60, 133.52, 131.5, 130.4, 130.0, 129.71, 129.55, 129.31, 129.27, 
129.13, 128.53, 128.38, 128.36, 128.27, 127.27, 127.24, 127.07, 126.6, 125.8, 124.4, 







































1318, 1257, 1195 cm-1; HRMS (ESI) m/z 558.1610 [C35H25N2OS (M+Na) requires 
558.1611.  
NMR Assignments: 1H NMR (400 MHz, CDCl3) δ 8.01 (d, J = 8.4 Hz, 1 H), 
7.94-7.92 (m, 2 H), 7.86 (t, J = 9.0 Hz, 2 H), 7.58-7.47 (m, 7 H), 7.36-7.28 (m, 3 H), 
7.21-7.19 (m, 2 H), 7.14 (ddd, J = 8.4, 7.0, 1.3 Hz, 1 H), 6.96-6.94 (m, 1 H), 6.86 (dd, J = 
8.3, 0.6 Hz, 1 H), 5.03-4.90 (m, 1 H), 4.40 (dd, J = 14.1, 4.1 Hz, 1 H); 13C NMR (100 
MHz, CDCl3) δ 147.5, 136.63, 136.61, 136.3, 133.60, 133.52, 131.5, 130.4, 130.0, 
129.71, 129.55, 129.31, 129.27, 129.13, 128.53, 128.38, 128.36, 128.27, 127.27, 127.24, 







2'-Hydroxy-3,3'-diphenyl-[1,1'-binaphthalene]-2-carbonitrile (4.4). Triflate 
4.3 (0.329 g, 0.577 mmol), Ni(PPh3)2Br2 (0.085 g, 0.115 mmol), triphenylphosphine 
(0.085 g, 0.324 mmol), potassium cyanide (0.075 g, 1.15 mmol), and zinc powder (0.030 
g, 0.461 mmol) were placed in a pear shaped flask.  The flask was evacuated under high 
vacuum and placed under a nitrogen atmosphere three times. Dry, degassed acetonitrile 
(1 mL) was introduced, and the reaction was stirred at room temperature until it turned 
red (5-10 min).  The flask was transferred to a 65 °C bath and was stirred for 4 h.  (Do 
not monitor reaction by TLC; the reaction turned a slightly different shade of red with 
some solid material in it as the reaction completes.)  The reaction was removed from 
bath, and the solids were removed by vacuum filtration through a pad of celite. The pad 
was washed with ether (5 mL) and concentrated under reduced pressure.  The crude 
product was purified via flash chromatography (8:1 hexanes/ethyl acetate) to provide 
0.124 g (48%) of 4.4 as an amorphous solid: 1H NMR (400 MHz, CDCl3) δ 8.07 (s, 1 H), 
8.02-7.97 (comp, 2 H), 7.91 (d, J = 8.0 Hz, 1 H), 7.79-7.62 (comp, 5 H), 7.56-7.36 


































MHz, CDCl3) δ 148.5, 142.3, 140.4, 138.7, 136.4, 134.9, 133.2, 131.2, 130.3, 129.4, 
129.3, 129.2, 128.9, 128.3, 127.7, 127.2, 126.9, 124.14, 124.11, 117.6, 116.7, 112.3; IR 
(NaCl, film) 3534, 3369, 3058, 2927, 2225, 1495, 1450, 1427, 1260, 1239 cm-1; HRMS 
(ESI) m/z 470.1514 [C33H22N2NaO (M+Na) requires 470.1515]. 
NMR Assignments: 1H NMR (400 MHz, CDCl3) δ 8.07 (s, 1 H), 8.02-7.97 
(comp, 2 H), 7.91 (d, J = 8.0 Hz, 1 H), 7.79-7.62 (comp, 5 H), 7.56-7.36 (comp, 9 H), 
7.32-7.28 (m, 1 H), 7.04 (d, J = 8.4 Hz, 1 H), 5.36 (s, 1 H); 13C NMR (100 MHz, CDCl3) 
δ 148.5, 142.3, 140.4, 138.7, 136.4, 134.9, 133.2, 131.2, 130.3, 129.4, 129.3, 129.2, 





2'-((Benzylamino)methyl)-[1,1'-binaphthalen]-2-ol. (JCH-III-128) A solution 
of 2'-(aminomethyl)-[1,1'-binaphthalen]-2-ol (0.50 g, 0.17 mmol) and benzaldehyde (0.20 
g, 0.19 mmol) in ethanol (0.7 mL) was heated at 70 °C for 10 h. The reaction was cooled 
to room temperature, whereupon sodium borohydride (0.13 g, 0.24 mmol) was added. 
The reaction was stirred for 3 h, whereupon H2O (1.5 mL) was added, and the ethanol 
was removed under reduced pressure. The aqeous layer was extracted with EtOAc (3 x 


























(MgSO4), and concentrated under reduced pressure. The residue was purified via column 
chromatography, eluting with hexanes/EtOAc (2:1 à 1:2) on SiO2 (15 mL) to provide 
0.40 g (61%) of the title compound: 1H NMR (400 MHz, CDCl3) δ 7.96-7.85 (comp, 5 
H), 7.54 (d, J = 8.4 Hz, 1 H), 7.48-7.34 (comp, 3 H), 7.34-7.25 (comp, 5 H), 7.21-7.17 
(m, 1 H), 7.14-7.10 (m, 1 H), 7.04-7.02 (m, 1 H), 6.70-6.78 (m, 1 H), 3.81-3.67 (comp, 4 
H); 13C NMR (100 MHz, CDCl3) δ 153.7, 138.1, 135.8, 134.3, 133.7, 133.6, 133.4, 
129.6, 129.1, 128.7, 128.64, 128.63, 128.4, 127.8, 127.5, 127.3, 127.2, 127.0, 126.4, 
126.0, 125.9, 125.3, 123.1, 121.8, 120.7, 53.5, 52.9; IR (NaCl, film) 3056, 2926, 2853, 
1618, 1591, 1505, 1455, 1434, 1343, 1272, 1233 cm-1; HRMS (ESI) m/z 390.1858 
[C28H23NO (M+H) requires 390.1852]. 
NMR Assignments: 1H NMR (400 MHz, CDCl3) δ 7.96-7.85 (comp, 5 H), 7.54 
(d, J = 8.4 Hz, 1 H), 7.48-7.34 (comp, 3 H), 7.34-7.25 (comp, 5 H), 7.21-7.17 (m, 1 H), 
7.14-7.10 (m, 1 H), 7.04-7.02 (m, 1 H), 6.70-6.78 (m, 1 H), 3.81-3.67 (comp, 4 H); 13C 
NMR (100 MHz, CDCl3) δ 153.7, 138.1, 135.8, 134.3, 133.7, 133.6, 133.4, 129.6, 129.1, 
128.7, 128.64, 128.63, 128.4, 127.8, 127.5, 127.3, 127.2, 127.0, 126.4, 126.0, 125.9, 






General procedure for iodolactonizations: 
NIS (1.2 mmol) and I2 (0.010 mmol), if used, were added in one portion to a 
solution of catalyst (0.010 mmol) and the appropriate olefinic acid (0.10 mmol) in a 
mixture (2:1) of toluene (2 mL) and CH2Cl2 (1 mL) at –20 °C with stirring.  The reaction 
was stirred for 14 h, whereupon a solution of saturated sodium thiosulfate (1 mL) was 
added.  The reaction was removed from the bath, and the stirring was continued for 0.5 h.  
The reaction mixture was transferred to a separatory funnel and extracted with Et2O (3 x 
3 mL).  The combined organic extracts were washed with 5% Na2CO3 (5 mL), saturated 
brine (5 mL), dried (Na2SO4), and concentrated under reduced pressure.  The crude 







(R)-5-((S)-1-Iodoethyl)-5-methyldihydrofuran-2(3H)-one (4.65). (JCH-II-190) 
0.1 mmol scale; purified via column chromatography, eluting with hexanes/EtOAc (6:1) 
on SiO2 (6 mL). Isolated 0.020 g (80%) as a clear, colorless oil: 1H NMR (300 MHz; 
CDCl3): δ 4.29 (q, J = 7.0 Hz, 1 H), 2.70-2.64 (m, 2 H), 2.35-2.13 (m, 2 H), 1.97 (d, J = 
7.0 Hz, 3 H), 1.59 (s, 3 H). 13C NMR (75 MHz; CDCl3): δ 176.1, 88.7, 34.8, 34.6, 29.7, 
23.6, 21.7; IR (neat) 2978, 2931, 1777, 1240, 1176, 1073 cm-1; HRMS (ESI) m/z 
276.9695 [C7H11O2INa (M+Na) requires 276.9696]; HPLC (259 nm): Whelk-O1 (20% i-
PrOH / hexanes, 1.2 mL/min) 14.4 min (minor), 17.3 min (major); 66:34 er (without I2), 
79:21 er (with 10 mol % I2). 
 NMR Assignment: 1H NMR (300 MHz; CDCl3): δ 4.29 (q, J = 7.0 Hz, 1 
H, C5-H), 2.70-2.64 (m, 2 H, C2-H), 2.35-2.13 (m, 2 H, C3-H), 1.97 (d, J = 7.0 Hz, 3 H, 
C6-H), 1.59 (s, 3 H, C7-H); 13C NMR (75 MHz; CDCl3): δ 176.1 (C1), 88.7 (C4), 34.8 



















209) 0.1 mmol scale; purified via column chromatography, eluting with hexanes/EtOAc 
(5:1) on SiO2 (6 mL):  1H NMR (400 MHz, CDCl3) δ 4.66–4.58 (m, 1 H), 4.08 (dd, J = 
10.0, 2.8 Hz, 1 H), 2.64–2.45 (comp, 3 H), 2.23–2.16 (m, 1 H), 1.57–1.45 (m, 1 H), 0.97 
(d, J = 6.4 Hz, 3 H), 0.92 (d, J = 6.4 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 176.6, 
80.6, 51.4, 30.1, 29.9, 29.1, 23.6, 19.0; IR (neat) 1783 cm–1; HRMS (ESI) m/z 290.9851 
[C8H13O2INa (M+Na) requires 290.9852]; HPLC (259 nm): OD-H (0.75% i-PrOH / 
hexanes, 1.0 mL/min) 26.5 min (major), 28.2 min (minor); 67:33 er (without I2), 68:32 
(with 10 mol % I2).  
NMR Assignments: 1H NMR (400 MHz, CDCl3) δ 4.66–4.58 (m, 1 H, C4-H), 
4.08 (dd, J = 10.0, 2.8 Hz, 1 H, C5-H), 2.64–2.45 (comp, 3 H, C-2H and C3-Ha), 2.23–
2.16 (m, 1 H, C3-Hb), 1.57–1.45 (m, 1 H, C6-H), 0.97 (d, J = 6.4 Hz, 3 H, C7-H or C8-
H), 0.92 (d, J = 6.4 Hz, 3 H, C7-H or C8-H); 13C NMR (100 MHz, CDCl3) δ 176.6 (C1), 



















(S)-5-(Iodomethyl)-5-phenyldihydrofuran-2(3H)-one (4.37). (JCH-II-185) 0.1 
mmol scale; purified via column chromatography, eluting with hexanes/EtOAc (6:1) on 
SiO2 (6 mL):  1H NMR (300 MHz, CDCl3) δ 7.42-7.33 (m, 5 H), 3.65 (d, J = 11.1 Hz, 1 
H), 3.61 (d, J = 11.1 Hz, 1 H), 2.83-2.68 (comp, 2 H), 2.66-2.45 (comp, 2 H); 13C NMR 
(75 MHz, CDCl3) δ 175.3, 140.6, 128.8, 128.6, 124.8, 86.0, 33.9, 29.2, 16.2; IR (neat) 
2924, 2853, 1779, 1448, 1151, 700 cm–1; HRMS (CI) m/z 302.9881  [C11H12O2I (M+H) 
requires 302.9882]; HPLC (214 nm): ODH (5% i-PrOH / hexanes, 1.0 mL/min) 19.0 min 
(minor), 23.8 min (major); 93:7 er (without I2), 98:2 (with 10 mol % I2), 81.5:18.5 (with 
100 mol % I2). 
NMR Assignments: 1H NMR (CDCl3, 300 MHz) δ 7.42-7.33 (m, 5 H, C6-H, 
C7-H, C8-H, C9-H, and C10-H), 3.65 (d, J = 11.1 Hz, 1 H, C11-Ha), 3.61 (d, J = 11.1 
Hz, 1 H, C11-Hb), 2.83-2.68 (comp, 2 H, C2-H), 2.66-2.45 (comp, 2 H, C3-H); 13C NMR 
(CDCl3, 75 MHz) δ 175.3 (C1), 140.6 (C5), 128.8 (C6 and C10 or C7 and C9), 128.6 






















208) 0.1 mmol scale; purified via column chromatography, eluting with hexanes/EtOAc 
(6:1) on SiO2 (6 mL):  1H NMR (300 MHz, CDCl3) δ 7.72 (d, J = 8.4 Hz, 2 H), 7.54 (d, J 
= 8.4 Hz, 2 H), 3.60 (s, 2 H), 2.85–2.74 (comp, 2 H), 2.64–2.51 (comp, 2 H); 13C NMR 
(75 MHz, CDCl3) δ 174.4, 145.9, 132.6, 125.8, 118.1, 112.7, 85.3, 33.8, 29.0, 14.6; IR 
(neat) 2921, 2230, 1783, 1413, 1164, 1028, 841 cm–1; HRMS (CI) m/z 327.9835  
[C12H11NO2I (M+H) requires 327.9835]; HPLC (231 nm): Whelk-O1 (3% CH3CN / 20% 
i-PrOH /hexanes, 1.2 mL/min) 17.5 min (minor), 20.2 min (major); 90:10 er (without I2), 
94:6 er (with 10 mol % I2) 
NMR Assignments: 1H NMR (300 MHz, CDCl3) δ 7.72 (d, J = 8.4 Hz, 2 H, C6-
H and C10-H), 7.54 (d, J = 8.4 Hz, 2 H, C7-H and C9-H), 3.60 (s, 2 H, C11-H), 2.85–
2.74 (comp, 2 H, C2-H), 2.64–2.51 (comp, 2 H, C3-H); 13C NMR (75 MHz, CDCl3) δ 
174.4 (C1), 145.9 (C8), 132.6 (C6 and C10), 125.8 (C5), 118.1 (C7 and C9C12)), 112.7 (, 






















(R)-6-(Iodomethyl)-6-phenyl-1,4-dioxan-2-one (4.75). (JCH-II-210) 0.1 mmol 
scale; purified via column chromatography, eluting with hexanes/EtOAc (6:1) on SiO2 (6 
mL):  1H NMR (400 MHz, CDCl3) δ 7.50–7.35 (comp, 5 H), 4.43 (d, J = 17.7 Hz, 1 H), 
4.32 (d, J = 12.9 Hz, 1 H), 4.28 (d, J = 17.7 Hz, 1 H), 4.19 (d, J = 12.9 Hz, 1 H), 3.70 (d, 
J = 11.2 Hz, 1 H), 3.66 (d, J = 11.2 Hz, 1 H); 13C NMR (100 MHz, CDCl3) δ 166.0, 
138.0, 129.0, 128.9, 125.1, 83.0, 69.6, 65.4, 10.7; HRMS (CI) m/z 317.9753  [C11H11IO3 
(M+H) requires 317.8753]; HPLC (210 nm): Whelk-O1 (20% i-PrOH / hexanes, 1.2 
mL/min) 19.5 min (minor), 24.3 min (major); 84:16 er (without I2), 90:10 er (with 10 mol 
% I2). 
NMR Assignments: 1H NMR (400 MHz, CDCl3) δ 7.50–7.35 (comp, 5 H, C6-H, 
C7-H, C8-H, C9-H, and C10-H), 4.43 (d, J = 17.7 Hz, 1 H, C2-Ha), 4.32 (d, J = 12.9 Hz, 
1 H, 3-Ha), 4.28 (d, J = 17.7 Hz, 1 H, C2-Hb), 4.19 (d, J = 12.9 Hz, 1 H, C3-Hb), 3.70 (d, 
J = 11.2 Hz, 1 H, C11-Ha), 3.66 (d, J = 11.2 Hz, 1 H, C11-Hb); 13C NMR (100 MHz, 
CDCl3) δ 166.0 (C1), 138.0 (C5), 129.0 (C7 and C9), 128.9 (C6 and C10), 125.1 (C8), 
























II-240) 0.1 mmol scale; purified via column chromatography, eluting with 
hexanes/EtOAc (7:1) on SiO2 (6 mL): 1H NMR (300 MHz, CDCl3) δ 4.21 (t, J = 7.5 Hz, 
1 H), 4.06 (s, 1 H), 2.75–2.65 (m, 1 H), 2.56–2.31 (comp, 2 H), 2.13– 2.01 (m, 1 H), 1.18 
(s, 9 H); 13C NMR (75 MHz, CDCl3) δ 176.6, 77.7, 60.0, 36.6, 29.6, 29.5, 27.8; IR (neat) 
2960, 1768, 1463, 1352, 1176, 914 cm–1; HRMS (CI) m/z 283.0196  [C7H11IO2 (M+H) 
requires 283.0195]; HPLC (259 nm): Whelk-O1 (20% i-PrOH / hexanes, 1.2 mL/min) 
11.1 min (minor), 15.4 min (major); 97:3 er (without I2), 98:2 er (with 10 mol % I2).  
NMR Assignments: 1H NMR (300 MHz, CDCl3) δ 4.21 (t, J = 7.5 Hz, 1 H, C4-
H), 4.06 (s, 1 H, C5-H), 2.75–2.65 (m, 1 H, C2-Ha), 2.56–2.31 (comp, 2 H, C2-Hb and 
C3-Ha), 2.13– 2.01 (m, 1 H, C3-Hb), 1.18 (s, 9 H, C7-H, C8-H, and C9-H); 13C NMR (75 
MHz, CDCl3) δ 176.6 (C1), 77.7 (C4), 60.0 (C6), 36.6 (C2), 29.6 (C3), 29.5 (C7, C8, and 






















(R)-6-((S)-1-Iodoethyl)-6-methyl-1,4-dioxan-2-one (4.77). (JCH-II-183) 0.1 
mmol scale; purified via column chromatography, eluting with hexanes/EtOAc (6:1) on 
SiO2 (6 mL), isolated 0.026 g (81%) as a clear, colorless oil: 1H NMR (300 MHz; 
CDCl3): δ 4.41 (q, J = 7.1 Hz, 1 H), 4.31 (s, 2 H), 4.05 (d, J = 12.6 Hz, 1 H), 3.96 (dd, J 
= 56.7, 12.6 Hz, 2 H), 3.87 (d, J = 12.6 Hz, 1 H), 2.02 (d, J = 7.1 Hz, 3 H), 1.61 (s, 3 H); 
13C NMR (75 MHz; CDCl3): δ 166.6, 84.1, 71.8, 65.5, 28.2, 22.5, 19.0; IR (neat) 2985, 
2932, 2872, 1749, 1273, 1102 cm-1; HRMS (ESI) m/z 292.9644 [C7H11INaO2 (M+Na) 
requires 292.9645]; HPLC (259 nm): Whelk-O1 (20% i-PrOH / hexanes, 1.2 mL/min) 
10.7 min (minor), 12.8 min (major); 79:21 er (without I2), 84:16 er (with 10 mol % I2). 
 NMR Assignment: 1H NMR (300 MHz; CDCl3): δ 4.41 (q, J = 7.1 Hz, 1 
H, C5-H), 4.31 (s, 2 H, C2-H), 4.05 (d, J = 12.6 Hz, 1 H, C6-H), 3.96 (dd, J = 56.7, 12.6 
Hz, 2 H, C3-H), 2.02 (d, J = 7.1 Hz, 3 H, C6-H), 1.61 (s, 3 H, C7-H); 13C NMR (75 MHz; 




















(R)-6-(Iodomethyl)-6-methyltetrahydro-2H-pyran-2-one (4.73). (JCH-II-207) 
0.1 mmol scale; purified via column chromatography, eluting with hexanes/EtOAc (6:1) 
on SiO2 (6 mL),  isolated 0.024 (89%) as clear, slightly yellow oil.  1H-NMR (300 MHz; 
CDCl3): δ  3.4 (dd, J = 10.5, 14.5 Hz, 2 H), 2.62-2.42 (m, 2 H), 2.16-2.02 (m, 1 H), 1.95-
1.82 (m, 3 H), 1.59 (s, 3 H); 13C NMR (75 MHz; CDCl3): δ 170.4, 81.9, 31.9, 29.4, 26.5, 
16.9, 15.3; IR (neat) 2955, 1730, 1275, 1215, 1183, 1050 cm-1; HRMS (CI) m/z 254.9872 
[C7H11IO2 (M+H) requires 254.9882]; 79:21 er (without I2), 80:20 er (with I2). 
 NMR Assignment: 1H NMR (300 MHz; CDCl3): δ 3.4 (dd, J = 10.5, 14.5 
Hz, 2 H, C6-H), 2.62-2.42 (m, 2 H, C2-H), 2.16-2.02 (m, 1 H, C3-Ha), 1.95-1.82 (m, 3 H, 
C4-H and C3-Hb), 1.59 (s, 3 H, C7-H); 13C NMR (75 MHz; CDCl3): δ 170.4 (C1), 81.9 


















(R)-2'-(bromomethyl)-[1,1'-binaphthalen]-2-ol (4.146). (JCH-III-223) 
Phosphorous tribromide (0.45 g, 0.17 mmol) was added to a solution of 4.145 in CH2Cl2 
(0.66 mL) at 0 °C, and the solution was stirred for 20 min. The reaction was poured into 
H2O (1.5 mL) and extracted with CH2Cl2 (3 x 2 mL). The combined organic layers were 
washed with brine (8 mL), dried (MgSO4), and concentrated under reduced pressure. The 
crude product was purified via column chromatography, eluting with hexanes/EtOAc 
(7:3) to provide 0.050 g (83%) of 4.146 as a pale yellow oil: 1H NMR (400 MHz, CDCl3) 
δ 8.05 (d, J = 8.4 Hz, 1 H), 7.95 (app t, J = 8.8, 7.2 Hz, 2 H), 7.88 (d, J = 11.2 Hz, 1 H), 
7.77 (d, J = 9.2 Hz, 1 H), 7.54-7.50 (m, 1 H), 7.38-7.30 (comp, 3 H), 7.26-7.22 (comp, 2 
H), 6.93 (d, J = 8.4 Hz, 1 H), 4.32 (dd, J = 10.0, 38.0 Hz, 2 H); 13C NMR (100 MHz, 
CDCL3) δ 151.3, 136.5, 133.7, 133.4, 132.9, 130.5, 130.3, 130.0, 129.0, 128.2, 128.1, 
127.9, 127.4, 127.0, 126.9, 126.1, 124.4, 123.7, 117.8, 115.7, 31.9; IR (NaCl, film) 3054, 
2926, 2853, 2357, 1620, 1596, 1506, 1380 cm-1; HRMS (ESI) m/z 361.0230 [C21H14BrO 
(M–H) requires 361.0233].  
NMR Assignments: 1H NMR (400 MHz, CDCl3) δ 8.05 (d, J = 8.4 Hz, 1 H), 
























7.54-7.50 (m, 1 H), 7.38-7.30 (comp, 3 H), 7.26-7.22 (comp, 2 H), 6.93 (d, J = 8.4 Hz, 1 
H), 4.32 (dd, J = 10.0, 38.0 Hz, 2 H); 13C NMR (100 MHz, CDCL3) δ 151.3, 136.5, 
133.7, 133.4, 132.9, 130.5, 130.3, 130.0, 129.0, 128.2, 128.1, 127.9, 127.4, 127.0, 126.9, 






291/292/293) Triethylamine (0.33 g, 0.32 mmol) and chlorotriethylsilane (0.37 g, 0.32 
mmol) were added to a solution of 4.146 (0.090 g, 0.25 mmol) in CH2Cl2 (7 mL), and the 
solution was stirred for 1 h. The reaction mixture was washed with 1 M HCl (5 mL), H2O 
(5 mL), bring (5 mL), dried (MgSO4), and concentrated under reduced pressure to 
provide crude 4.153: 1H NMR (400 MHz, CDCl3) δ 7.94-7.85 (comp, 4 H), 7.72 (d, J = 
8.0 Hz, 1 H), 7.45-7.42 (m, 1 H), 7.34-7.31 (m, 1 H), 7.25-7.19 (comp, 3 H), 7.16 (d, J = 
8.0 Hz, 1 H), 7.06 (d, J = 7.6 Hz, 1 H), 4.37 (s, 2 H), 0.58 (t, J = 8 Hz, 9 H), 0.46-0.29 
(comp, 6 H). 
Degassed ethanol (12 mL) was added to a stirred mixture of dibenzyl diselenide 




























continued until a clear, colorless solution was obtained; stirring was continued for an 
additional 15 min. A solution of 4.153 (0.08 g, 1.68 mmol) in degassed ethanol (2 mL) 
was added, and the reaction was stirred for 7 h. The reaction was concentrated, and the 
residue was dissolved in methanol (1 mL), whereupon K2CO3 (0.25 g, 0.17 mmol) was 
added. The reaction was stirred for 1 h, then diluted with EtOAc (4 mL). The organic 
layer was washed with 1 M HCl (3 mL), brine 3 mL), dried (MgSO4), and concentrated 
under reduced pressure to provide crude 4.140. The crude product was purified with 
column chromatography eluting with hexanes/EtOAc (15:1) on SiO2 (15 mL) to provide 
0.048 g (75%) of 4.140 as a colorless oil: 1H NMR (400 MHz, CDCl3) δ 7.98-7.86 
(comp, 4 H), 7.54-7.51 (m, 1 H), 7.47-7.44 (m, 1 H), 7.36-7.27 (comp, 3 H), 7.23-7.15 
(comp 5 H), 7.03-6.95 (comp, 3 H), 3.61-3.44 (comp, 4 H); IR (NaCl, film) 3402, 3056, 
2924, 2851, 1619, 1596, 1506, 1379, 1344 cm-1; HRMS (CI) m/z 454.0837 [C28H22OSe 







Ethyl 2-(5-oxocyclopent-1-en-1-yl)acetate (6.6). (JCH-IV-111 and JCH-IV-113) 
Prepared via Barco’s procedure.289 A solution of 4-(cylopent-1-en-1-yl)morpholine (6.9) 
(prepared via condensation of morpholine and cyclopentane288) (10 g, 65 mmol) and ethyl 
glyoxylate (8 g, 78 mmol) in cyclohexane (100 mL) was prepared in a round-bottom 
flask equipped with a Dean-Stark trap and heated under reflux for 20 h. The solution was 
cooled to 40 °C (internal temperature) and 6 M HCl (12 mL) was added. The solution 
was stirred 2 h at 40 °C and cooled to room temperature. Water (50 mL) was added, and 
the layers were separated. The aqueous layer was extracted with toluene (2 x 50 mL), and 
the combined organic layers were dried (Na2SO4) and concentrated under reduced 
pressure to provide 10.5 g (96%, >95% pure by 1H NMR) of ethyl 2-(2-
oxocyclopentylidene)acetate (6.10) as a brown oil. 
Ethyl 2-(2-oxocyclopentylidene)acetate (6.10) (10.5 g, 61.8 mmol) was dissolved 
in EtOH (125 mL) and concentrated HCl (4 mL) was added. The solution was heated 
under reflux for 9 h. The reflux condenser was replaced with a distillation head and the 
EtOH, H2O, and HCl were removed via distillation to provide 10.5 g (>99%, >95% pure 
by 1H NMR) of 6.6 as a brown oil. The spectra were consistent with reported literature 













Ethyl 2-(5-methyl-2-((trimethylsilyl)oxy)cyclopent-1-en-1-yl)acetate (6.19). 
(JCH-IV-119). Methyllithium (1.43 mmol, 1.46 M) was added dropwise to a suspension 
of CuBr•DMS (0.146 g, 0.713 mmol) in THF (1.80 mL) at –78 °C. The reaction was 
stirred 1 h, whereupon a solution of enone 6.6289 (0.100 g, 0.595 mmol) and 
chlorotrimethylsilane (0.259 g, 2.38 mmol) in THF (0.60 mL) was added with stirring. 
After 0.5 h, the reaction was poured into water (10 mL), and the resultant mixture was 
extracted with ether (3 x 10 mL). The combined organic extracts were dried (MgSO4) and 
concentrated in vacuo. The crude product was purified by column chromatography, 
eluting with hexanes/ethyl acetate (10:1) on 40 mL SiO2 to provide 0.057 g (36%) of 6.19 
as a colorless oil: 1H NMR (400 MHz, CDCl3) δ 4.11 (q, J = 7.1 Hz, 2 H), 3.17 (d, J = 
15.7 Hz, 1 H), 2.84 (d, J = 15.7 Hz, 1 H), 2.71-2.66 (m, 1 H), 2.30-2.26 (m, 2 H), 2.12-
2.03 (m, 1 H), 1.39-1.30 (m, 1 H), 1.24 (t, J = 7.1 Hz, 3 H), 0.98 (d, J = 6.8 Hz, 3 H), 
0.18 (s, 9 H); 13C NMR (100 MHz; CDCl3) δ 171.9, 149.4, 114.6, 60.2, 37.3, 32.4, 30.5, 
29.3, 19.9, 14.2, 0.5; IR (film, NaCl) 2956, 1738, 1783, 1253 846 cm-1; HRMS (CI) m/z 





















NMR Assignments: 1H NMR (400 MHz, CDCl3): δ 4.11 (q, J = 7.1, 2 H, C8-H), 
3.17 (d, J = 15.7 Hz, 1 H, C6-Ha), 2.84 (d, J = 15.7 Hz, 1 H, C6-Hb), 2.71-2.66 (m, 1 H, 
C4-H), 2.30-2.26 (m, 2 H, C2-H), 2.12-2.03 (m, 1 H, C3-Ha), 1.39-1.30 (m, 1 H, C3-Hb), 
1.24 (t, J = 7.1, 3 H, C9-H), 0.98 (d, J = 6.8, 3 H, C10-H), 0.18 (s, 9 H, C11-H); 13C 
NMR (100 MHz; CDCl3): δ 171.9 (C7), 149.4 (C1), 114.6 (C5), 60.2 (C8), 37.3 (C4), 









Allyl (2R)-2-methyl-5-oxocyclopentane-1-carboxylate (6.27). (JCH-IV-273) A 
solution of methyl (2R)-2-methyl-5-oxocyclopentane-1-carboxylate (6.24)318 (2.00 g, 
12.8 mmol), DMAP (0.39 g, 3.2 mmol), and allyl alcohol (7.43 g, 128 mmol) in 
cyclohexane (25 mL) was heated at 80 °C with continuous removal of solvent (vigreux 
column with Claisen head) until methanol and cyclohexane were no longer condensing in 
the collection vessel. After removal of methanol and some cyclohexane, the temperature 
was raised to 105 °C and the cyclohexane and most of the allyl alcohol was removed by 
distillation. The crude product was purified by column chromatography eluting with 
hexanes/EtOAc (15:1) on silica gel (260 mL) to provide 1.6 g (69%) of 6.27 as a 
colorless oil: 1H NMR (400 MHz; CDCl3) δ 5.99-5.85 (m, 1 H), 5.34 (dq, J = 17.2, 1.5 
Hz, 1 H), 5.24 (dt, J = 10.5, 1.2 Hz, 1 H), 4.70-4.59 (comp, 2 H), 2.79 (d, J = 11.4 Hz, 1 
H), 2.67-2.55 (m, 1 H), 2.48-2.27 (comp, 2 H), 2.20 (dddd, J = 12.6, 8.4, 6.4, 2.0 Hz, 1 
H), 1.48 (dtd, J = 12.6, 11.2, 8.6 Hz, 1 H), 1.19 (d, J = 6.4 Hz, 3 H); 13C NMR (100 
MHz; CDCl3) δ 211.6, 168.8, 131.8, 118.4, 65.8, 63.0, 38.7, 36.4, 29.3, 19.3; IR (film, 
NaCl) 2961, 2875, 1756, 1728, 1295, 1192, 1129 cm-1; HRMS (CI) m/z 183.1021 
















NMR Assignments: 1H NMR (400 MHz; CDCl3) δ 5.99-5.85 (m, 1 H, C9-H), 
5.34 (dq, J = 17.2, 1.3 Hz, 1 H, C10-Hcis), 5.24 (dt, J = 10.5, 1.3 Hz, 1 H, C10-Htrans), 
4.70-4.59 (comp, 2 H, C8-H), 2.79 (d, J = 11.4 Hz, 1 H, C5-H), 2.67-2.55 (m, 1 H, C2-
Ha), 2.48-2.27 (comp, 2 H, C2-Hb, C3-Ha), 2.20 (dddd, J = 12.6, 8.4, 6.4, 2.0 Hz, 1 H, 
C4-H), 1.48 (dtd, J = 12.6, 11.2, 8.6 Hz, 1 H, C3-Hb), 1.19 (d, J = 6.4 Hz, 3 H, C7-H); 
13C NMR (100 MHz; CDCl3) δ 211.6 (C1), 168.8 (C6), 131.8 (C9), 118.4 (C10), 65.8 






carboxylate (6.23). (JCH-IV-186) A suspension of allyl carboxylate 6.27 (1.2 g, 8.2 
mmol), ethyl bromoacetate (2.7 g, 16.5 mmol), and K2CO3 (3.4 g, 25.0 mmol) in acetone 
(40 mL) was heated at 55 °C for 12 h. The reaction was cooled to room temperature and 
partitioned between Et2O (200 mL) and H2O (160 mL). The layers were separated, and 
the aqueous phase was extracted with Et2O (3 x 150 mL). The combined organic extracts 
were washed with brine (300 mL), dried (MgSO4), and concentrated under reduced 




















with hexanes/EtOAc (12:1) on SiO2 (250 mL) to provide 1.2 g (60%) of 6.23 as a 
colorless oil: 1H NMR (400 MHz, CDCl3) δ 5.86 (ddt, J = 17.2, 10.4, 5.8 Hz, 1 H), 5.29 
(dq, J = 17.2, 1.3 Hz, 1 H), 5.24 (dq, J = 10.4, 1.3 Hz, 1 H), 4.63-4.52 (comp, 2 H), 4.12-
4.04 (comp, 2 H), 3.12 (d, J = 17.9 Hz, 1 H), 2.82 (d, J = 17.9 Hz, 1 H), 2.59-2.49 (m, 3 
H), 2.15-2.08 (m, 1 H), 1.89-1.78 (m, 1 H), 1.25-1.21 (t, J = 7.2 Hz, 3 H), 1.03 (d, J = 6.7 
Hz, 3 H); 13C NMR (100 MHz; CDCl3) δ 215.2, 170.8, 169.3, 131.3, 119.1, 65.8, 60.77, 
60.76, 39.2, 38.1, 35.9, 28.3, 15.4, 14.1; IR (film, NaCl) 2962, 2881, 1730, 1215, 1158, 
1120 cm-1; HRMS (CI) m/z 269.1388 [C14H21O5 (M+1) requires 269.1389]. 
NMR Assignments: 1H NMR (400 MHz, CDCl3) δ 5.86 (ddt, J = 17.2, 10.4, 5.8 
Hz, 1 H, C9-H), 5.29 (dq, J = 17.2, 1.3 Hz, 1 H, C10-Hcis), 5.24 (dq, J = 10.4, 1.3 Hz, 1 
H, C10-Htrans), 4.63-4.52 (comp, 2 H, C8-H), 4.12-4.04 (comp, 2 H, C13-H), 3.12 (d, J = 
17.9 Hz, 1 H, C11-Ha), 2.82 (d, J = 17.9 Hz, 1 H, C11-Hb), 2.59-2.49 (m, 3 H, C2-H, C3-
H), 2.15-2.08 (m, 1 H, C4-H), 1.89-1.78 (m, 1 H, C3-H), 1.25-1.21 (t, J = 7.2 Hz, 3 H, 
C14-H), 1.03 (d, J = 6.7 Hz, 3 H, C7-H); 13C NMR (100 MHz; CDCl3) δ 215.2 (C1), 
170.8 (C6 or C12), 169.3 (C6 or C12), 131.3 (C9), 119.1 (C10), 65.8 (C5), 60.77 (C8 or 
C13), 60.76 (C8 or C13), 39.2 (C2), 38.1 (C4), 35.9 (C3), 28.3 (C11), 15.4 (C7 or C14), 









(E)-But-2-en-1-yl (2R)-2-methyl-5-oxocyclopentane-1-carboxylate (6.31). 
(JCH-IV-274). A solution of methyl (2R)-2-methyl-5-oxocyclopentane-1-carboxylate 
(6.24) (0.50 g, 3.2 mmol), DMAP (0.97 g, 0.80 mmol), and E-crotyl alcohol (2.3 g, 32.0 
mmol) in cyclohexane (6.5 mL) was heated at 80 °C with continuous removal of solvent 
(vigreux column with Claisen head) until methanol and cyclohexane were no longer 
condensing in the collection vessel. After removal of methanol and some cyclohexane, 
the temperature was raised to 105 °C and the cyclohexane and most of the crotyl alcohol 
was removed by distillation. The crude product was purified by column chromatography, 
eluting with hexanes/EtOAc (15:1) to provide 0.30 g (50%) of 6.31 as a colorless oil: 1H 
NMR (400 MHz, CDCl3) δ 5.84-5.74 (m, 1 H), 5.62-5.53 (m, 1 H), 4.58-4.55 (m, 2 H), 
2.75 (d, J = 11.3 Hz, 1 H), 2.65-2.53 (m, 1 H), 2.45-2.21 (comp, 2 H), 2.20-2.14 (m, 1 
H), 1.72-1.70 (m, 3 H), 1.51-1.39 (m, 1 H), 1.16 (d, J = 6.5 Hz, 3 H); 13C (100 MHz, 
CDCl3) δ 211.8, 168.9, 131.6, 124.7, 65.9, 63.1, 38.7, 36.4, 29.3, 19.3, 17.8; IR (NaCl, 
film) 2960, 2875, 1755, 1729, 1456, 1380, 1332 cm-1; HRMS (CI) m/z 197.1177 
[C11H17O3 (M+1) requires 197.1178]. 
NMR Assignments: 1H NMR (400 MHz, CDCl3) δ 5.84-5.74 (m, 1 H, C8-H), 
















2.65-2.53 (m, 1 H, C4-H)), 2.45-2.21 (comp, 2 H, C2-H), 2.20-2.14 (m, 1 H, C3-Ha), 
1.72-1.70 (m, 3 H, C10-H), 1.51-1.39 (m, 1 H, C3-Hb), 1.16 (d, J = 6.5 Hz, 3 H, C11-H); 
13C (100 MHz, CDCl3) δ 211.8 (C1), 168.9 (C6), 131.6 (C8), 124.7 (C9), 65.9 (C7), 63.1 





oxocyclopentane-1-carboxylate (6.32). (JCH-IV-278) A suspension of crotyl 
carboxylate 6.31 (0.260 g, 1.32 mmol), ethyl bromoacetate (0.441 g, 2.64 mmol), and 
K2CO3 (0.547 g, 3.96 mmol) in acetone (7 mL) was heated at 55 °C for 12 h. The 
reaction was cooled to room temperature and partitioned between Et2O (20 mL) and H2O 
(16 mL). The layers were separated, and the aqueous phase was extracted with Et2O (3 x 
15 mL). The combined organic extracts were washed with brine (30 mL), dried (MgSO4), 
and concentrated under reduced pressure. The resulting crude product was purified by 
column chromatography eluting with hexanes/EtOAc (12:1) to provide 0.290 g (77%) of 
6.32 as a colorless oil: 1H NMR (400 MHz; CDCl3): δ 5.81-5.72 (m, 1 H), 5.56-5.48 (m, 
1 H), 4.58-4.52 (m, 1 H), 4.49-4.43 (m, 1 H), 4.12-4.04 (comp, 2 H), 3.11 (d, J = 17.9 




















1.78 (m, 1 H), 1.72-1.69 (m, 3 H), 1.23 (t, J = 7.1 Hz, 3 H), 1.02 (d, J = 6.9 Hz, 3 H); 13C 
NMR (100 MHz; CDCl3): δ 215.4, 170.9, 169.5, 132.1, 124.3, 65.9, 60.8, 60.7, 39.2, 
38.1, 35.9, 28.2, 17.8, 15.4, 14.1; IR (film, NaCl) 2963, 1754, 1731, 1215, 1159 cm -1; 
HRMS (CI) m/z 283.1542 [C15H23O5 (M+1) requires 283.1545]. 
NMR Assignments: 1H NMR (400 MHz; CDCl3): δ 5.81-5.72 (m, 1 H, C9), 
5.56-5.48 (m, 1 H, C10), 4.58-4.52 (m, 1 H, C8-Ha), 4.49-4.43 (m, 1 H, C8-Hb), 4.12-
4.04 (comp, 2 H, C14), 3.11 (d, J = 17.9 Hz, 1 H, C12-Ha), 2.81 (d, J = 17.9 Hz, 1 H, 
C12-Hb), 2.59-2.45 (comp, 3 H, C2-H and C4-H), 2.14-2.07 (m, 1 H, C3-Ha), 1.89-1.78 
(m, 1 H, C3-Hb), 1.72-1.69 (m, 3 H, C11-H), 1.23 (t, J = 7.1 Hz, 3 H, C15-H), 1.02 (d, J 
= 6.9 Hz, 3 H, C7-H); 13C NMR (100 MHz; CDCl3): δ 215.4 (C1), 170.9 (C6), 169.5 
(C13), 132.1 (C9), 124.3 (C10), 65.9 (C5), 60.8 (C8), 60.7 (C14), 39.2 (C12), 38.1 (C2), 









carboxylate (6.51). (JCH-V-115) A suspension of 6.50 (0.040 g, 0.160 mmol), ethyl 
bromoacetate (0.530 g, 0.320 mmol), and K2CO3 (0.088 g, 0.640 mmol) in acetone (1 
mL) was heated at 55 °C for 12 h. The reaction was cooled to room temperature and 
partitioned between Et2O (2 mL) and H2O (1 mL). The layers were separated, and the 
aqueous phase was extracted with Et2O (3 x 2 mL). The combined organic extracts were 
washed with brine (3 mL), dried (MgSO4), and concentrated under reduced pressure. The 
resulting crude product was purified by column chromatography eluting with 
hexanes/EtOAc (5:1) on SiO2 (40 mL) to provide 0.038 g (70%) of 6.51 as a colorless oil: 
1H NMR (400 MHz, CDCl3) δ 5.86 (ddt, J = 17.1, 10.5, 5.8, 1 H), 5.32-5.23 (m, 2 H), 
4.64-4.54 (m, 2 H), 4.09 (q, J = 7.1, 2 H), 3.11 (d, J = 17.7, 1 H), 2.79 (d, J = 17.7, 1 H), 
2.62-2.47 (m, 3 H), 2.20-2.12 (m, 1 H), 1.87-1.76 (m, 1 H), 1.23 (t, J = 7.1, 3 H), 0.79 
(dd, J = 14.3, 2.5, 1 H), 0.34 (dd, J = 14.3, 12.4, 1 H), 0.03 (s, 9 H); 13C (100 MHz, 
CDCl3) δ 216.0, 171.8, 170.3, 132.3, 119.9, 66.7, 63.2, 61.7, 42.0, 39.3, 36.6, 29.5, 18.8, 
15.1, 0.0; IR (NaCl, film) 2953, 1754, 1733, 1373, 1249, 1223, 1175, 1025 cm-1; HRMS 


























NMR Assignments: 1H NMR (400 MHz, CDCl3) δ 5.86 (ddt, J = 17.1, 10.5, 5.8, 
1 H, C12-H), 5.32-5.23 (m, 2 H, C13-H), 4.64-4.54 (m, 2 H, C11-H), 4.09 (q, J = 7.1, 2 
H, C8-H), 3.11 (d, J = 17.7, 1 H, C6-Ha), 2.79 (d, J = 17.7, 1 H, C6-Hb), 2.62-2.47 (m, 3 
H, C2-H and C4-H), 2.20-2.12 (m, 1 H, C3-Ha), 1.87-1.76 (m, 1 H, C3-Hb), 1.23 (t, J = 
7.1, 3 H, C9-H), 0.79 (dd, J = 14.3, 2.5, 1 H, C14-Ha), 0.34 (dd, J = 14.3, 12.4, 1 H C14-
Hb), 0.03 (s, 9 H, C15-H, C16-H, and C17-H); 13C (100 MHz, CDCl3) δ 216.0 (C1), 
171.8 (C10), 170.3 (C7), 132.3 (C11), 119.9 (C13), 66.7 (C5), 63.2 (C11), 61.7 (C8), 








Ethyl 2-(1-allyl-2-oxo-5-((trimethylsilyl)methyl)cyclopentyl)acetate (6.52). 
(JCH-V-127) Ester 6.51 (0.025 g, 0.073 mmol) was added to a solution of Pd(PPh3)4 
(0.008 g, 0.007 mmol) in THF (3 mL). The reaction was stirred for 12 h, whereupon it 
was concentrated under reduced pressure to provide crude 6.52 as a mixture (1:1.6) of 
diastereomers. The crude product was purified via column chromatography eluting with 
hexanes/Et2O (5:1) on SiO2 (15 mL) to provide 0.18 g (80%) of 6.52 as a mixture (1:1.6) 
of diastereomers: 1H NMR (600 MHz, CDCl3) δ 5.72-5.65 (m, 0.6 H), 5.62-5.55 (m, 0.3 
H), 5.06-4.98 (m, 2 H), 4.11-4.00 (m, 2 H), 2.75 (d, J = 16.7 Hz, 0.6 H), 2.45-2.37 (m, 
1.8 H), 2.34-2.28 (m, 1.6 H), 2.27-2.22 (m, 1 H), 2.15-2.00 (m, 3 H), 1.54-1.48 (m, 1 H), 
1.22-1.19 (m, 3 H), 0.68-0.63 (m, 1 H), 0.53-0.49 (m, 0.6 H), 0.41-0.36 (m, 0.4 H), 0.01 
(bs, 9 H); 13C NMR (125 MHz, CDCl3) δ 221.1, 219.9, 171.6, 171.4, 133.4, 133.2, 118.9, 
118.6, 60.6, 60.4, 53.4, 53.2, 39.7, 39.5, 38.2, 37.8, 37.7, 37.2, 35.2, 27.8, 27.2, 17.4, 
16.3, 14.2, 14.11, 14.0, -0.72, -0.89; IR (NaCl, film) 2958, 2904, 1730, 1462, 1279 cm-1; 
HRMS (ESI) m/z 319.1703 [C17H28O3Si (M+Na) requires 319.1700].  
NMR Assignments: 1H NMR (600 MHz, CDCl3) δ 5.72-5.65 (m, 0.6 H, C11-
Hmajor), 5.62-5.55 (m, 0.3 H, C11-Hminor), 5.06-4.98 (m, 2 H, C12-H), 4.11-4.00 (m, 2 H, 






















H, ), 2.27-2.22 (m, 1 H, C4-H), 2.15-2.00 (m, 3 H, C3Ha, C10-H), 1.54-1.48 (m, 1 H, C3-
Hb), 1.22-1.19 (m, 3 H, C9-H), 0.68-0.63 (m, 1 H, C13-Ha), 0.53-0.49 (m, 0.6 H, C13-Hb 
major), 0.41-0.36 (m, 0.4 H, C-13b minor), 0.01 (bs, 9 H, C14-H, C15-H, and C16-H); 13C 
NMR (125 MHz, CDCl3) δ 221.1 (C1minor), 219.9 (C1major), 171.6 (C7minor), 171.4 
(C7major), 133.4 (C11minor), 133.2 (C11major), 118.9 (C12minor), 118.6 (C11major), 60.6 
(C5minor), 60.4 (C5major), 53.4 (C8minor), 53.2 (C8major), 39.7, 39.5, 38.2, 37.8, 37.7, 37.2, 
35.2, 27.8, 27.2, 17.4, 16.3, 14.2 , 14.11 (C9minor), 14.0 (C9major), -0.72 (C14, C15, and 






(6.43). (JCH-V-075) A suspension of 6.27 (0.500 g, 2.74 mmol), ethyl bromoacetate 
(1.09 g, 7.94 mmol), and K2CO3 (1.51 g, 7.94 mmol) in acetone (17 mL) was heated at 55 
°C for 12 h. The reaction was cooled to room temperature and partitioned between Et2O 
(30 mL) and H2O (15 mL). The layers were separated, and the aqueous phase was 
extracted with Et2O (3 x 20 mL). The combined organic extracts were washed with brine 




















product was purified by column chromatography eluting with hexanes/EtOAc (20:1) on 
SiO2 (120 mL) to provide 0.536 g (65%) of 6.43 as a colorless oil: 1H NMR (400 MHz, 
CDCl3) δ 5.86 (ddt, J = 17.2, 10.4, 5.8 Hz, 1 H), 5.67 (t, J = 1.2 Hz, 1 H), 5.54-5.53 (m, 1 
H), 5.32-5.23 (m, 2 H), 4.65-4.53 (m, 2 H), 3.28-3.23 (m, 1 H), 3.17 (d, J = 15.1 Hz, 1 
H), 2.64-2.55 (m, 2 H), 2.36 (ddd, J = 19.1, 11.5, 9.1 Hz, 1 H), 2.14-2.06 (m, 1 H), 1.92-
1.81 (m, 1 H), 1.05 (d, J = 6.9, 3 H); 13C (100 MHz, CDCl3) δ 215.2, 169.4, 131.2, 128.2, 
122.3, 119.2, 65.9, 63.2, 41.2, 38.9, 37.4, 27.9, 15.3; IR (NaCl, film) 2961, 1752, 1730, 
1624, 1224, 1164, 1117 cm-1; HRMS (CI) m/z 301.0432 [C13H18O3Br (M+1) requires 
301.0439]. 
NMR Assignments: 1H NMR (400 MHz, CDCl3) δ 5.86 (ddt, J = 17.2, 10.4, 5.8 
Hz, 1 H, C11-H), 5.67 (t, J = 1.2 Hz, 1 H, C8-Ha), 5.54-5.53 (m, 1 H, C8-Hb), 5.32-5.23 
(m, 2 H, C12-H), 4.65-4.53 (m, 2 H, C10-H), 3.28-3.23 (m, 1 H, C6-Ha), 3.17 (d, J = 15.1 
Hz, 1 H, C6-Hb), 2.64-2.55 (m, 2 H, C2-H), 2.36 (ddd, J = 19.1, 11.5, 9.1 Hz, 1 H, C4-H), 
2.14-2.06 (m, 1 H, C3-Ha), 1.92-1.81 (m, 1 H, C3-Hb), 1.05 (d, J = 6.9, 3 H, C13-H); 13C 
(100 MHz, CDCl3) δ 215.2 (C1), 169.4 (C9), 131.2 (C7), 128.2 (C11), 122.3 (C8), 119.2 









066) A solution of 6.43 (0.020 g, 0.70 mmol) in THF (1 mL) was added to a solution of 
Pd(PPh3)4 (0.008 g, 0.007 mmol) in THF (1.3 mL), and the solution was stirred for 12 h. 
The reaction was concentrated under reduced pressure to provide crude 6.44 as a mixture 
(3:1) of diastereomers. The crude product was purified via column chromatography 
eluting with hexanes/EtOAc (25:1) on SiO2 (30 mL) to provide 0.013 g (67%) of 6.44 as 
a single diasteromer: 1H NMR (600 MHz, CDCl3) δ 5.71-5.64 (m, 1 H), 5.55-5.49 (m, 1 
H), 5.44-5.44 (m, 1 H), 5.05-5.99 (m, 2 H), 3.01 (d, J = 14.0 Hz, 1 H), 2.45-2.37 (m, 2 
H), 2.35-2.30 (m, 1 H), 2.26-2.19 (m, 1 H), 2.13-2.10 (m, 1 H), 2.04-1.99 (m, 2 H), 1.60-
1.53 (m, 1 H), 1.07 (d, J = 6.9 Hz, 3 H); 13C (125 MHz, CDCl3) δ 220.3, 133.0, 129.7, 
120.9, 118.5, 54.5, 44.6, 37.6, 36.5, 35.9, 26.9, 14.2; IR (NaCl, film) 3077, 2959, 2901, 
1737, 1624, 1465, 1436, 1404, 1380, 1121 cm-1; HRMS (CI) m/z 257.0536 [C12H18O1Br 
(M+1) requires 257.0541]. 
NMR Assignments: 1H NMR (600 MHz, CDCl3) δ 5.71-5.64 (m, 1 H, C10-H), 
5.55-5.49 (m, 1 H, C8-Ha), 5.44-5.44 (m, 1 H, C8-Hb), 5.05-5.99 (m, 2 H, C11-H), 3.01 
(d, J = 14.0 Hz, 1 H, C6-Ha), 2.45-2.37 (m, 2 H, C6-Hb and C2-Ha), 2.35-2.30 (m, 1 H, 
C2-Hb), 2.26-2.19 (m, 1 H, C4-H), 2.13-2.10 (m, 1 H, C9-Ha), 2.04-1.99 (m, 2 H, C9-Hb 















CDCl3) δ 220.3 (C1), 133.0 (C10), 129.7 (C7), 120.9 (C8), 118.5 (C11), 54.5 (C5), 44.6 
(C6), 37.6 (C2), 36.5 (C4), 35.9 (C9), 26.9 (C3), 14.2 (C12) 
NOE Correlations: 









NOE between the Me group and all positions of the allyl group











3-Methylbut-2-en-1-yl (2R)-2-methyl-5-oxocyclopentane-1-carboxylate (6.28). 
(JCH-V-062) A solution of methyl (2R)-2-methyl-5-oxocyclopentane-1-carboxylate 
(6.24) (0.50 g, 3.2 mmol), DMAP (0.97 g, 0.80 mmol), and prenyl alcohol (2.7 g, 32.0 
mmol) in cyclohexane (7 mL) was heated at 80 °C with until methanol and cyclohexane 
with continuous removal of solvent (vigreux column with Claisen head) until methanol 
and cyclohexane were no longer condensing in the collection vessel. After removal of 
methanol and some cyclohexane by distillation, the temperature was raised to 105 °C and 
the cyclohexane and most of the crotyl alcohol was removed. The crude product was 
purified by column chromatography, eluting with hexanes/EtOAc (15:1) to provide 0.35 
g (53%) of 6.28 as a pale yellow oil: 1H NMR (400 MHz, CDCl3) δ 5.35 (dddt, J = 7.2, 
5.8, 2.8, 1.4 Hz, 1 H), 4.64 (d, J = 7.2 Hz, 2 H), 2.75 (dd, J = 11.3, 0.6 Hz, 1 H), 2.64-
2.53 (m, 1 H), 2.45-2.26 (m, 2 H), 2.22-2.15 (m, 1 H), 1.75 (s, 3 H), 1.70 (s, 3 H), 1.46 
(dtd, J = 12.6, 11.2, 8.5, 1 H), 1.18 (d, J = 6.5 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 
211.9, 163.7, 133.0, 115.3, 66.1, 62.9, 46.8, 38.7, 31.7, 31.3, 20.2, 16.9; IR (NaCl, film) 
cm-1; HRMS (CI) m/z 211.1255 [C12H19O3 (M+H) requires 211.1256]. 
NMR Assignments: 1H NMR (400 MHz, CDCl3) δ 5.35 (dddt, J = 7.2, 5.8, 2.8, 


















2.64-2.53 (m, 1 H, C2-Ha), 2.45-2.26 (m, 2 H, C2-Hb and C4-H), 2.22-2.15 (m, 1 H, C3-
Ha), 1.75 (s, 3 H, C10-H or C11-H), 1.70 (s, 3 H, C10-H or C11-H), 1.46 (dtd, J = 12.6, 
11.2, 8.5, 1 H, C3-Hb), 1.18 (d, J = 6.5 Hz, 3 H, C12-H); 13C NMR (100 MHz, CDCl3) δ 
211.9 (C1), 163.7 (C6), 133.0 (C9), 115.3 (C8), 66.1 (C5), 62.9 (C7), 46.8 (C2), 38.7 






oxocyclopentane-1-carboxylate (6.29). (JCH-V-074) A suspension of 6.28 (0.300 g, 
1.43 mmol), ethyl bromoacetate (0.955 g, 5.72 mmol), and K2CO3 (0.394 g, 2.85 mmol) 
in acetone (9 mL) was heated at 55 °C for 12 h. The reaction was cooled to room 
temperature and partitioned between Et2O (20 mL) and H2O (10 mL). The layers were 
separated, and the aqueous phase was extracted with Et2O (3 x 10 mL). The combined 
organic extracts were washed with brine (30 mL), dried (MgSO4), and concentrated under 
reduced pressure. The resulting crude product was purified by column chromatography, 
eluting with hexanes/EtOAc (12:1) on SiO2 (70 mL) to provide 0.318 g (75%) of 6.29 as 
a colorless oil: 1H NMR (400 MHz, CDCl3) δ 5.31-5.26 (m, 1 H), 4.64 (dd, J = 12.2, 7.2 























2.80 (d, J = 17.9 Hz, 1 H), 2.59-2.44 (m, 3 H), 2.13-2.06 (m, 1 H), 1.88-1.77 (m, 1 H), 
1.74 (s, 3 H), 1.68 (s, 3 H) 1.23 (t, J = 7.2 Hz, 3 H), 1.01 (d, J = 7.1 Hz, 3 H); 13C NMR 
(100 MHz, CDCl3) δ 215.5, 170.9, 169.6, 139.8, 117.9, 62.0, 60.73, 60.70, 39.2, 38.1, 
35.9, 28.2, 25.7, 18.0, 15.3, 14.1; IR (NaCl, film) 2966, 2880, 1754, 1730, 1455, 1404, 
1373, 1338, 1216, 1159, 1120, 1026 cm-1; HRMS (CI) m/z 297.1699 [C16H26O5 (M+1) 
requires 297.1702]. 
NMR Assignments: 1H NMR (400 MHz, CDCl3) δ 5.31-5.26 (m, 1 H, C12-H), 
4.64 (dd, J = 12.2, 7.2 Hz, 1 H, C11-Ha), 4.50 (dd, J = 12.2, 7.2 Hz, 1 H, C11-Hb), 4.12-
4.04 (m, 2 H, C8-H), 3.10 (d, J = 17.9 Hz, 1 H, C6-Ha), 2.80 (d, J = 17.9 Hz, 1 H, C6-
Hb), 2.59-2.44 (m, 3 H, C2-H and C4-H), 2.13-2.06 (m, 1 H, C3-Ha), 1.88-1.77 (m, 1 H, 
C3-Hb), 1.74 (s, 3 H, C14-H or C15-H), 1.68 (s, 3 H, C14-H or C15-H) 1.23 (t, J = 7.2 
Hz, 3 H, C9-H), 1.01 (d, J = 7.1 Hz, 3 H, C16-H); 13C NMR (100 MHz, CDCl3) δ 215.5 
(C1), 170.9 (C10), 169.6 (C7), 139.8 (C13), 117.9 (C12), 62.0 (C5), 60.73 (C11), 60.70 
(C8), 39.2 (C4), 38.1 (C6), 35.9 (C3), 28.2 (C14 or C15), 25.7 (C14 or C15), 18.0 (C2), 








2-Chloroallyl (2R)-2-methyl-5-oxocyclopentane-1-carboxylate (unnumbered). 
(JCH-V-080) A solution of 6.24 (0.500 g, 3.20 mmol), DMAP (0.980 g, 0.800 mmol), 
and 2-chloro-2-propenol (2.96 g, 32.0 mmol) in cyclohexane (8 mL) was heated at 80 °C 
with continuous removal of solvent (vigreux column with Claisen head) until methanol 
and cyclohexane were no longer condensing in the collection vessel. After removal of 
methanol and some cyclohexane, the temperature was raised to 105 °C and the 
cyclohexane and most of the 2-chloro-2-propenol was removed by distillation. The crude 
reaction was purified by column chromatography, eluting with hexanes/EtOAc (12:1) on 
SiO2 (140 mL) to provide 0.462 g (67%) of the title compound as a colorless oil: 1H 
NMR (400 MHz, CDCl3) δ 5.54-5.53 (m, 1 H), 5.41 (dt, J = 1.8, 0.8 Hz, 1 H), 4.77-4.68 
(m, 2 H), 2.84 (d, J = 11.5 Hz, 1 H), 2.68-2.56 (m, 1 H), 2.48-2.29 (m, 2 H), 2.21 (dddd, 
J = 12.6, 8.4, 6.4, 2.0 Hz, 1 H), 1.50 (dtd, J = 12.6, 11.3, 8.5 Hz, 1 H), 1.21 (d, J = 6.4, 3 
H); 13C NMR (100 MHz, CDCl3) δ 211.3, 168.3, 135.2, 114.9, 66.3, 62.9, 38.7, 36.5, 
29.4, 19.2; IR (NaCl, film) 2961, 2875, 1757, 1733, 1639, 1458, 1404, 1381, 1331, 1284, 
1227, 1187, 1125 cm-1; HRMS (CI) m/z 217.0630 [C10H14O3Cl (M+1) requires 
217.0631]. 
NMR Assignments: 1H NMR (400 MHz, CDCl3) δ 5.54-5.53 (m, 1 H, C10-Ha), 
















H, C5-H), 2.68-2.56 (m, 1 H, C2-Ha), 2.48-2.29 (m, 2 H, C2-Hb and C4-H), 2.21 (dddd, J 
= 12.6, 8.4, 6.4, 2.0 Hz, 1 H, C3-Ha), 1.50 (dtd, J = 12.6, 11.3, 8.5 Hz, 1 H, C3-Hb), 1.21 
(d, J = 6.4, 3 H, C10-H); 13C NMR (100 MHz, CDCl3) δ 211.3 (C1), 168.3 (C6), 135.2 









(6.45). (JCH-V-081) A suspension of 2-chloroallyl (2R)-2-methyl-5-oxocyclopentane-1-
carboxylate  (0.200 g, 0.923 mmol), allyl bromide (0.447 g, 3.69 mmol), and K2CO3 
(0.255 g, 1.85 mmol) in acetone (6 mL) was heated at 55 °C for 12 h. The reaction was 
cooled to room temperature and partitioned between Et2O (12 mL) and H2O (6 mL). The 
layers were separated, and the aqueous phase was extracted with Et2O (3 x 10 mL). The 
combined organic extracts were washed with brine (30 mL), dried (MgSO4), and 
concentrated under reduced pressure. The resulting crude product was purified by column 
chromatography eluting with hexanes/EtOAc (20:1) on SiO2 (60 mL) to provide 0.170 g 
(72%) of 6.45 as a colorless oil: 1H NMR (400 MHz, CDCl3) δ 5.67-5.57 (m, 1 H), 5.45-
5.41 (m, 2 H), 5.14-5.09 (m, 2 H), 4.73-4.69 (m, 1 H), 4.63-4.59 (m, 1 H), 2.67 (ddt, J = 
14.2, 6.3, 1.3 Hz, 1 H), 2.61-2.49 (m, 2 H), 2.41-2.31 (m, 1 H), 2.21-2.02 (m, 3 H), 1.94-
1.83 (m, 1 H), 1.06 (d, J = 6.9 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 215.6, 169.7, 
135.2, 132.8, 119.7, 116.2, 66.6, 62.9, 38.9, 38.7, 35.6, 28.1, 15.3; IR (NaCl, film) 3078, 
2961, 1753, 1733, 1640, 1459, 1434, 1403, 1382, 1222, 1185, 1161, 1114 cm-1; HRMS 




















NMR Assignments: 1H NMR (400 MHz, CDCl3) δ 5.67-5.57 (m, 1 H, C7-H), 
5.45-5.41 (m, 2 H, C12-H), 5.14-5.09 (m, 2 H, C8-H), 4.73-4.69 (m, 1 H, C10-Ha), 4.63-
4.59 (m, 1 H, C10-Hb), 2.67 (ddt, J = 14.2, 6.3, 1.3 Hz, 1 H, C6-Ha), 2.61-2.49 (m, 2 H, 
C6-Hb and C2-Ha), 2.41-2.31 (m, 1 H, C2-Hb), 2.21-2.02 (m, 2 H, C4-H and C3-Ha), 
1.94-1.83 (m, 1 H, C3-Hb), 1.06 (d, J = 6.9 Hz, 3 H, C13-H); 13C NMR (100 MHz, 
CDCl3) δ 215.6 (C1), 169.7 (C9), 135.2 (C11), 132.8 (C7), 119.7 (C12), 116.2 (C8), 66.6 





Ethyl 2-((1R,2R)-1-allyl-2-methyl-5-oxocyclopentyl)acetate (6.5). (JCH-V-249) 
Ligand 6.59 (0.323 g, 0.542 mmol) was dissolved in THF (55 mL) and Pd2pmdba3 (0.232 
g, 0.210 mmol) was added. The reaction was stirred for 0.5 h, and the color progressed 
from dark red/purple to red/orange. A solution of β-keto ester 6.27 (1.13 g, 4.23 mmol) in 
THF (3 mL) was added, whereupon the solution turned green, and the reaction was 
stirred for 12 h. Upon completion of the reaction, the solvent was removed under reduced 
pressure to provide crude 6.5 as a mixture (10:1) of diastereomers. The crude reaction 
mixture was purified via flash column chromatography eluting with hexanes/EtOAc (4:1) 



















NMR (500 MHz, CDCl3): δ 5.69-5.61 (m, 1 H), 5.10-5.03 (comp, 2 H), 4.13-4.04 (m, 2 
H), 2.46-2.39 (comp, 3 H), 2.35-2.29 (m, 2 H), 2.23-2.15 (comp, 2 H), 2.10-2.03 (m, 1 
H), 1.63-1.58 (m, 1 H), 1.24 (t, J = 7.3 Hz, 3 H), 1.00 (d, J = 7.1 Hz, 3 H); 13C NMR (125 
MHz, CDCl3): δ 220.9, 171.6, 133.2, 118.9, 60.5, 52.6, 41.0, 38.2, 37.3, 36.9, 27.5, 15.7, 
14.1; IR (film, NaCl) 2961, 1731, 1639, 1463, 1443, 1407, 1372, 1325, 1288, 1201, 1170 
cm-1; HRMS (CI) m/z 225.1492 [C13H21O3 (M+1) requires 225.1491]. 
NMR Assignments: 1H NMR (500 MHz, CDCl3): δ 5.69-5.61 (m, 1 H, C7-H), 
5.10-5.03 (comp, 2 H, C8-H), 4.13-4.04 (m, 2 H, C12-H), 2.46-2.39 (comp, 3 H, C10-H 
and C6-Ha), 2.35-2.29 (m, 2 H, C6-Ha and C4-H), 2.23-2.15 (comp, 2 H, C2-Hb and C6-
Hb), 2.10-2.03 (m, 1 H, C3-Htop face), 1.63-1.58 (m, 1 H, C3-Hbottom face), 1.24 (t, J = 7.3 
Hz, 3 H, C13-H), 1.00 (d, J = 7.1 Hz, 3 H, C9-H); 13C NMR (125 MHz, CDCl3): δ 220.9 
(C1), 171.6 (C11), 133.2 (C7), 118.9 (C8), 60.5 (C12), 52.6 (C5), 41.0 (C2, C6, or C10), 
38.2 (C4), 37.3 (C2, C6, or C10), 36.9 (C2, C6, or C10), 27.5 (C3), 15.7 (C9), 14.1 (C13) 
NOE Correlations: 










NOE between both protons of the ester and methyl









Ethyl 2-((1S,2R)-1-allyl-2-methyl-5-oxocyclopentyl)acetate (epi-6.5). (JCH-V-
249). Product is the minor diastereomer from the above reaction: 1H NMR (500 MHz, 
CDCl3): δ 5.75-5.65 (m, 1 H), 5.09-5.02 (comp, 2 H), 4.11-4.03 (m, 2 H), 2.76 (d, J = 
16.8 Hz, 1 H), 2.47-2.30 (comp, 4 H), 2.22-2.01 (comp, 3 H), 1.63-1.54 (m, 1 H), 1.22 (t, 
J = 7.2 Hz, 3 H), 1.05 (d, J = 6.9 Hz, 3 H); 13C (125 MHz, CDCl3) 220.4, 171.5, 133.1, 
118.7, 60.4, 52.1, 40.9, 38.14, 38.10, 35.1 27.2, 14.2, 14.1. 
NMR Assignments: 1H NMR (500 MHz, CDCl3): δ 5.75-5.65 (m, 1 H, C7-H), 
5.09-5.02 (comp, 2 H, C8-H), 4.11-4.03 (m, 2 H, C12-H), 2.76 (d, J = 16.8 Hz, 1 H, C10-
Ha), 2.47-2.30 (comp, 4 H, C4-H, C2-H, C10-Hb), 2.22-2.01 (comp, 3 H, C3-Htop face, C6-
H), 1.63-1.54 (m, 1 H, C3-Hbottom face), 1.22 (t, J = 7.2 Hz, 3 H, C13-H), 1.05 (d, J = 6.9 
Hz, 3 H, C9-H); 13C (125 MHz, CDCl3) 220.4 (C5), 171.5 (C11), 133.1 (C7), 118.7 (C8), 
60.4 (C12), 52.1 (C5), 40.9 (C2), 38.14 (C10), 38.10 (C3), 35.1 (C6), 27.2 (C3), 14.2 
































NOE between both allylic protons and methyl
NOE between one vinyl proton and methyl










Ethyl 2-((2R)-2-methyl-5-oxo-1-(2-oxoethyl)cyclopentyl)acetate (6.4). (JCH-
VI-137/138) Potassium osmate (VI) dihydrate (0.008 g, 0.022 mmol) was added to a 
solution of 6.5 (0.100 g, 0.446 mmol) and NMO (0.083 g, 0.714 mmol) in mixture (5:2) 
of THF/H2O (1.3 mL). The reaction was stirred at room temperature for 15 h, whereupon 
saturated aqueous sodium thiosulfate (1.3 mL) was added. The mixture was extracted 
with EtOAc (3 x 2 mL), and the combined organic layers were washed with brine (1 x 5 
mL), dried (MgSO4), and concentrated under reduced pressure. The crude diol was 
dissolved in a mixture (2:1) of THF/H2O (3.4 mL), and cooled to 0 °C, whereupon 
sodium periodate (0.229 g, 1.07 mmol) was added. The cooling bath was removed, and 
the reaction was stirred at room temperature for 1 h. The reaction was filtered through 
celite, washing with EtOAc (6 mL). The layers were separated and the aqueous layer was 
extracted with EtOAc (3 x 2 mL). The combined organic layers were washed with brine 
(1 x 8 mL), dried (MgSO4), and concentrated under reduced pressure. The crude product 
was purified via flash column chromatography eluting with CH2Cl2/Et2O (20:1) to 
provide 0.80 g (80%) of aldehyde 6.4 as a colorless oil: 1H NMR (600 MHz, CDCl3) δ 
9.61 (t, J = 1.1 Hz, 1 H), 4.08 (q, J = 7.2 Hz, 2 H), 3.00 (dd, J = 0.9, 18.2 Hz, 1 H), 2.78 
(dd, J = 1.5, 18.2 Hz, 1 H), 2.53-2.31 (comp, 5 H), 2.11-2.06 (m, 1 H), 1.61-1.54 (m, 1 



















219.7, 199.67, 170.8, 60.9, 50.6, 48.7, 38,5, 36.7, 36.4, 27.6, 14.64, 14.03; IR (film, 
NaCl) 2925, 2854, 2360, 1732, 1458, 1364, 1183, 1096, 1037 cm-1; HRMS (ESI) m/z 
249.1098 [C12H18O4 (M+Na) requires 249.1097]. 
NMR Assignments: 1H NMR (600 MHz, CDCl3) δ 9.61 (t, J = 1.1 Hz, 1 H, C7-
H), 4.08 (q, J = 7.2 Hz, 2 H, C12-H), 3.00 (dd, J = 0.9, 18.2 Hz, 1 H, C6-Ha), 2.78 (dd, J 
= 1.5, 18.2 Hz, 1 H, C6-Hb), 2.53-2.31 (comp, 5 H, C2-H, C4-H, C10-H), 2.11-2.06 (m, 1 
H, C3-Ha), 1.61-1.54 (m, 1 H, C3-Hb), 1.22 (t, J = 7.2 Hz, 3 H, C13-H), 0.99 (d, J = 7.0 
Hz, 3 H, C9-H); 13C NMR (150 MHz, CDCl3): δ 219.7 (C1), 199.67 (C7), 170.8 (C11), 










oxocyclopentyl)but-2-enoate (6.76). (JCH-V-260) Hoveyda-Grubbs catalyst 2nd 
generation (0.005 g, 0.008 mmol) was added to a solution of 2-oxopropyl acrylate (6.75) 
396 (0.020 g, 0.134 mmol) and 6.5 (0.015 g, 0.067 mmol) in CH2Cl2 (0.2 mL). The 
reaction was stirred for 12 h at 40 °C in a sealed vial, whereupon the reaction was 
concentrated under reduced pressure. The crude pruduct was purified via flash column 
chromatography, eluting with hexanes/EtOAc (2:1) on SiO2 (10 mL) to provide 0.19 g 
(85%) of 6.76 as a colorless oil: 1H NMR (600 MHz, CDCl3) δ 6.87 (ddd, J = 15.6, 8.3, 
7.5 Hz, 1 H), 5.78 (dt, J = 15.6, 1.3 Hz, 1 H), 4.67 (s, 2 H), 4.11-4.04 (m, 2 H), 2.53-2.49 
(m, 1 H), 2.47-2.38 (comp, 4 H), 2.23-2.17 (comp, 2 H), 2.15 (s, 3 H), 2.08-2.04 (m, 1 
H), 1.62-1.59 (m, 1 H), 1.22 (t, J = 7.1 Hz, 3 H), 0.99 (d, J = 7.0 Hz, 3 H); 13C NMR (125 
MHz, CDCl3) δ 219.8, 201.7, 171.1, 164.9, 145,5, 123.7, 68.0, 60.8, 52.8, 38.73, 38.70, 
36.9, 36.7, 27.4, 26.1 15.4, 14.0; IR (NaCl, film) 2963, 1729, 1654, 1419, 1372, 1276, 
1159 cm-1; HRMS (ESI) m/z 347.1472 [C17H24O6 (M+Na) requires 347.1465]. 
NMR Assignments: 1H NMR (600 MHz, CDCl3) δ 6.87 (ddd, J = 15.6, 8.3, 7.5 
























(m, 2 H, C12-H), 2.53-2.49 (m, 1 H, C6-Ha), 2.47-2.38 (comp, 4 H, C10-H, C6-Hb, C2-
Ha), 2.23-2.17 (comp, 2 H, C6-Hb, C4-H), 2.15 (s, 3 H, C17-H), 2.08-2.04 (m, 1 H, C3-
Ha), 1.62-1.59 (m, 1 H, C3-Hb), 1.22 (t, J = 7.1 Hz, 3 H, C13-H), 0.99 (d, J = 7.0 Hz, 3 H, 
C14-H); 13C NMR (125 MHz, CDCl3) δ 219.8(C1), 201.7 (C16), 171.1 (C11), 164.9 
(C9), 145.5 (C7), 123.7 (C8), 68.0 (C15), 60.8 (C12), 52.8 (C5), 38.73 (C2 or C4), 38.70 








5-oxocyclopentane-1-carboxylate. (JCH-VI-149) A suspension of 6.24 (0.300 g, 3.20 
mmol), 6.16 (0.848 g, 34.80 mmol), sodium iodide (0.720, 4.80 mmol) and K2CO3 (0.885 
g, 6.40 mmol) in acetone (16 mL) was heated at 55 °C for 12 h. The reaction was cooled 
to room temperature and partitioned between Et2O (30 mL) and H2O (15 mL). The layers 
were separated, and the aqueous phase was extracted with Et2O (3 x 20 mL). The 
combined organic extracts were washed with brine (50 mL), dried (MgSO4), and 
concentrated under reduced pressure. The resulting crude product was purified by column 
chromatography eluting with hexanes/EtOAc (1.5:1) on SiO2 (100 mL) to provide 0.300 
g (30%) of the title compound as a colorless oil: 1H NMR (400 MHz, CDCl3) δ 5.30 (s, 1 
H), 3.71 (s, 3 H), 3.02 (d, J = 15.1 Hz, 1 H), 2.76 (d, J = 15.1 Hz, 1 H), 2.62-2.55 (m, 1 
H), 2.32-2.17 (comp, 2 H), 2.12-2.04 (m, 1 H), 1.88-1.77 (m, 1 H), 1.63 (s, 6 H), 1.03 (d, 
J = 6.8 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ213.6, 169.7, 167.3, 160.5, 106.7, 96.3, 
61.7, 52.4, 38.9, 38.1, 34.9, 27.9, 25.4, 24.6, 15.4; IR (NaCl, film) 3100, 2959, 1729, 
1633, 1461, 1433, 1391, 1273, 1273, 1230, 1170, 1122, 1013 cm-1;  HRMS (ESI) m/z 
319.1162 [C15H20O6 (M+Na) requires 319.1152]. 
NMR Assignments: 1H NMR (400 MHz, CDCl3) δ 5.30 (s, 1 H, C8-H), 3.71 (s, 




















2.55 (m, 1 H, C2-Ha), 2.32-2.17 (comp, 2 H, C2-Hb and C4-H), 2.12-2.04 (m, 1 H, C3-
Ha), 1.88-1.77 (m, 1 H, C3-Hb), 1.63 (s, 6 H, C11-H and C12-H), 1.03 (d, J = 6.8 Hz, 3 
H, C15-H); 13C NMR (100 MHz, CDCl3) δ213.6 (C1), 169.7, 167.3, 160.5, 106.7, 96.3, 






(6.116). (JCH-VI-175) A solution of 6.47 (0.953 g, 3.20 mmol), DMAP (0.186 g, 1.52 
mmol), and 2-chloro-2-propenol (2.89 g, 24.4 mmol) in cyclohexane (8 mL) was with 
continuous removal of solvent (vigreux column with Claisen head) until methanol and 
cyclohexane were no longer condensing in the collection vessel. After removal of 
methanol and some cyclohexane, the temperature was raised to 105 °C and the 
cyclohexane and most of the alcohol was removed by distillation. The crude product was 
purified by column chromatography, eluting with hexanes/EtOAc (12:1) on SiO2 (150 
mL) to provide 1.20 g (81%) of 6.116 as a pale yellow oil: 1H NMR (400 MHz, CDCl3) δ 
4.19 (t, J = 8.4 Hz, 2 H), 2.68 (d, J = 11.2 Hz, 1 H), 2.61-2.51 (m, 1 H), 2.41-2.22 (m, 2 
H), 2.19-2.11 (m, 1 H), 1.49-1.38 (m, 1 H), 1.15-1.14 (m, 3 H), 1.01-0.96 (m, 2 H), -0.01 



















14.1, -1.6; IR (NaCl, film) 2956, 2900, 1754, 1728, 1458, 1407, 1381, 1331, 1293, 1250, 
1129, 1153 cm-1; HRMS (ESI) m/z 265.1234 [C12H22O3Si (M+Na) requires 254.1230]. 
NMR Assignments: 1H NMR (400 MHz, CDCl3) δ 4.19 (t, J = 8.4 Hz, 2 H, C7-
H), 2.68 (d, J = 11.2 Hz, 1 H, C5-H), 2.61-2.51 (m, 1 H, C4-H), 2.41-2.22 (m, 2 H, C2-
H), 2.19-2.11 (m, 1 H, C3-Ha), 1.49-1.38 (m, 1 H, C3-Hb), 1.15-1.14 (m, 3 H, C12-H), 
1.01-0.96 (m, 2 H, C8-H), -0.01 (bs, 9 H, C8-H, C9-H, and C10-H); 13C NMR (100 MHz, 
CDCl3) δ 211.9 (C1), 169.3 (C6), 63.6 (C7), 38.7 (C5), 36.4 (C4), 29.3 (C2), 19.2 (C3), 






oxocyclopentane-1-carboxylate (6.110). (JCH-VI-176) A suspension of 6.116 (1.00 g, 
4.13 mmol), ethyl bromoacetate (1.03 g, 6.20 mmol), and K2CO3 (1.14 g, 8.26 mmol) in 
acetone (20 mL) was heated at 55 °C for 12 h. The reaction was cooled to room 
temperature and partitioned between Et2O (40 mL) and H2O (20 mL). The layers were 
separated, and the aqueous phase was extracted with Et2O (3 x 20 mL). The combined 

























reduced pressure. The resulting crude product was purified by column chromatography 
eluting with hexanes/EtOAc (20:1) on SiO2 (100 mL) to provide 0.544 g (40%) of 6.110 
as a pale yellow oil: 1H NMR (400 MHz, CDCl3) δ 4.16-4.03 (comp, 4 H), 3.07 (d, J = 
17.8 Hz, 1 H), 2.78 (d, J = 17.8 Hz, 1 H), 2.61-2.45 (m, 3 H), 2.12-2.04 (m, 1 H), 1.88-
1.77 (m, 1 H), 1.21 (t, J = 7.2 Hz, 3 H), 1.01 (d, J = 6.9 Hz, 3H), 0.98-0.93 (m, 2 H), 0.0 
(s, 9 H); 13C NMR (100 MHz, CDCl3) δ  215.5, 169.8, 167.2, 63.7, 62.3, 60.7, 39.1, 38.1, 
35.9, 28.2, 25.9, 17.5, 15.4, 14.1, 13.9, -1.7; IR (NaCl, film)  cm-1; HRMS (ESI) m/z 
351.1600 [C16H28O5Si (M+Na) requires 351.1598].  
NMR Assignments: 1H NMR (400 MHz, CDCl3) δ 4.16-4.03 (comp, 4 H, C8-H 
and C11-H), 3.07 (d, J = 17.8 Hz, 1 H, C6-Ha), 2.78 (d, J = 17.8 Hz, 1 H, C6-Hb), 2.61-
2.45 (m, 3 H, C2-H and C4-H), 2.12-2.04 (m, 1 H, C3-Ha), 1.88-1.77 (m, 1 H, C3-Hb), 
1.21 (t, J = 7.2 Hz, 3 H, C9-H), 1.01 (d, J = 6.9 Hz, 3H, C16-H), 0.98-0.93 (m, 2 H, C12-
H), 0.0 (s, 9 H, C13-H, C14-H, and C15-H); 13C NMR (100 MHz, CDCl3) δ 215.5 (C1), 
169.8 (C7), 167.2 (C10), 63.7 (C5), 39.1 (C8), 38.1 (C11), 35.9 (C7), 28.2 (C2), 25.9 










(JCH-VI-184) Methylmagnesium bromide (3 mL, 3 M) and copper iodide (0.914 g, 4.8 
mmol) in Et2O (12 mL) was stirred at 0 °C for 30 min. The reaction was cooled to –78 
°C, whereupon a solution of epoxide 6.123397 (1.00 g, 3.00 mmol) in Et2O (4 mL) was 
added dropwise. The reaction was warmed to 0 °C and stirring continued for 3 h. 
Saturated NH4Cl (5 mL) was added, and the cooling bath was removed.  Upon reaching 
room temperature, the septum was removed, and the solution was stirred until a 
homogeneous blue solution was obtained.  . The layers were separated and the aqueous 
layer was extracted with Et2O (3 x 5 mL). The combined organic layers were dried 
(MgSO4) and concentrated under reduced pressure. The crude product was purified via 
column chromatography eluting with hexanes/EtOAc (20:1) on SiO2 (100 mL) to provide 
0.645 g (65%) of 6.124 as a colorless oil: 1H NMR (400 MHz, CDCl3) δ 4.37 (ddd, J = 
6.5, 4.8, 1.9 Hz, 1 H), 4.02 (dd, J = 5.6, 3.0 Hz, 2 H), 3.64 (dd, J = 9.9, 6.0 Hz, 1 H), 3.47 
(dd, J = 9.9, 6.9 Hz, 1 H), 3.17-3.11 (m, 1 H), 2.72 (d, J = 4.7 Hz, 1 H), 0.91 (s, 9 H), 
0.89 (s, 10 H), 0.87 (d, J = 8.1 Hz, 3 H), 0.10 (s, 3 H), 0.09 (s, 3 H), 0.08 (s, 3 H), 0.07 (s, 





















14.1, -5.3, -5.4, -5.5; IR (NaCl, film) 3393, 2954, 2930, 2885, 2858, 1471, 1256, 1102, 
1102 cm-1; HRMS (ESI) m/z 371.2412 [C17H40O3Si2 (M+Na) requires 371.2408]. 
NMR Assignments: 1H NMR (400 MHz, CDCl3) δ 4.37 (ddd, J = 6.5, 4.8, 1.9 
Hz, 1 H), 4.02 (dd, J = 5.6, 3.0 Hz, 2 H), 3.64 (dd, J = 9.9, 6.0 Hz, 1 H), 3.47 (dd, J = 9.9, 
6.9 Hz, 1 H), 3.17-3.11 (m, 1 H), 2.72 (d, J = 4.7 Hz, 1 H), 0.91 (s, 9 H), 0.89 (s, 10 H), 
0.87 (d, J = 8.1 Hz, 3 H), 0.10 (s, 3 H), 0.09 (s, 3 H), 0.08 (s, 3 H), 0.07 (s, 3 H); 13C 









(JCH-VI-185). Dess-Martin periodinane (0.584 g, 1.38 mmol) and 6.124 (0.400 g, 1.15 
mmol) in CH2Cl2 (25 mL) was stirred 15 h. The reaction was concentrated under reduced 
pressure and purified via column chromatography, eluting with hexanes/Et2O (15:1) on 
SiO2 (40 mL) to provide 0.380 g (90%) of 6.125 as a colorless oil: 1H (400 MHz, CDCl3) 
δ 4.80 (dd, J = 5.6, 8.9 Hz, 1 H), 4.48 (d, J = 17.6 Hz, 1 H), 4.27 (d, J = 18.6 Hz, 1 H), 
4.06 (dd, J = 9.1, 10.4 Hz, 1 H), 3.83 (dd, J = 5.6, 10.4 Hz, 1 H), 0.95 (d, J = 6.9 Hz, 3 
H), 0.92 (s, 9 H), 0.85 (s, 9 H), 0.11 (s, 3 H), 0.09 (s, 3 H), 0.06 (s, 3 H), 0.04 (s, 3 H); 
13C NMR (400 MHz, CDCl3) δ 204.3, 66.7, 64.4, 34.6, 34.5, 31.5, 25.7, 25.6, 22.6, 14.1, 
-5.42, -5.44, -5.5, -5.6; IR (NaCl, film) 2929, 1748, 1732, 1716, 1698, 11683, 1656, 
1638, 1540, 1456 cm-1; HRMS (ESI) m/z 369.2249 [C17H38O3Si2 (M+Na) requires 
369.2252]. 
NMR Assignments: 1H (400 MHz, CDCl3) δ 4.80 (dd, J = 5.6, 8.9 Hz, 1 H, C2-
H), 4.48 (d, J = 18.0 Hz, 1 H, C4-Ha), 4.27 (d, J = 18.0 Hz, 1 H, C4-Hb), 4.06 (dd, J = 
9.1, 10.4 Hz, 1 H, C1-Ha), 3.83 (dd, J = 5.6, 10.4 Hz, 1 H, C1-Hb), 0.95 (d, J = 6.9 Hz, 3 
H, C5-H), 0.92 (s, 9 H, C8-H, C9-H, and C10-H or C13-H, C14-H, and C15-H), 0.85 (s, 
9 H, C8-H, C9-H, and C10-H or C13-H, C14-H, and C15-H), 0.11 (s, 3 H, C6-H, C7-H, 





















H, C11-H, or C12-H), 0.04 (s, 3 H, C6-H, C7-H, C11-H, or C12-H); 13C NMR (400 
MHz, CDCl3) δ 204.3 (C3), 66.7 (C4), 64.4 (C1), 34.6, 34.5, 31.5, 25.7 (C8, C9, and C10 
or C11, C12, and C13), 25.6 (C8, C9, and C10 or C11, C12, and C13), 22.6, 14.1 (C5), -
5.42 (C6, C7, C8, or C9)  , -5.44 (C6, C7, C8, or C9)  , -5.5 (C6, C7, C8, or C9)  , -5.6 






7.3 CRYSTALLOGRAPHIC DATA 
Figure 7.2 Crystal structure of 2.61 showing the atom labeling scheme.  
Displacement ellipsoids are scaled to the 50% probability level. 
 
X-ray Experimental for C19H34O4:  Crystals grew as large, colorless laths by 
vapor diffusion of hexanes into an ethyl acetate solution containing the target molecule.  
The data crystal was cut from a larger crystal and had approximate dimensions; 0.61 x 




Mercury CCD using a graphite monochromator with MoKa radiation (l = 0.71075Å). A 
total of 1440 frames of data were collected using w-scans with a scan range of 0.5° and a 
counting time of 20 seconds per frame. The data were collected at 153 K using a Rigaku 
XStream low temperature device. Details of crystal data, data collection and structure 
refinement are listed in Table 1. Data reduction were performed using the Rigaku 
Americas Corporation’s Crystal Clear version 1.40.398 The structure was solved by direct 
methods using SIR97399 and refined by full-matrix least-squares on F2 with anisotropic 
displacement parameters for the non-H atoms using SHELXL-97.400 Structure analysis 
was aided by use of the programs PLATON98401 and WinGX.402 The hydrogen atoms on 
carbon were calculated in ideal positions with isotropic displacement parameters set to 
1.2xUeq of the attached atom (1.5xUeq for methyl hydrogen atoms). The hydrogen atom 
on O3 was observed in a ∆F map and refined with an isotropic displacement parameter.  
The absolute configuration was determined by internal comparison to the known 
configuration of the starting material. The function, Σw(|Fo|2 - |Fc|2)2, was minimized, 
where w = 1/[(s(Fo))2 + (0.0562*P)2 + (0.0427*P)] and P = (|Fo|2 + 2|Fc|2)/3.  Rw(F2) 
refined to 0.0836, with R(F) equal to 0.0296 and a goodness of fit, S, = 1.02. Definitions 
used for calculating R(F), Rw(F2) and the goodness of fit, S, are given below.403 The data 
were checked for secondary extinction effects but no correction was necessary. Neutral 
atom scattering factors and values used to calculate the linear absorption coefficient are 
from the International Tables for X-ray Crystallography (1992).404 All figures were 
generated using SHELXTL/PC.405 Tables of positional and thermal parameters, bond 





Table 7.1 Crystal data and structure refinement for 2.61. 
Empirical formula    C19 H34 O4 
Formula weight    326.46 
Temperature     153(2) K 
Wavelength     0.71075 Å 
Crystal system    Triclinic 
Space group     P1 
Unit cell dimensions   a = 5.491(2) Å  α= 98.701(8)°. 
     b = 5.543(2) Å β= 95.642(9)°. 
     c = 16.171(6) Å γ = 90.291(8)°. 
Volume    484.1(3) Å3 
Z     1 
Density (calculated)   1.120 Mg/m3 
Absorption coefficient  0.076 mm-1 
F(000)     180 
Crystal size    0.61 x 0.33 x 0.15 mm 
Theta range for data collection 3.72 to 27.49°. 
Index ranges    -7<=h<=7, -7<=k<=7, -20<=l<=20 
Reflections collected   6769 
Independent reflections  2196 [R(int) = 0.0267] 
Completeness to theta = 27.49° 99.4 %  
Absorption correction   Semi-empirical from equivalents 




Refinement method   Full-matrix least-squares on F2 
Data / restraints / parameters  2196 / 3 / 214 
Goodness-of-fit on F2   1.017 
Final R indices [I>2sigma(I)]  R1 = 0.0296, wR2 = 0.0832 
R indices (all data)   R1 = 0.0300, wR2 = 0.0836 
Absolute structure parameter  n/a 






Table 7.2 Atomic coordinates (x 104) and equivalent isotropic displacement parameters 
(Å2x103) for 2.61.  
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
_______________________________________________________________________ 
       x      y      z  U(eq) 
_______________________________________________________________________  
C1  1752(2) 3631(2) 5640(1) 20(1) 
C2  -266(2) 3928(2) 6241(1) 19(1) 
C3  948(3)  3225(2) 7072(1) 20(1) 
C4  3159(3) 1832(2) 6785(1) 23(1) 
C5  -1353(2) 6441(2) 6327(1) 22(1) 
C6  1762(3) 5306(3) 7785(1) 27(1) 
C7  827(3)  2497(3) 4753(1) 28(1) 
C8  2777(3) 2066(3) 4137(1) 32(1) 
C9  4021(3) 4366(3) 3950(1) 28(1) 
C10  5518(3) 3787(3) 3195(1) 29(1) 
C11  6941(3) 5955(3) 2993(1) 30(1) 
C12  8368(3) 5263(3) 2230(1) 31(1) 
C13  9864(3) 7356(3) 2014(1) 31(1) 
C14  11240(3) 6641(3) 1240(1) 31(1) 
C15  12776(3) 8719(3) 1030(1) 32(1) 
C16  14152(3) 8013(3) 257(1)  32(1) 
C17  15703(3) 10087(3) 49(1)  34(1) 




C19  18703(4) 11407(4) -906(1) 45(1) 
O1  3520(2) 2001(2) 5995(1) 24(1) 
O2  -678(2) 8086(2) 5993(1) 38(1) 
O3  -3165(2) 6604(2) 6811(1) 34(1) 






Table 7.3 Bond lengths [Å] and angles [°] for 2.61. 
C1-O1  1.4643(16) 
C1-C7  1.5147(19) 
C1-C2  1.5375(18) 
C1-H1  1.00 
C2-C5  1.5107(18) 
C2-C3  1.5446(18) 
C2-H2  1.00 
C3-C4  1.5159(19) 
C3-C6  1.5328(19) 
C3-H3  1.00 
C4-O4  1.2162(18) 
C4-O1  1.3288(17) 
C5-O2  1.2017(18) 
C5-O3  1.3210(18) 
C6-H6A  0.98 
C6-H6B  0.98 
C6-H6C  0.98 
C7-C8  1.528(2) 
C7-H7A  0.99 
C7-H7B  0.99 
C8-C9  1.526(2) 
C8-H8A  0.99 
C8-H8B  0.99 
C9-C10  1.534(2) 
C9-H9A  0.99 
C9-H9B  0.99 
C10-C11  1.524(2) 
C10-H10A  0.99 
C10-H10B  0.99 
C11-C12  1.528(2) 
C11-H11A  0.99 
C11-H11B  0.99 
C12-C13  1.520(2) 
C12-H12A  0.99 
C12-H12B  0.99 
C13-C14  1.527(2) 
C13-H13A  0.99 
C13-H13B  0.99 
C14-C15  1.523(2) 
C14-H14A  0.99 
C14-H14B  0.99 
C15-C16  1.525(2) 
C15-H15A  0.99 




C16-C17   1.525(2) 
C16-H16A   0.99 
C16-H16B   0.99 
C17-C18   1.524(2) 
C17-H17A   0.99 
C17-H17B   0.99 
C18-C19   1.515(2) 
C18-H18A   0.99 
C18-H18B   0.99 
C19-H19A   0.98 
C19-H19B   0.98 
C19-H19C   0.98 
O3-H3O   0.83(3)  
O1-C1-C7  109.02(11) 
O1-C1-C2  105.08(10) 
C7-C1-C2  113.23(11) 
O1-C1-H1  109.8 
C7-C1-H1  109.8 
C2-C1-H1  109.8 
C5-C2-C1  112.73(10) 
C5-C2-C3  114.46(11) 
C1-C2-C3  104.79(11) 
C5-C2-H2  108.2 
C1-C2-H2  108.2 
C3-C2-H2  108.2 
C4-C3-C6  109.91(12) 
C4-C3-C2  102.10(10) 
C6-C3-C2  117.51(11) 
C4-C3-H3  109.0 
C6-C3-H3  109.0 
C2-C3-H3  109.0 
O4-C4-O1  121.64(13) 
O4-C4-C3  125.53(13) 
O1-C4-C3  112.82(12) 
O2-C5-O3  123.95(13) 
O2-C5-C2  124.66(13) 
O3-C5-C2  111.39(11) 
C3-C6-H6A  109.5 
C3-C6-H6B  109.5 
H6A-C6-H6B  109.5 
C3-C6-H6C  109.5 
H6A-C6-H6C  109.5 
H6B-C6-H6C  109.5 
C1-C7-C8  115.41(13) 
C1-C7-H7A  108.4 




C1-C7-H7B  108.4 
C8-C7-H7B  108.4 
H7A-C7-H7B  107.5 
C9-C8-C7  115.41(13) 
C9-C8-H8A  108.4 
C7-C8-H8A  108.4 
C9-C8-H8B  108.4 
C7-C8-H8B  108.4 
H8A-C8-H8B  107.5 
C8-C9-C10  111.12(12) 
C8-C9-H9A  109.4 
C10-C9-H9A  109.4 
C8-C9-H9B  109.4 
C10-C9-H9B  109.4 
H9A-C9-H9B  108.0 




C9-C10-H10B  108.6 
H10A-C10-H10B 107.6 

























































C4-O1-C1  110.94(10) 






Table 7.4 Anisotropic displacement parameters (Å2x103) for 2.61 
The anisotropic displacement factor exponent takes the form: -2p2[ h2 a*2U11 + 
...  + 2 h k a* b* U12 ] 
_______________________________________________________________________ 
  U11 U22  U33 U23 U13 U12 
_______________________________________________________________________ 
C1  20(1)  19(1) 23(1)  6(1) 5(1)  2(1) 
C2  20(1)  15(1) 23(1)  5(1) 5(1)  2(1) 
C3  24(1)  17(1) 22(1)  6(1) 6(1)  6(1) 
C4  25(1)  18(1) 26(1)  1(1) 4(1)  5(1) 
C5  19(1)  17(1) 28(1)  4(1) 2(1)  3(1) 
C6  32(1)  26(1) 24(1)  0(1) 6(1)  7(1) 
C7  30(1)  32(1) 23(1)  3(1) 4(1)  -5(1) 
C8  41(1)  31(1) 23(1)  0(1) 11(1)  -3(1) 
C9  32(1)  31(1) 22(1)  3(1) 7(1)  0(1) 
C10  34(1)  34(1) 20(1)  3(1) 7(1)  -1(1) 
C11  33(1)  33(1) 24(1)  4(1) 9(1)  0(1) 
C12  35(1)  34(1) 24(1)  3(1) 10(1)  -2(1) 
C13  35(1)  34(1) 26(1)  2(1) 10(1)  -2(1) 
C14  36(1)  33(1) 25(1)  2(1) 10(1)  -4(1) 
C15  35(1)  33(1) 28(1)  3(1) 10(1)  -4(1) 
C16  37(1)  34(1) 26(1)  3(1) 9(1)  -4(1) 




C18  47(1)  42(1) 27(1)  5(1) 10(1)  -10(1) 
C19  52(1)  47(1) 40(1)  12(1) 15(1)  -9(1) 
O1  23(1)  24(1) 26(1)  4(1) 7(1)  8(1) 
O2  47(1)  21(1) 53(1)  16(1) 20(1)  8(1) 
O3  32(1)  20(1) 55(1)  10(1) 20(1)  12(1) 





Table 7.5 Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x103) 
for 2.61. 
_______________________________________________________________________ 
  x   y   z   U(eq) 
_______________________________________________________________________ 
  
H1  2553  5251  5633  24 
H2  -1604  2707  6014  23 
H3  -177  2087  7284  24 
H6A  2829  4663  8219  41 
H6B  320  6027  8030  41 
H6C  2657  6557  7562  41 
H7A  -430  3569  4529  34 
H7B  16  912  4775  34 
H8A  4050  1020  4366  38 
H8B  2009  1152  3600  38 
H9A  5112  5096  4450  34 
H9B  2763  5574  3831  34 
H10A  6688  2492  3305  35 
H10B  4393  3127  2694  35 
H11A  8095  6607  3486  35 
H11B  5785  7261  2882  35 
H12A  9484  3923  2338  37 




H13A  11058  7963  2501  37 
H13B  8756  8709  1914  37 
H14A  12325  5268  1336  37 
H14B  10042  6060  751  37 
H15A  13975  9299  1518  38 
H15B  11691  10093  934  38 
H16A  15229  6632  351  38 
H16B  12953  7442  -233  38 
H17A  14618  11441  -69  41 
H17B  16857  10704  546  41 
H18A  18238  7986  -586  46 
H18B  16003  8733  -1201  46 
H19A  17635  12702  -1069  67 
H19B  19662  10791  -1370  67 
H19C  19811  12062  -409  67 







Table 7.6 Torsion angles [°] for 2.61. 
  O1-C1-C2-C5      145.72(11) 
C7-C1-C2-C5      -95.39(14) 
O1-C1-C2-C3      20.63(12) 
C7-C1-C2-C3      139.52(12) 
C5-C2-C3-C4      -142.04(11) 
C1-C2-C3-C4      -18.04(12) 
C5-C2-C3-C6      -21.76(16) 
C1-C2-C3-C6      102.24(13) 
C6-C3-C4-O4      63.28(18) 
C2-C3-C4-O4      -171.27(13) 
C6-C3-C4-O1      -115.80(13) 
C2-C3-C4-O1      9.66(15) 
C1-C2-C5-O2      -2.7(2) 
C3-C2-C5-O2      116.90(17) 
C1-C2-C5-O3      176.74(12) 
C3-C2-C5-O3      -63.62(15) 
O1-C1-C7-C8      -61.11(16) 
C2-C1-C7-C8      -177.69(12) 
C1-C7-C8-C9      -64.70(19) 
C7-C8-C9-C10     -167.78(13) 
C8-C9-C10-C11     -176.76(13) 




C10-C11-C12-C13     -178.76(13) 
C11-C12-C13-C14     -178.95(14) 
C12-C13-C14-C15     -179.02(14) 
C13-C14-C15-C16     -179.95(13) 
C14-C15-C16-C17     -179.64(14) 
C15-C16-C17-C18     177.63(15) 
C16-C17-C18-C19     -179.78(16) 
O4-C4-O1-C1      -175.49(13) 
C3-C4-O1-C1      3.63(15) 
C7-C1-O1-C4      -137.17(12) 





Table 7.7 Hydrogen bonds for 2.61 [Å and °] 
_______________________________________________________________________ 
D-H...A  d(D-H) d(H...A) d(D...A) <(DHA) 
_______________________________________________________________________  
 O3-H3O...O4#1 0.83(3)  1.82(3)  2.6270(18) 163(2) 
_______________________________________________________________________ 
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